ELENCO CONTRIBUTI INVIATI


ID Autore Titolo
1 Abbracchio MP. GPR17-expressing oligodendrocyte... Visualizza
2 Abbracchio MP. Multiple sclerosis and depressio... Visualizza
3 Abdo S. Effects of ethanolic extracts of... Visualizza
4 Abete L. Effects of the metronomic treatm... Visualizza
5 Abete L. Antiviral and antioxidant activi... Visualizza
3680 Abete L. _-Caryophyllene oxide as a new c... Visualizza
3681 Accarino G. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
6 Accattatis F. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
7 Accattatis F. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
8 Achatz-straussberger G. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
9 Acquaviva T. POTENTIAL MECHANISMS LINKING DEF... Visualizza
10 Adamo A. Proatherosclerotic effect of tri... Visualizza
11 Adamo EB. Cadmium and its role in brain dy... Visualizza
12 Adamo F. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3682 Adamo F. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3683 Adamo V. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
13 Addis A. RISK OF MORTALITY BETWEEN BIOSIM... Visualizza
14 Addis A. Real world data about biosimilar... Visualizza
3684 Addis A. The high price of anticancer dru... Visualizza
15 Adesso S. Intestine as a Source of Inflamm... Visualizza
16 Adesso S. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
3685 Adorisio S. Artocarpus tonkinensis, a Vietna... Visualizza
17 Adorni MP. Vitamin D replacement in pre-men... Visualizza
3686 Agabiti N. Real-world evidence on the risk ... Visualizza
3687 Agapito G. Identification and validation of... Visualizza
3688 Agnati L.F. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
18 Agnelli FA. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
19 Agosti F. Hedonic eating in Prader-Willi s... Visualizza
20 Agostinis P. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
21 Aguilar M.A. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
22 Aiello A. Access to the market of medicine... Visualizza
23 Aiello E. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
24 Airoldi C. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
3689 Aitta-aho T. Dopamine D3 receptor-dependent c... Visualizza
25 Alberti S. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
26 Albertini B. Development of microparticles fo... Visualizza
3690 Albini E. REINSTALLING IMMUNE REGULATORY T... Visualizza
27 Alboni S. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
3581 Alboni S. Fluoxetine counteracts the oppos... Visualizza
31 Aliquò F. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
32 Aliquò G. EVALUATION OF HEALTH DIRECT COST... Visualizza
33 Aliquò G. Intravitreal anti-VEGF injection... Visualizza
34 Aliquo' G. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3691 Allardyce C. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
35 Allegri L. Tacrolimus Therapeutic Drug Moni... Visualizza
36 Alllegra A. Curcumin Ameliorates the In Vitr... Visualizza
37 Altamura C. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
38 Altamura C. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
39 Altavilla D. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
40 Altavilla D. Activation of the EPOR-b common ... Visualizza
41 Altavilla D. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
42 Altavilla D. MODELING ROS1 TRANSLOCATION IN L... Visualizza
43 Altavilla D. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
44 Altavilla D. Cadmium and its role in brain dy... Visualizza
45 Altavilla D. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
46 Altavilla D. Survivin and NAIP in Human Benig... Visualizza
3692 Altavilla D. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
3693 Altavilla D. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
3694 Altavilla D. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
3695 Altavilla D. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
3696 Altomare E. Identification and validation of... Visualizza
3515 Alvarado P. Experience of risk communication... Visualizza
3572 Alvaro D. Obeticholic acid in primary bili... Visualizza
47 Amadio M. MODULATION OF OXIDATIVE AND INFL... Visualizza
48 Amadio P. Environmental Chronic Stress Ind... Visualizza
49 Amato M. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
50 Amato M. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
51 Ambra AA. INVESTIGATION OF A PUTATIVE NICO... Visualizza
52 Ambrosi A. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
53 Ambrosiani L. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
54 Ambrosino P. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
55 Ambrosino P. Compound heterozygosis in the kc... Visualizza
56 Amisano G. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
57 Ammazzalorso A. CM554, A NEW POTENT AND SELECTIV... Visualizza
58 Amodeo G. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
59 Amodeo G. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
60 Amodio N. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
61 Amoroso C. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
62 Amoroso R. CM554, A NEW POTENT AND SELECTIV... Visualizza
63 Amoroso S. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
3697 Amoroso S. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
3698 Amoroso S. Calcium and ATP-Dependent Potent... Visualizza
3699 Andersen M. Effect of Chronic Kidney Disease... Visualizza
3700 Andersen M. Un-Suggested Prescriptions of No... Visualizza
64 Anderson DA. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
65 Andrea A. Targeting nicotinamide phosphory... Visualizza
66 Andriani L. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
67 Anfuso CD. Sulodexide prevents high glucose... Visualizza
68 Angela L. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
69 Angela L. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
70 Angelelli M. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
71 Angelelli M. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
72 Angelici L. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
73 Angelinetta C. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
74 Angelini J. The importance of Integrated Car... Visualizza
75 Angelini J. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
3701 Angelini J. Insulin analogue glargine 300 U/... Visualizza
76 Angelini JA. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
77 Angelini S. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
78 Angelini S. DNA METHYLATION: GENE PROFILING ... Visualizza
79 Angelini S. TARGETING THE CANCER RESISTOME T... Visualizza
3499 Angelini S. microRNA (miRNA) deregulation as... Visualizza
80 Angius A. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
3569 Annicchiarico G. The role of regional coordinatio... Visualizza
82 Anniciello AM. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
83 Annovazzi L. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
84 Annunziata C. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
85 Annunziata C. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
3702 Annunziata C. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
86 Annunziato L. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1895 annunziato L. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
87 Antinori A. Pharmacokinetics of darunavir/co... Visualizza
88 Antognoni F. Effects of ethanolic extracts of... Visualizza
89 Antonazzo IC. Occurrence of Liver Injury with ... Visualizza
90 Antoniazzi S. On the possible relationship bet... Visualizza
91 Antonioli L. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
92 Antonioli L. Enteric glia is involved in colo... Visualizza
93 Antonioli L. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
94 Antonioli L. Bifidobacterium Longum and Lacto... Visualizza
95 Antonioli L. Alteration of visceral sensitivi... Visualizza
3622 Antonioli L. Obesity and related enteric neur... Visualizza
3703 Antonioli L. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
96 Antoniotti C. Colon cancer therapy beyond tumo... Visualizza
3705 Antonucci F. ATM INHIBITION AS INNOVATIVE STR... Visualizza
97 Apicella C. In vitro and in vivo antibacteri... Visualizza
98 Appendino G. The antimigraine butterbur ingre... Visualizza
99 Aprea G. TRPM8 and experimental colorecta... Visualizza
100 Aquino RP. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
101 Aragno M. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
102 Aragno M. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
103 Aragno M. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3706 Aragno M. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
104 Aragones G. Proatherosclerotic effect of tri... Visualizza
105 Arancio O. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
106 Arancio O. cGMP MODULATES LONG-TERM POTENTI... Visualizza
3707 Arbitrio M. Identification and validation of... Visualizza
107 Arcadu F. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
3632 Arcangeli A. hERG1 Channels: from antitargets... Visualizza
108 Arcoraci V. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
109 Arcoraci V. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
110 Arcoraci V. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
3673 Arcoraci V. Antiosteoporotic drugs use reduc... Visualizza
3708 Arcoraci V. Facilitation Of Reporting in hos... Visualizza
3709 Arcoraci V. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
111 Ardau R. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
3710 Argenziano M. Megalin and Sodium-Hydrogen Exch... Visualizza
112 Ariaudo A. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3711 Ariaudo A. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
3712 Aringhieri S. Clozapine as the most efficaciou... Visualizza
113 Armando AA. Targeting nicotinamide phosphory... Visualizza
3713 Armando M. A precision medicine genetic mar... Visualizza
114 Armogida C. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
115 Armogida C. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
116 Armogida C. Modulation of the inflammatory r... Visualizza
3714 Armogida CA. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
117 Arnaboldi L. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
118 Arnaboldi L. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
119 Arnaboldi L. UNRAVELING THE MECHANISM OF ACTI... Visualizza
120 Arnaboldi L. Recombinant LCAT rescues defecti... Visualizza
3715 Aroni S. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
3716 Arrigo T. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
121 Arrigoni E. The ABCB1 pharmacogenetics of R-... Visualizza
122 Artudi F. MONITORING SAFETY AND USE OF OLD... Visualizza
123 Arturi F. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
124 Arzenton E. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
3717 Arzenton E. WEB-BASED REPORTING OF ADVERSE D... Visualizza
3450 Ascierto. P. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
3718 Asteriti E. In vitro effects of mediators de... Visualizza
3719 Asth L. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
3674 Atteritano M. Antisclerostin Antibody... Visualizza
125 Auricchio F. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
126 Autore G. Intestine as a Source of Inflamm... Visualizza
127 Autore G. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
128 Avagliano C. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
129 Avagliano C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
130 Avola R. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
131 Awada K. Studying the mechanism of rat ad... Visualizza
132 Awada K. Development of an in vitro model... Visualizza
133 Awada K. Alteration of visceral sensitivi... Visualizza
134 Awada K. A PRECLINICAL SET UP OF A RAT MO... Visualizza
135 Awada K. Into the unexplored pathophysiol... Visualizza
3720 Awada K. Brassicaceae as source of H2S-re... Visualizza
136 Azari EK. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
137 B S. Healthcare resources use in pati... Visualizza
138 B S. Burden of comorbidities in HCV p... Visualizza
139 Bagadia P. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
140 Baggiani G. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
141 Bagini L. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
142 Baiula M. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
143 Baiula M. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
144 Balbi M. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
145 Balbi M. cGMP MODULATES LONG-TERM POTENTI... Visualizza
146 Balbi M. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
147 Balboni G. Involvement of the Prokineticin ... Visualizza
148 Baldan F. Tacrolimus Therapeutic Drug Moni... Visualizza
149 Baldan V. Phytochemical Investigation and ... Visualizza
150 Baldan V. HPLC-MS Analysis of Glucosinolat... Visualizza
151 Baldassarre D. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
152 Baldassarre D. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
153 Baldassarri S. Subcutaneous slow-release metfor... Visualizza
3533 Balducci C. Neuroinflammation and Alzheimer’... Visualizza
154 Balducci S. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
3721 Balduini W. THE SILENT INFORMATION REGULATOR... Visualizza
155 Balestra B. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
156 Ballabeni V. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
157 Ballabeni V. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
158 Ballabeni V. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
159 Ballantini F. REtrospective study on ItaliaN A... Visualizza
160 Ballerini P. Conditioned medium of human peri... Visualizza
161 Ballerini P. Targeting platelet purinergic si... Visualizza
3722 Balzarotti G. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
3723 Balzi D. Incidence of ticagrelor-related ... Visualizza
162 Baragetti A. Apolipoprotein E modulates adapt... Visualizza
163 Baraldo M. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
164 Baraldo M. Tacrolimus Therapeutic Drug Moni... Visualizza
165 Barbagallo A. NABILONE AND THC/CBD FOR THE TRE... Visualizza
166 Barbetta B. Characterization of adipokines s... Visualizza
167 Barbieri F. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
168 Barbieri F. PRION PROTEIN SIGNALLING CONTROL... Visualizza
169 Barbieri F. Subcutaneous slow-release metfor... Visualizza
170 Barbieri M. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
1905 Barbieri M.A. Safety profile of antipsychotic ... Visualizza
171 Barbieri SS. Carbaprostacyclin prevents venou... Visualizza
172 Barbieri SS. Environmental Chronic Stress Ind... Visualizza
173 Barca E. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
174 Bardelli F. Utilization of biological drugs ... Visualizza
175 Barge A. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
176 Barocelli E. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
177 Barocelli E. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
178 Barocelli E. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
179 Barocelli E. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3724 Barocelli E. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
180 Baronchelli F. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
181 Barone E. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
3725 Barone-adesi F. The high price of anticancer dru... Visualizza
182 Barreca D. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
3726 Barresi M. Chronic treatment with fluoxetin... Visualizza
183 Bartolini C. Utilization of biological drugs ... Visualizza
184 Bartolini C. NSAIDs utilization in a large co... Visualizza
185 Bascì J. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
186 Bashllari R. Curcumin Potentiates Antitumor A... Visualizza
187 Bashllari R. In Vitro Protective Effects of C... Visualizza
3727 Bashllari R. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
3728 Basili S. Results from an e-learning cours... Visualizza
188 Basilico N. Cutaneous hypoxia: effect of oxy... Visualizza
189 Bassetti M. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
190 Bassi FD. Inhibition of SIRT1 Deacetylase ... Visualizza
191 Basta G. Prevention of diabetes in NOD mi... Visualizza
192 Bastioli G. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
193 Battaglia G. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
194 Battaglia L. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
195 Battista DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
196 Battista S. Proatherosclerotic effect of tri... Visualizza
197 Battistello E. A2B adenosine receptors stimulat... Visualizza
198 Baumann I. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3729 Baumann I. MICRORNA-574-5P MODULATES MICROS... Visualizza
1206 bazzan E. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
199 Bazzani LB. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
3730 Bazzu G. Real-time monitoring of MPTP-ind... Visualizza
3731 Bazzu G. Real-time detection of ethanol i... Visualizza
200 Bedini A. Morphine differently influences ... Visualizza
201 Bedini A. Identification of a novel, funct... Visualizza
3732 Beggiato S. Gestational cannabinoid exposure... Visualizza
202 Begni V. LONG-LASTING EFFECTS OF STRESS I... Visualizza
3733 Bejaoui M. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
203 Belardo C. Palmitoylethanolamide Reduces Ne... Visualizza
204 Belardo C. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
205 Belardo C. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
206 Belisario A. A multiple approach allowed unve... Visualizza
207 Bellani G. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
3734 Bellavista E. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
208 Belleudi V. RISK OF MORTALITY BETWEEN BIOSIM... Visualizza
209 Belleudi V. Real world data about biosimilar... Visualizza
3735 Bellia AB. Drug interactions with levothyro... Visualizza
210 Bellin A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
211 Bellini T. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
212 Bellocco E. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
213 Belluomini L. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
214 Belperio D. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
215 Belperio D. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3501 Beltrami A. P. Mechanotransduction in cardiovas... Visualizza
216 Belvedere R. Hypoxia regulates ANXA1 expressi... Visualizza
217 Belvedere R. Effects of Prisma® Skin dermal ... Visualizza
3736 Belvedere R. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
2025 benarese M. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
218 Benatti C. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
219 Benatti C. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
220 Bencivenni S. A2B adenosine receptors stimulat... Visualizza
221 Benemei S. The antimigraine butterbur ingre... Visualizza
222 Benemei SB. Aromatase inhibitor-evoked pain ... Visualizza
223 Benetti E. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
224 Benetti E. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
225 Beneventano M. THE CONTRIBUTION OF MICROGLIA TO... Visualizza
226 Benfante R. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
227 Benfante R. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3737 Benfante R. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
228 Benfatto G. Off-label drug use and safety of... Visualizza
229 Benfatto G. Off-label drug use at the Policl... Visualizza
230 Benfatto G. Ensure patients access to invest... Visualizza
231 Benfatto G. Off-label drug use at the Univer... Visualizza
232 Bennardo L. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
233 Bennardo L. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
234 Benvenuti F. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
235 Benvenuti L. Enteric glia is involved in colo... Visualizza
236 Benvenuti L. Bifidobacterium Longum and Lacto... Visualizza
237 Benvenuti L. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
238 Benvenuti L. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3738 Benvenuti L. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
239 Bereshchenko O. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
240 Bereshchenko O. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3739 Bereshchenko O. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
241 Bergamini BM. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
242 Bergamo A. TARGETING THE CANCER RESISTOME T... Visualizza
3740 Bergamo A. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
3741 Bernardi FF. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
243 Bernardi P. The Impact Of ALDH-2 Activity On... Visualizza
244 Bernardini C. Effects of ethanolic extracts of... Visualizza
3742 Bernardini C. In vitro effects of mediators de... Visualizza
245 Bernardini N. Enteric glia is involved in colo... Visualizza
246 Bernardini N. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
247 Bernardini N. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
248 Bernardini S. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
249 Bernini DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
250 Bernini F. Proatherosclerotic effect of tri... Visualizza
251 Bernini F. Vitamin D replacement in pre-men... Visualizza
252 Bernini SK. Characterization of adipokines s... Visualizza
253 Berretta M. Next generation sequencing for i... Visualizza
254 Berretta M. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3743 Berretta M. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
255 Berretta N. VULNERABILITY TO SEIZURES AND AS... Visualizza
256 Berrino L. Ranolazine attenuates adverse my... Visualizza
257 Berrino L. Effects of lung resident mesench... Visualizza
3744 Berrino L. Cardio-renal positive effects of... Visualizza
258 Berruti A. In vitro identification of molec... Visualizza
259 Berruti A. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
260 Berry SE. IN VITRO AND IN VIVO MODELING OF... Visualizza
261 Bertini M. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
262 Bertini M. ESTIMATING INCIDENCE RATES OF AD... Visualizza
263 Bertini M. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
3745 Bertini M. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
264 Berton V. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
265 Bertoni S. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
266 Bertoni S. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
267 Bettiol A. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
268 Bettiol A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
269 Bettiol A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
270 Bettiol A. Drug-utilization of new oral ant... Visualizza
271 Bettiol A. Pharmacoutilization of Antidiabe... Visualizza
272 Bettiol A. Adverse drug reactions in paedia... Visualizza
273 Bettiol A. Risk of bone fractures among use... Visualizza
3746 Bettiol A. Real-world evidence on the risk ... Visualizza
3747 Biagioli M. The bile acid receptor GPBAR1 re... Visualizza
3748 Bianchini EB. Drug interactions with levothyro... Visualizza
274 Bianco S. IMPORTANCE OF ADHERENCE TO TREAT... Visualizza
275 Bianco S. Pathological gambling new therap... Visualizza
276 Biasco E. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
277 Biasibetti E. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
278 Biasotta A. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
279 Bibic L. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
280 Bifari F. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
281 Bifari F. FATTY ACIDS RESTORE IN VITRO ANG... Visualizza
282 Bifari F. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
283 Bifari F. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
3749 Bifari F. Meninges are a reservoir for new... Visualizza
284 Bifulco G. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
285 Bifulco M. RIMONABANT KILLS COLON CANCER ST... Visualizza
286 Bigagli E. AN IN VITRO MODEL FOR SCREENING ... Visualizza
287 Bigagli E. Effects of electronic cigarette ... Visualizza
288 Bigagli E. Effects of NO and H2S releasing ... Visualizza
3750 Bigagli E. Nutraceutical properties of Arth... Visualizza
3751 Biggio F. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
3752 Biggio G. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
289 Bignucolo A. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
290 Bignucolo A. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3753 Bignucolo A. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
291 Bilancia R. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
292 Bilel S. Acute behavioral and molecular e... Visualizza
293 Binaschi A. Sestrin 3 as a regulator of pro-... Visualizza
294 Binello A. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
295 Bini S. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
296 Bini S. Hedonic eating in Prader-Willi s... Visualizza
297 Bini V. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3754 Biondi N. Nutraceutical properties of Arth... Visualizza
963 biondini D. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
298 Bisecco A. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
299 Bisignano C. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
300 Bisignano C. IN VITRO AND IN VIVO MODELING OF... Visualizza
301 Bitonto V. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
302 Bitonto V. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
303 Bitto A. MODELING ROS1 TRANSLOCATION IN L... Visualizza
304 Bitto A. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
305 Bitto A. Activation of the EPOR-b common ... Visualizza
306 Bitto A. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
307 Bitto A. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
308 Bitto A. Cadmium and its role in brain dy... Visualizza
309 Bitto A. Survivin and NAIP in Human Benig... Visualizza
3675 Bitto A. Adenosine receptor stimulation i... Visualizza
3755 Bitto A. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
3756 Bitto A. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
3757 Bitto A. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
3758 Bitto A. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
310 Biundo FB. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
311 Biundo FB. Inhibition of inflammasome activ... Visualizza
312 Bizzarro V. Hypoxia regulates ANXA1 expressi... Visualizza
313 Bizzarro V. Effects of Prisma® Skin dermal ... Visualizza
3759 Bizzarro V. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
314 Blandina P. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
315 Blandina P. An Omega-3 PUFA/Vitamin A enrich... Visualizza
316 Blandini F. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
317 Blandizzi C. INTENSIVE MONITORING PROGRAM OF ... Visualizza
318 Blandizzi C. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
319 Blandizzi C. Bifidobacterium Longum and Lacto... Visualizza
320 Blandizzi C. A CLINICIAN NETWORK FOR SHARING ... Visualizza
321 Blandizzi C. Enteric glia is involved in colo... Visualizza
322 Blandizzi C. Alteration of visceral sensitivi... Visualizza
323 Blandizzi C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
324 Blandizzi C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3491 Blandizzi C. Functional intestinal dysmotilit... Visualizza
3760 Blandizzi C. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
3761 Blandizzi C. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
325 Blescia S. Angiotensin-II activates p-38 an... Visualizza
326 Blom J. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
327 Bluher M. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
328 Boccella S. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
329 Boccella S. Palmitoylethanolamide Reduces Ne... Visualizza
3762 Boccella S. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
330 Bocchetta A. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
331 Bocci G. Metronomic vinorelbine is active... Visualizza
332 Bocci G. Melanocortin receptor-4 as a nov... Visualizza
333 Bocci G. Colon cancer therapy beyond tumo... Visualizza
334 Boffa L. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
3763 Boggio E. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
335 Boglione L. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3764 Boglione L. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
3765 Boi L. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
336 Bolcato J. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
337 Bolcato J. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
338 Bolego C. Effects of digitoxin on cell mig... Visualizza
339 Bolego C. Anti-angiogenic effect of therap... Visualizza
340 Bolego C. G-protein coupled estrogen recep... Visualizza
341 Bollati V. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
342 Bonacina F. Apolipoprotein E modulates adapt... Visualizza
343 Bonacina F. Fatty acid synthesis is crucial ... Visualizza
344 Bonacina F. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
345 Bonaldo G. DRUGS - INDUCED DISSEMINATED INT... Visualizza
346 Bonaldo G. Reporting of adverse drug reacti... Visualizza
347 Bonaldo G. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
348 Bonanni D. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
349 Bonanno G. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
350 Bonanno G. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
351 Bonanno G. Altered Mechanisms Underlying th... Visualizza
352 Bonanno G. Prophylactic versus Therapeutic ... Visualizza
3531 Bonci A. From single synapses to clinical... Visualizza
353 Bondi H. SALMETEROL, A SELECTIVE AND LONG... Visualizza
354 Bonfiglio T. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
355 Bonfiglio T. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
356 Bonfiglio T. Prophylactic versus Therapeutic ... Visualizza
357 Bonifacino T. Altered Mechanisms Underlying th... Visualizza
358 Bonifacino T. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
359 Bonifacino T. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
360 Bonifacio A. Surfaced-enhanced Raman spectros... Visualizza
361 Bonifazi D. Failures to further developing o... Visualizza
3766 Bonifazi D. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
362 Bonifazi F. Failures to further developing o... Visualizza
3767 Bonifazi F. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
363 Bonomi A. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
364 Bordano V. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
365 Bordi P. Monitoring of Epidermal Growth F... Visualizza
366 Bordin F. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
367 Borea P. A2B adenosine receptors stimulat... Visualizza
368 Borea PA. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
369 Borea PA. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
370 Borrelli F. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
371 Borrelli F. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3395 Borrelli F. TRPM8 and experimental colorecta... Visualizza
3768 Borrelli F. Herbal dietary supplements for e... Visualizza
372 Borroni AP. Inhibition of SIRT1 Deacetylase ... Visualizza
3769 Borroto-esquela D.O. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
373 Borruto AM. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
3770 Borruto AM. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
374 Borsani E. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
375 Bortolato M. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
376 Bortolotto V. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
377 Bortolotto V. SALMETEROL, A SELECTIVE AND LONG... Visualizza
3771 Bortolotto V. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
378 Bortolozzo K. CLINICAL VALIDATION OF THE REALQ... Visualizza
379 Bortolozzo K. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
3772 Bortolus R. Immunogenetics of prostate cance... Visualizza
380 Bortone AS. POTENTIAL MECHANISMS LINKING DEF... Visualizza
381 Boscaro C. G-protein coupled estrogen recep... Visualizza
382 Boscaro C. Effects of digitoxin on cell mig... Visualizza
383 Boscaro V. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
384 Boscaro V. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
385 Boscaro V. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
386 Bosco BF. Sildenafil improves cardiac func... Visualizza
387 Bosco F. Early up-regulation of hepatic m... Visualizza
388 Bosco F. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
389 Bosello O. A prospective observational stud... Visualizza
390 Bosone E. Failures to further developing o... Visualizza
391 Bossert JM. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
392 Bossi S. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
3773 Botta C. Identification and validation of... Visualizza
3774 Botta M. High density lipoproteins inhibi... Visualizza
393 Botti G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
394 Bottoni U. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
3775 Botzenhardt S. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
395 Bouché A. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
396 Bova G. NABILONE AND THC/CBD FOR THE TRE... Visualizza
397 Bove G. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
398 Bove M. STUDYING SOCIAL WITHDRAWAL IN A ... Visualizza
399 Braegger FE. ROLE OF THE AREA POSTREMA IN THE... Visualizza
400 Braida D. PROSOCIAL AND ANXIOLYTIC EFFECT ... Visualizza
401 Braida D. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
402 Bramanti P. Growth inhibition, cell-cycle ar... Visualizza
3776 Brambilla M. Vitamin D levels and Tissue Fact... Visualizza
403 Branca J. Into the unexplored pathophysiol... Visualizza
404 Brancaleone V. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3777 Brancaleone V. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3526 Brancato A. Vesicular glutamate transporter ... Visualizza
405 Breda M. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
406 Breschi M. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3778 Breschi M.C. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
407 Breschi MC. Potential relationship between t... Visualizza
408 Breschi MC. Role of miR-34a as biomarker and... Visualizza
409 Breschi MC. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
3779 Breschi MC. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
3780 Breschi MC. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
410 Bresciani E. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
411 Bresciani E. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
412 Bressanello D. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
3396 Brini A.T. ASC-DERIVED CONDITIONED MEDIUM (... Visualizza
413 Brini AT. Bisphosphonates modulate bone bi... Visualizza
414 Brini AT. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
415 Brini AT. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
416 Briseño CG. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
417 Brivio P. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
3781 Briz O. _-Caryophyllene oxide as a new c... Visualizza
418 Bronzuoli MR. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
419 Bronzuoli MR. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
3782 Brotzu G. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
420 Brovedani V. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
3783 Brugia M. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
421 Brullo C. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
422 Brunello N. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
423 Brunetti L. Effects of Growth Hormone-Releas... Visualizza
424 Brunetti L. Peripheral RVD-hemopressin(_) ad... Visualizza
425 Brunetti L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3784 Brunetti L. Emotional Disorders Induced by H... Visualizza
426 Bruno A. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
427 Bruno A. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
428 Bruno A. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
429 Bruno A. Conditioned medium of human peri... Visualizza
433 Bruno O. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
434 Brunori G. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
435 Brusco S. ESTIMATING INCIDENCE RATES OF AD... Visualizza
436 Brusco S. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
437 Brusco S. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
3785 Brusco S. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
438 Bruscoli S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
439 Bruscoli S. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
3489 Bruscoli S. Glucocorticoid and B lymphocytes... Visualizza
3786 Bruscoli S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
440 Bucci M. Kv7 channels are involved in hum... Visualizza
441 Bucci M. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
442 Bucci M. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
3787 Bucci M. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3788 Buckhardt R. Sphingosine 1-Phosphate And Athe... Visualizza
443 Bucolo C. Small molecules to treat diabeti... Visualizza
444 Bucolo C. Role of P2X7 receptor in early d... Visualizza
445 Bucolo C. Autoregulation of retinal gangli... Visualizza
446 Bucolo C. Structure based approach for sea... Visualizza
447 Bucolo C. Effects of Taurine in dry eye mo... Visualizza
448 Bucolo C. Role of TGF-_1 in age-related ma... Visualizza
449 Bucolo C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
450 Bucolo C. Sulodexide prevents high glucose... Visualizza
3789 Bucolo C. Retinal bioavailability of curcu... Visualizza
3790 Bucolo C. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
3791 Bucolo C. Dopamine D3 receptor-dependent c... Visualizza
3792 Bucolo C. Buspirone rescues MK-801-induced... Visualizza
451 Bulotta S. Anti-proliferative effects of Cy... Visualizza
452 Buonadonna A. Next generation sequencing for i... Visualizza
453 Buonadonna A. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
454 Buonadonna A. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
3793 Buonadonna A. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
455 Buono L. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
456 Burke LK. Hypothalamic Circuit Mediates Th... Visualizza
457 Burrai C. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
458 Buscaglia E. Analytically confirmed post-inje... Visualizza
459 Buscaglia E. Methotrexate therapeutic error i... Visualizza
460 Buscaglia E. Gamma-hydroxybutyrate intoxicati... Visualizza
461 Buscaglia E. Antidote treatment in Viper enve... Visualizza
462 Busnelli M. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
463 Butelman ER. EFFECTS OF A NOVEL SELECTIVE SHO... Visualizza
464 Buzzella A. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
465 Caberlotto L. Cross-Disease Analysis of Alzhei... Visualizza
466 Cacciola F. Evaluation of protective effect ... Visualizza
467 Caccuri AM. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
468 Cadamuro S. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
3795 Caderni G. Potential of a flavonoid-rich ex... Visualizza
3796 Caderni G. INHIBITION OF SPONTANEOUS COLON ... Visualizza
469 Cadossi M. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
470 Cadossi R. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
471 Caffino L. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
472 Caffino L. Acute behavioral and molecular e... Visualizza
473 Caffino L. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
3524 Caffino L. Adolescent exposure to cocaine i... Visualizza
3797 Caffino L. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
3670 Caffo M. Role of dickkopf-related protein... Visualizza
3798 Caiazzo E. A ROLE FOR FIBROBLAST GROWTH FAC... Visualizza
475 Calabrese F. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
1298 calabrese F. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3545 Calabrese F. Involvement of the glutamatergic... Visualizza
476 Calabresi L. Recombinant LCAT rescues defecti... Visualizza
3800 Calabresi L. High density lipoproteins inhibi... Visualizza
477 Calabro' M. In search of biological substant... Visualizza
478 Calafiore R. Prevention of diabetes in NOD mi... Visualizza
479 Calapai F. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
480 Calapai F. NABILONE AND THC/CBD FOR THE TRE... Visualizza
481 Calapai G. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
482 Calapai G. NABILONE AND THC/CBD FOR THE TRE... Visualizza
3656 Calapai G. Nutraceuticals pre-clinical rese... Visualizza
474 Calò G. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3799 Calò G. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
483 Calcabrini C. Creatine preserves the myogenic ... Visualizza
484 Calcabrini C. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3801 Calcabrini C. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
485 Calcagnini S. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
486 Calcagno E. cGMP MODULATES LONG-TERM POTENTI... Visualizza
487 Calcagno E. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
488 Caldeira G. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
489 Calderaro A. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
490 Calderone V. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
491 Calderone V. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
492 Calderone V. 3-Mercaptopyruvate relaxes aorta... Visualizza
493 Calderone V. Kv7 channels are involved in hum... Visualizza
3802 Calderone V. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
3803 Calderone V. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
3804 Calderone V. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
3805 Calderone V. Brassicaceae as source of H2S-re... Visualizza
494 Calevro A. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
3806 Calevro A. MECHANISM OF HYDROGEN SULFIDE AG... Visualizza
3807 Calevro A. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
495 Calignano A. Behavioral and Metabolic Charact... Visualizza
496 Calignano A. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
497 Calignano A. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
498 Calignano A. Hypothalamic Circuit Mediates Th... Visualizza
499 Calignano A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
500 Calignano A. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
501 Calignano A. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
502 Calignano A. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3808 Calignano A. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
503 Calissano P. Involvement of bradykinin B2 rec... Visualizza
504 Calvani M. Enhancement of cardiac different... Visualizza
3809 Cameli M. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3810 Camera M. Shedding light on PCSK9 function... Visualizza
3811 Camera M. Vitamin D levels and Tissue Fact... Visualizza
505 Camerino C. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
3543 Camerino G. Correlation between long-lasting... Visualizza
506 Camerino GM. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
507 Camerino GM. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
508 Camerino GM. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
509 Camerino GM. Gender-dependent involvement of ... Visualizza
510 Camerino GM. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
511 Camerino GM. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
512 Camerino GM. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
513 Camerino GM. EFFECT OF A LONG TERM TREATMENT ... Visualizza
514 Camero S. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
515 Cammarota S. Increasing trend in admission ra... Visualizza
516 Campanella F. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
517 Campiglia P. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
518 Campisi M. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
519 Campolo M. Multiple mechanisms of dimethyl ... Visualizza
520 Campolo M. Dimethyl fumarate attenuates neu... Visualizza
521 Campolo M. Absence of TLR4 reduces neuroinf... Visualizza
522 Campolo M. Intestine as a Source of Inflamm... Visualizza
3812 Campolo M. INHIBITION OF MAMMALIAN TARGET O... Visualizza
523 Campolo MC. Inhibition of inflammasome activ... Visualizza
524 Campolongo P. AMPHETAMINE AND THE 3,4-METHYLE... Visualizza
525 Campolongo P. Involvement of the Prokineticin ... Visualizza
3813 Camussi G. Megalin and Sodium-Hydrogen Exch... Visualizza
527 Canalini F. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
3814 Canalini F. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
3815 Canalini F. MECHANISM OF HYDROGEN SULFIDE AG... Visualizza
528 Cananzi P. Access to the market of medicine... Visualizza
529 Cananzi P. Trends in Spontaneous Adverse Dr... Visualizza
530 Cananzi P. Intravitreal anti-VEGF injection... Visualizza
531 Cananzi P. Real world data about biosimilar... Visualizza
532 Cananzi P. EVALUATION OF HEALTH DIRECT COST... Visualizza
533 Canazza I. Acute behavioral and molecular e... Visualizza
526 Canì PD. Chronic Oleoylethanolamide Treat... Visualizza
3816 Canciani B. Shedding light on PCSK9 function... Visualizza
3817 Candeletti S. N/OFQ and CRF systems dysregulat... Visualizza
534 Candelletti S. Selective dynorphin and nocicept... Visualizza
535 Canevini MP. OVERTREATMENT IN PHARMACORESISTA... Visualizza
536 Canistro D. Development of microparticles fo... Visualizza
537 Canistro D. The chemopreventive effects of i... Visualizza
538 Canistro D. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
539 Canistro D. Effects of electronic cigarette ... Visualizza
3818 Cannataro M. Identification and validation of... Visualizza
540 Cannataro R. Therapeutic benefits of methylxa... Visualizza
541 Cannavò S. Real world data about biosimilar... Visualizza
3819 Cannella N. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
542 Cannizzaro L. UNRAVELING THE MECHANISM OF ACTI... Visualizza
543 Canonico PL. The pharmacogenetics of the resp... Visualizza
544 Canonico PL. SALMETEROL, A SELECTIVE AND LONG... Visualizza
3820 Canonico PL. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
545 Cantalupo A. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
546 Cantatore P. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
547 Cantile C. ESTIMATING INCIDENCE RATES OF AD... Visualizza
548 Cantile C. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
549 Cantoni AM. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
550 Cantoni AM. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
3821 Canzano P. Vitamin D levels and Tissue Fact... Visualizza
551 Caparrotta L. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
552 Capasso A. HYPERPROLACTINEMIA INDUCED BY AN... Visualizza
553 Capasso A. DO CANNABINOIDS CONFER NEUROPROT... Visualizza
554 Capasso A. THE PSYCHOBIOLOGY OF ENDOCANNABI... Visualizza
555 Capasso A. BENEFICAL EFFECTS OF POLYPHENOLS... Visualizza
556 Capasso A. PROTECTIVE EFFECT OF HDAC INHIBI... Visualizza
557 Capasso A. CANNABINOIDS INVOLVEMENT IN NEUR... Visualizza
558 Capasso C. Role of miR-34a as biomarker and... Visualizza
559 Capasso R. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3822 Capogrosso A. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
560 Capogrosso RF. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
561 Capogrosso RF. A LONG TERM TREATMENT WITH TAURI... Visualizza
562 Capogrosso RF. EFFECT OF A LONG TERM TREATMENT ... Visualizza
563 Capogrosso sansone A. INTENSIVE MONITORING PROGRAM OF ... Visualizza
564 Capogrosso sansone A. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
565 Capogrosso-sansone A. A CLINICIAN NETWORK FOR SHARING ... Visualizza
3424 Capone M. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
3823 Capone ML. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
566 Caporarello N. Sulodexide prevents high glucose... Visualizza
567 Capovilla G. OVERTREATMENT IN PHARMACORESISTA... Visualizza
568 Cappetta D. Ranolazine attenuates adverse my... Visualizza
569 Cappetta D. Effects of lung resident mesench... Visualizza
3824 Cappetta D. Cardio-renal positive effects of... Visualizza
570 Caprioli D. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
3825 Caprodossi A. Platelet-derived microparticles ... Visualizza
571 Capuano A. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
572 Capuano A. ESTIMATING INCIDENCE RATES OF AD... Visualizza
573 Capuano A. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
574 Capuano A. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
575 Capuano A. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
576 Capuano A. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3567 Capuano A. Orphan drugs: post-marketing sur... Visualizza
3609 Capuano A. Monitoring of psychiatric drugs ... Visualizza
3826 Capuano A. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
3827 Capuano A. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
3828 Capuano A. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
3829 Capuano A. Effect of Chronic Kidney Disease... Visualizza
3830 Capuano A. Un-Suggested Prescriptions of No... Visualizza
577 Capucchio MT. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
3498 Caputi F. F. Addictive drugs and epigenetic r... Visualizza
578 Caputi FF. Selective dynorphin and nocicept... Visualizza
3831 Caputi FF. N/OFQ and CRF systems dysregulat... Visualizza
579 Caputi V. Involvement of catechol-O-methyl... Visualizza
580 Caputi V. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
581 Caputi V. Enteric glia is involved in colo... Visualizza
582 Caputi, V. Antibiotic-induced dysbiosis aff... Visualizza
583 Caputi, V. Changes of small bowel inhibitor... Visualizza
3532 Caraci F. b-Amyloid and cell cycle activat... Visualizza
3832 Caraci F. Dopamine D3 receptor-dependent c... Visualizza
3833 Caraci F. Buspirone rescues MK-801-induced... Visualizza
584 Caramuscio R. REtrospective study on ItaliaN A... Visualizza
598 carbone C. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
585 Carbone M. Analytically confirmed post-inje... Visualizza
586 Carboni L. Cross-Disease Analysis of Alzhei... Visualizza
3834 Carboni L. Rat Nicotine Sensitization Modul... Visualizza
587 Carcieri C. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3835 Carcieri C. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
588 Cardani S. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
589 Cardani S. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3836 Cardani S. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
590 Cardellicchio M. Tryptophan 2,3-dioxygenase inhib... Visualizza
591 Cardenia V. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
592 Cardia L. NABILONE AND THC/CBD FOR THE TRE... Visualizza
593 Cardile V. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
3619 Cardinale D. Cardiotoxicity-induced by antitu... Visualizza
594 Cargnin S. The pharmacogenetics of the resp... Visualizza
595 Cari L. Prevention of diabetes in NOD mi... Visualizza
3837 Cari L. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
596 Carini M. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3838 Carino A. The bile acid receptor GPBAR1 re... Visualizza
3839 Carli M. Clozapine as the most efficaciou... Visualizza
3840 Carloni S. THE SILENT INFORMATION REGULATOR... Visualizza
597 Carmeliet P. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
3841 Carmeliet P. Meninges are a reservoir for new... Visualizza
599 Carnovale C. On the possible relationship bet... Visualizza
600 Carnovale C. MARKAR survey: influence of dire... Visualizza
3468 Carnovale C. Management of therapy in a pedia... Visualizza
3842 Carnovale C. Interactions between vaccines ag... Visualizza
3521 Carola V. Exposure to childhood maltreatme... Visualizza
601 Caroleo MC. Myotrophin and miR-375 as pharma... Visualizza
602 Carozzi CV. Understanding the pathogenesis o... Visualizza
603 Carpi S. Role of miR-34a as biomarker and... Visualizza
604 Carpi S. Potential relationship between t... Visualizza
605 Carpi S. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
606 Carradori S. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
607 Carrara M. Antiproliferative effect of Cuba... Visualizza
608 Carratù M. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
3398 Carratù M.R. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
609 Carratù MR. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
610 Carresi C. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
611 Carresi C. Early up-regulation of hepatic m... Visualizza
612 Carresi C. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
613 Carresi C. Impaired glucose and lipid metab... Visualizza
614 Carresi CC. Sildenafil improves cardiac func... Visualizza
3578 Carrì M. Energy metabolism as a target fo... Visualizza
615 Carrubba A. Phytochemical Profile and Photot... Visualizza
616 Carta F. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
3843 Carta S. Real-time monitoring of MPTP-ind... Visualizza
617 Cartocci V. CHANGES IN THE ENDOCANNABINOID S... Visualizza
618 Caruso D. Fatty acid synthesis is crucial ... Visualizza
619 Caruso D. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
620 Carvalho AL. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
621 Casamassima D. Evaluation of protective effect ... Visualizza
622 Casella M. Fluoroscopy-associated oxidative... Visualizza
623 Caselli G. Characterization of adipokines s... Visualizza
624 Cases DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
625 Casili G. Dimethyl fumarate attenuates neu... Visualizza
626 Casili G. Absence of TLR4 reduces neuroinf... Visualizza
627 Casili G. Multiple mechanisms of dimethyl ... Visualizza
628 Cassano T. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
629 Cassano T. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
630 Cassano T. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
3481 Cassano T. “The ugly the bad and the good”:... Visualizza
631 Cassano V. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
632 Castaldo P. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
3844 Castaldo P. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
633 Castellani G. Effect of amphetamine on choroid... Visualizza
634 Castellani G. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
635 Castelli R. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
3845 Castelli R. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
636 Castellotti B. Compound heterozygosis in the kc... Visualizza
637 Casula M. USE OF PROTON PUMP INHIBITORS AN... Visualizza
3846 Casula M. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
638 Cataldi A. CM554, A NEW POTENT AND SELECTIV... Visualizza
639 Catanzaro D. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
640 Catanzaro D. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
641 Catanzaro E. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3847 Catanzaro E. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
642 Catanzaro M. MODULATION OF OXIDATIVE AND INFL... Visualizza
643 Catapano A. Fatty acid synthesis is crucial ... Visualizza
644 Catapano A. Apolipoprotein E modulates adapt... Visualizza
645 Catapano AL. USE OF PROTON PUMP INHIBITORS AN... Visualizza
3848 Catapano AL. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
3849 Catapano AL. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
3850 Catarinicchia S. Megalin and Sodium-Hydrogen Exch... Visualizza
646 Catarzi D. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
647 Cattaneo L. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
648 Cattaneo L. Altered Mechanisms Underlying th... Visualizza
649 Cattaneo MG. FATTY ACIDS RESTORE IN VITRO ANG... Visualizza
650 Cattaneo MG. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
651 Cavagnoli R. Characterization of adipokines s... Visualizza
652 Cavalca V. Fluoroscopy-associated oxidative... Visualizza
3851 Cavalca V. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
3852 Cavaliere G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
653 Cavallaro S. Involvement of bradykinin B2 rec... Visualizza
3853 Cavalleri L. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
654 Cavaluzzi MM. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
655 Caviglioli G. Subcutaneous slow-release metfor... Visualizza
656 Ceccarelli G. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
657 Cecchin E. Next generation sequencing for i... Visualizza
658 Cecchin E. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
659 Cecchin E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
3854 Cecchin E. Immunogenetics of prostate cance... Visualizza
660 Ceci A. Failures to further developing o... Visualizza
3855 Ceci A. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
661 Cedazo-minguez A. Cross-Disease Analysis of Alzhei... Visualizza
662 Celano M. Anti-proliferative effects of Cy... Visualizza
663 Celano M. Evaluation of protective effect ... Visualizza
664 Celestino I. Antiviral and antioxidant activi... Visualizza
665 Cella SG. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
666 Cella SG. Hedonic eating in Prader-Willi s... Visualizza
667 Cellini M. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
668 Cento AS. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
669 Cento AS. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
670 Cerantola S. Involvement of catechol-O-methyl... Visualizza
671 Cerantola S. Enteric glia is involved in colo... Visualizza
672 Cerantola, S. Antibiotic-induced dysbiosis aff... Visualizza
673 Cerantola, S. Changes of small bowel inhibitor... Visualizza
674 Cerbai E. Enhancement of cardiac different... Visualizza
675 Cerbai E. Angiotensin-II activates p-38 an... Visualizza
3452 Cerbai E. Isoform-selective blockade of HC... Visualizza
3629 Cerbai E. Ion channels and cardiac disease... Visualizza
3856 Cerbai E. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3857 Cerbai E. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
676 Ceriani M. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
677 Cerlesi MC. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
678 Cermenati G. Fatty acid synthesis is crucial ... Visualizza
679 Cerretani D. NO level and oxidative stress in... Visualizza
680 Cerri S. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
681 Cerullo V. Role of miR-34a as biomarker and... Visualizza
682 Cervelli M. VULNERABILITY TO SEIZURES AND AS... Visualizza
683 Cervetto C. VULNERABILITY TO SEIZURES AND AS... Visualizza
684 Cervetto C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
685 Cervetto C. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
3858 Cervetto C. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
686 Charlier B. Health status and concomitant pr... Visualizza
3399 Charlier B. A novel methodology for the dosa... Visualizza
3859 Chazot PL. Megalin and Sodium-Hydrogen Exch... Visualizza
687 Chegaev K. Effects of NO and H2S releasing ... Visualizza
688 Chegaev K. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
689 Chen J. Functional interaction between n... Visualizza
3860 Chen J. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
690 Chessa S. IN VITRO AND IN VIVO MODELING OF... Visualizza
3861 Chiamulera C. METAPLASTIC TREATMENTS WITH KETA... Visualizza
3862 Chiamulera C. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
3863 Chiamulera C. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
3864 Chiamulera C. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
691 Chiara C. Targeting nicotinamide phosphory... Visualizza
693 Chiariotti L. Behavioral and Metabolic Charact... Visualizza
694 Chiavaroli A. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
695 Chiavaroli A. Peripheral RVD-hemopressin(_) ad... Visualizza
696 Chiavaroli A. Effects of Growth Hormone-Releas... Visualizza
3865 Chiavaroli A. Emotional Disorders Induced by H... Visualizza
697 Chiazza F. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
698 Chiazza F. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
699 Chiazza F. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
3866 Chiazza F. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3867 Chiechio S. Chronic treatment with fluoxetin... Visualizza
700 Chillotti C. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
701 Chillotti C. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
702 Chinellato A. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
703 Chinellato A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
704 Chinellato A. Real world data about biosimilar... Visualizza
705 Chinellato A. EVALUATION OF HEALTH DIRECT COST... Visualizza
706 Chinellato A. NSAIDs utilization in a large co... Visualizza
3868 Chinellato A. Real-world evidence on the risk ... Visualizza
707 Chini B. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
708 Chini MG. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
3870 Chiocchetti A. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
3871 Chiodelli P. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
3872 Chisari M. MODULATION OF ASTROCYTE PROCESSE... Visualizza
3873 Chisari M. Dopamine D3 receptors control dy... Visualizza
709 Chou TH. Autoregulation of retinal gangli... Visualizza
710 Ciabatti E. The ABCB1 pharmacogenetics of R-... Visualizza
711 Ciana P. Inhibition of SIRT1 Deacetylase ... Visualizza
712 Cibelli A. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
3874 Cicala C. A ROLE FOR FIBROBLAST GROWTH FAC... Visualizza
713 Cicala G. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
1389 Cicala G. Safety profile of antipsychotic ... Visualizza
714 Ciccarelli M. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
715 Ciccocioppo R. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
716 Ciccocioppo R. PPAR gamma Activation reduces al... Visualizza
3875 Ciccocioppo R. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
3876 Ciccocioppo R. N/OFQ and CRF systems dysregulat... Visualizza
717 Ciccone V. Tumor stemness and cancer drug-r... Visualizza
3657 Cicero A. F. G. Clinical research applied to nut... Visualizza
3877 Cicero N. Aldose Reductase Inhibitors from... Visualizza
3878 Cidlowski JA. A NOVEL INTERACTION BETWEEN GLUC... Visualizza
718 Cifani C. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
719 Cifani C. ROLE OF THE AREA POSTREMA IN THE... Visualizza
3548 Cifani C. Corticotropin-releasing hormone ... Visualizza
720 Cignarella A. G-protein coupled estrogen recep... Visualizza
721 Cignarella A. Effects of digitoxin on cell mig... Visualizza
722 Cimino F. Curcumin Ameliorates the In Vitr... Visualizza
723 Cimino F. In Vitro Protective Effects of C... Visualizza
724 Cimino F. Phytochemical Profile and Photot... Visualizza
3879 Cimino F. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
725 Cimino M. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
726 Cimino M. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
727 Cimino S. Survivin and NAIP in Human Benig... Visualizza
728 Cimmaruta D. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
729 Cimmaruta D. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
3880 Cimmaruta D. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
730 Cinci L. Effects of NO and H2S releasing ... Visualizza
731 Cinci L. AN IN VITRO MODEL FOR SCREENING ... Visualizza
3881 Cinci L. Nutraceutical properties of Arth... Visualizza
3882 Cinti S. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
732 Cioccoloni G. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
733 Cione E. Myotrophin and miR-375 as pharma... Visualizza
734 Ciotti MT. Involvement of bradykinin B2 rec... Visualizza
3883 Cipriani S. The bile acid receptor GPBAR1 re... Visualizza
3884 Ciranna L. Dopamine D3 receptors control dy... Visualizza
3885 Ciranna L. MODULATION OF ASTROCYTE PROCESSE... Visualizza
3886 Circosta C. Aldose Reductase Inhibitors from... Visualizza
735 Cirillo S. Development of microparticles fo... Visualizza
736 Cirillo S. Effects of electronic cigarette ... Visualizza
737 Cirillo S. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
738 Cirillo S. The chemopreventive effects of i... Visualizza
739 Cirino G. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
740 Cirino G. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
741 Cirino G. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
742 Cirino G. Modulation of the inflammatory r... Visualizza
743 Cirino G. 3-Mercaptopyruvate relaxes aorta... Visualizza
744 Cirino G. Kv7 channels are involved in hum... Visualizza
745 Cirino G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
3887 Cirino G. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3888 Cirino G. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
3889 Cirino G. Hydrogen sulfide pathway as a ne... Visualizza
3890 Cirino GC. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
746 Cirmi S. Growth inhibition, cell-cycle ar... Visualizza
3891 Cirmi S. Potential of a flavonoid-rich ex... Visualizza
747 Cirronis M. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
748 Citarella A. Increasing trend in admission ra... Visualizza
749 Citi V. 3-Mercaptopyruvate relaxes aorta... Visualizza
750 Citi V. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
751 Citi V. Kv7 channels are involved in hum... Visualizza
752 Citi V. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3892 Citi V. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
3893 Citi V. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
3894 Citi V. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
753 Citraro R. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
754 Citraro R. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
755 Citraro R. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
756 Citraro R. MONITORING SAFETY AND USE OF OLD... Visualizza
757 Citraro R. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
758 Ciuffreda LP. Ranolazine attenuates adverse my... Visualizza
759 Ciuffreda LP. Effects of lung resident mesench... Visualizza
3895 Ciuffreda LP. Cardio-renal positive effects of... Visualizza
760 Clark A. THE ROLE OF THE mRNA BINDING PRO... Visualizza
761 Clemente N. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
3896 Clemente N. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
762 Clementi E. On the possible relationship bet... Visualizza
763 Clementi E. MARKAR survey: influence of dire... Visualizza
3513 Clementi E. Pharmacovigilance and Pharmacoge... Visualizza
3897 Clementi E. Interactions between vaccines ag... Visualizza
764 Cocchi M. An Omega-3 PUFA/Vitamin A enrich... Visualizza
765 Cocchi V. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
766 Cocchi V. 6-(METHYLSULFINYL)HEXYLISOTHIOCY... Visualizza
767 Cocetta V. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
768 Cocolin L. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
769 Coe D. Apolipoprotein E modulates adapt... Visualizza
770 Coggi D. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
771 Coggi D. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
772 Cojutti P. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
773 Colalto C. NEED FOR EVIDENCE-BASED GUIDELIN... Visualizza
774 Colarusso C. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3898 Colarusso CC. Human Peripheral blood mononucle... Visualizza
775 Colasanti M. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
776 Collino M. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
777 Collino M. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
778 Collino M. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
3899 Collino M. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
779 Colliva C. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
780 Colliva C. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
3900 Collo G. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
781 Collodel G. NO level and oxidative stress in... Visualizza
782 Collotta D. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
3901 Collotta D. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
783 Colombo F. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
784 Colombo G. INVESTIGATION OF A PUTATIVE NICO... Visualizza
3902 Colombo L. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
3903 Colombo V. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
785 Colotta V. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
786 Colucci P. AMPHETAMINE AND THE 3,4-METHYLE... Visualizza
787 Colucci R. Bifidobacterium Longum and Lacto... Visualizza
788 Colucci R. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
789 Colucci R. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
790 Colucci R. Enteric glia is involved in colo... Visualizza
3904 Colucci R. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
791 Coluccia M. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
792 Colzani M. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3905 Comi C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
793 Commodo M. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
794 Conciarelli G. Tryptophan 2,3-dioxygenase inhib... Visualizza
795 Congiu D. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
796 Contarini G. CANNABINOID INVOLVMENT IN THE DE... Visualizza
797 Contarini G. Involvement of catechol-O-methyl... Visualizza
798 Contarini G. Effect of amphetamine on choroid... Visualizza
799 Conte Camerino D. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
800 Conte Camerino D. Gender-dependent involvement of ... Visualizza
801 Conte camerino D. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
802 Conte D. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
803 Conte D. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
804 Conte E. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
805 Conte E. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
806 Conte E. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
807 Conte E. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
808 Conte E. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
809 Conte E. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
810 Conte E. EFFECT OF A LONG TERM TREATMENT ... Visualizza
3906 Conte R. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
811 Conti F. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
812 Conti P. Inhibition of SIRT1 Deacetylase ... Visualizza
813 Conti V. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
814 Conti V. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
815 Conti V. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
3907 Conti V. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
3594 Contin M. Update on treatment of Parkinson... Visualizza
816 Contursi A. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
817 Contursi A. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
3908 Contursi A. MICRORNA-574-5P MODULATES MICROS... Visualizza
818 Convertino I. A CLINICIAN NETWORK FOR SHARING ... Visualizza
819 Convertino I. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
820 Convertino I. INTENSIVE MONITORING PROGRAM OF ... Visualizza
3909 Convertino I. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
821 Cooper EC. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
822 Coppi E. The antimigraine butterbur ingre... Visualizza
823 Coppi E. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
3910 Coppi E. Molecular basis of adenosine A3 ... Visualizza
824 Coppi EC. Aromatase inhibitor-evoked pain ... Visualizza
3505 Coppini R. Late sodium current inhibitors t... Visualizza
3911 Coppini R. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
825 Coppolino GT. Multiple sclerosis and depressio... Visualizza
826 Coppolino GT. GPR17-expressing oligodendrocyte... Visualizza
827 Corace G. Development of microparticles fo... Visualizza
828 Corbi G. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
3912 Corbi G. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
829 Corciulo C. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
830 Cordaro M. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
3913 Cordaro M. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
3914 Cordaro M. INHIBITION OF MAMMALIAN TARGET O... Visualizza
831 Cordero C. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
832 Cordero C. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
833 Coretti L. Behavioral and Metabolic Charact... Visualizza
834 Corona T. INTENSIVE MONITORING PROGRAM OF ... Visualizza
835 Corona T. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
837 Corrao G. USE OF PROTON PUMP INHIBITORS AN... Visualizza
838 Corrao G. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
839 Corrao G. NSAIDs utilization in a large co... Visualizza
3915 Corrao G. Real-world evidence on the risk ... Visualizza
3916 Corrao G. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
840 Corrao S. Access to the market of medicine... Visualizza
836 Corrà M. The protective effect of naringe... Visualizza
841 Correale CC. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
842 Corsaro A. PRION PROTEIN SIGNALLING CONTROL... Visualizza
843 Corsi M. Cross-Disease Analysis of Alzhei... Visualizza
844 Corsini A. UNRAVELING THE MECHANISM OF ACTI... Visualizza
845 Corsini A. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
846 Corsini A. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
847 Corsini A. Recombinant LCAT rescues defecti... Visualizza
3917 Corsini A. Geranylgeraniol prevents the sim... Visualizza
848 Corsini AC. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
849 Cortelazzo S. The ABCB1 pharmacogenetics of R-... Visualizza
3595 Cortelli P. Update on treatment of Parkinson... Visualizza
3918 Cortelli P. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
3400 Cosentino M. Tithonia diversifolia (Hemsl.) A... Visualizza
3919 Cosentino N. Vitamin D levels and Tissue Fact... Visualizza
1978 cosio M. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3920 Cosmi C. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
3921 Cossu A. Real-time detection of ethanol i... Visualizza
850 Cossu M. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
29 costa A. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
851 Costa A. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
852 Costa A. An Omega-3 PUFA/Vitamin A enrich... Visualizza
853 Costa B. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
854 Costa M. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
855 Costa V. Gamma-hydroxybutyrate intoxicati... Visualizza
856 Costabile G. Development of hyaluronan/mannit... Visualizza
857 Costantino D. TREND OF ADVERSE DRUG REACTION R... Visualizza
858 Costantino M. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
859 Costantino M. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
860 Costantino M. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
3922 Costantino M. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
3923 Costanza F. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
861 Costanzi G. MOLECULAR MONITORING OF CHRONIC ... Visualizza
862 Cotugno R. A multiple approach allowed unve... Visualizza
863 Couture F. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
864 Cozzi A. Alteration of visceral sensitivi... Visualizza
865 Cozzoli A. EFFECT OF A LONG TERM TREATMENT ... Visualizza
866 Cozzoli A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
867 Cravotto G. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
868 Crema F. Involvement of catechol-O-methyl... Visualizza
869 Cremolini C. Colon cancer therapy beyond tumo... Visualizza
870 Crescioli G. Adverse drug reactions in paedia... Visualizza
871 Crescioli G. Drug-utilization of new oral ant... Visualizza
872 Crescioli G. Pharmacoutilization of Antidiabe... Visualizza
3924 Crescioli G. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
873 Crevani M. Gamma-hydroxybutyrate intoxicati... Visualizza
874 Crevani M. Antidote treatment in Viper enve... Visualizza
3925 Cricelli CC. Drug interactions with levothyro... Visualizza
3926 Cricelli CI. Drug interactions with levothyro... Visualizza
3579 Crippa V. The role of protein quality cont... Visualizza
875 Crisafulli C. In search of biological substant... Visualizza
876 Cristani M. Phytochemical Profile and Photot... Visualizza
877 Cristani M. In Vitro Protective Effects of C... Visualizza
878 Cristiano C. Hypothalamic Circuit Mediates Th... Visualizza
879 Cristiano C. Behavioral and Metabolic Charact... Visualizza
880 Cristiano C. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
881 Cristiano C. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
882 Cristiano C. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
883 Cristiano C. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
884 Cristiano C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
885 Cristina C. Targeting nicotinamide phosphory... Visualizza
886 Crocetti L. Development of an in vitro model... Visualizza
887 Cronstein BN. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
888 Crooks JC. CpG type-A induction of an early... Visualizza
889 Crucitta S. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
890 Crupi R. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
891 Cuccurazzu B. SALMETEROL, A SELECTIVE AND LONG... Visualizza
3927 Cucherat M. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
892 Culicchi F. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
893 Cuomo R. Increasing trend in admission ra... Visualizza
894 Cuomo V. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
895 Curci A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
896 Curci A. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
897 Curci A. Gender-dependent involvement of ... Visualizza
898 Currò D. EFFECTS OF TETRAETHYLAMMONIUM ON... Visualizza
899 Cusato J. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3928 Cusato J. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
900 Cutrignelli A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
901 Cutrignelli A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
902 Cutrin JC. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
903 Cutrin JC. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3929 Cutrin JC. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
904 Cutroneo P. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
3930 Cutroneo P. Facilitation Of Reporting in hos... Visualizza
2401 Cutroneo P.M. Safety profile of antipsychotic ... Visualizza
905 Cutroneo PM. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
906 Cutroneo PM. Trends in Spontaneous Adverse Dr... Visualizza
907 Cuzzocrea S. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
908 Cuzzocrea S. Absence of TLR4 reduces neuroinf... Visualizza
909 Cuzzocrea S. Intestine as a Source of Inflamm... Visualizza
910 Cuzzocrea S. Multiple mechanisms of dimethyl ... Visualizza
911 Cuzzocrea S. Dimethyl fumarate attenuates neu... Visualizza
3931 Cuzzocrea S. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
3932 Cuzzocrea S. INHIBITION OF MAMMALIAN TARGET O... Visualizza
912 Cuzzocrea SC. Bergamot Juice extract treatment... Visualizza
913 Cuzzocrea SC. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
914 Cuzzocrea SC. Inhibition of inflammasome activ... Visualizza
915 Cvijetic S. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
3933 Cvijetic S. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
917 D'addario C. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
3397 D'Agostino B NOCICEPTIN/ORPHANINFQ (N/OFQ) CO... Visualizza
430 d'agostino B. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
431 d'agostino B. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
432 d'agostino B. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
921 D'agostino B. Effects of lung resident mesench... Visualizza
922 D'agostino B. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
3937 D'agostino B. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
923 D'agostino G. Hypothalamic Circuit Mediates Th... Visualizza
924 D'agostino I. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
3938 D'agostino I. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
926 D'alessandro N. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
931 D'aloia A. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
3940 D'amario D. Cardio-renal positive effects of... Visualizza
933 D'ambrosio M. AN IN VITRO MODEL FOR SCREENING ... Visualizza
934 D'ambrosio M. Effects of NO and H2S releasing ... Visualizza
3941 D'ambrosio M. Nutraceutical properties of Arth... Visualizza
935 D'amelio M. VULNERABILITY TO SEIZURES AND AS... Visualizza
3402 D'Amico D. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
936 D'amico G. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
937 D'amico M. MODULATION OF DIABETIC RETINOPAT... Visualizza
938 D'amico M. PHARMACOLOGICAL MODULATION OF CA... Visualizza
939 D'amico RD. Bergamot Juice extract treatment... Visualizza
940 D'amico RD. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
941 D'amore C. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
942 D'amore C. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
943 D'andrea M. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
3942 D'andrea M. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
950 D'angelo I. Development of hyaluronan/mannit... Visualizza
3943 D'Angelo V. Aldose Reductase Inhibitors from... Visualizza
951 D'aniello A. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
952 D'anna A. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
953 D'anna R. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
955 D'antona G. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
956 D'armineto M. TRPM8 and experimental colorecta... Visualizza
957 D'Atanasio N. In vitro and in vivo antibacteri... Visualizza
3944 D'aurizio R. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
960 D'ausilio A. Access to the market of medicine... Visualizza
965 D'avolio A. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3946 D'avolio A. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
1065 D'elia N. The protective effect of naringe... Visualizza
1073 D'emmanuele di villa bianca R. Development of hyaluronan/mannit... Visualizza
1074 D'emmanuele di villa bianca R. 3-Mercaptopyruvate relaxes aorta... Visualizza
3970 D'emmanuele Di Villa Bianca R. Hydrogen sulfide pathway as a ne... Visualizza
1078 D'errico V. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
916 Da cas R. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
3934 Da Cas R. The high price of anticancer dru... Visualizza
3935 Da cas R. Suspected adverse reactions to h... Visualizza
3936 Da Pozzo E. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
918 Daga A. Subcutaneous slow-release metfor... Visualizza
919 Daga A. PRION PROTEIN SIGNALLING CONTROL... Visualizza
920 Daga A. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
3939 Dahl K. Dopamine D3 receptor-dependent c... Visualizza
925 Dal Piaz F. Health status and concomitant pr... Visualizza
3463 Dal Piaz F. A novel methodology for the dosa... Visualizza
929 Dall'acqua S. Phytochemical Investigation and ... Visualizza
930 Dall'acqua S. HPLC-MS Analysis of Glucosinolat... Visualizza
927 Dalla Porta F. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
928 Dalla Pozza A. CLINICAL VALIDATION OF THE REALQ... Visualizza
932 Damante G. Tacrolimus Therapeutic Drug Moni... Visualizza
3429 Damiano M. The loss of Aristaless related h... Visualizza
944 Danese SD. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
945 Danesi R. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
946 Danesi R. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
947 Danesi R. Monitoring of Epidermal Growth F... Visualizza
948 Danesi R. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
949 Danesi R. The ABCB1 pharmacogenetics of R-... Visualizza
3516 Danesi R. New perspectives of tumour immun... Visualizza
954 Dante G. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
958 Dattoli S.D. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
959 Dattoli S.D. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
961 Dautaj E. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
3945 Davì G. Shedding light on PCSK9 function... Visualizza
964 Davidson iv JT. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3616 De Angelis A. Diastolic dysfunction in doxorub... Visualizza
966 De angelis A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
967 De angelis A. Ranolazine attenuates adverse my... Visualizza
968 De angelis A. Effects of lung resident mesench... Visualizza
3947 De angelis A. Cardio-renal positive effects of... Visualizza
969 De angioletti M. Effects of NO and H2S releasing ... Visualizza
970 De bellis M. EFFECT OF A LONG TERM TREATMENT ... Visualizza
971 De bellis M. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
972 De bellis M. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
973 De bellis M. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
974 De bock M. Into the unexplored pathophysiol... Visualizza
3464 De Bonis E. A novel methodology for the dosa... Visualizza
975 De Caro C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
976 De Caro C. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
977 De caro C. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
978 De caro C. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
979 De caro C. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
980 De cicco P. Modulation of the inflammatory r... Visualizza
981 De cicco P. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
982 De cicco P. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
3948 De cicco PD. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
983 De cillis E. POTENTIAL MECHANISMS LINKING DEF... Visualizza
984 De col A. Hedonic eating in Prader-Willi s... Visualizza
985 De dominicis G. Kv7 channels are involved in hum... Visualizza
986 De falco G. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3949 De felice M. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
987 De feo V. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
988 De filippis B. CM554, A NEW POTENT AND SELECTIV... Visualizza
989 De fina M. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
990 De francesco A. Intravitreal anti-VEGF injection... Visualizza
991 De francesco R. Proatherosclerotic effect of tri... Visualizza
992 De gregorio D. Palmitoylethanolamide Reduces Ne... Visualizza
993 De gregorio D. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3950 De gregorio D. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
994 De iudicibus S. THE ROLE OF THE mRNA BINDING PRO... Visualizza
995 De iudicibus S. Pharmacoepigenomic markers invol... Visualizza
996 De L. Healthcare resources use in pati... Visualizza
997 De L. Burden of comorbidities in HCV p... Visualizza
998 De logu F. The antimigraine butterbur ingre... Visualizza
999 De logu FD. Aromatase inhibitor-evoked pain ... Visualizza
1000 De lorenzo A. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
1001 De luca A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
1002 De luca A. EFFECT OF A LONG TERM TREATMENT ... Visualizza
1003 De luca A. A LONG TERM TREATMENT WITH TAURI... Visualizza
1004 De luca A. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
3951 De luca MA. Dopamine D3 receptors control dy... Visualizza
3952 De luca MA. A precision medicine genetic mar... Visualizza
3623 De Marchi E. Role of P2X7 receptor (purinocep... Visualizza
1005 De marco R. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
1006 De martin S. Effect of amphetamine on choroid... Visualizza
1007 De martin S. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
3953 De masi S. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
1008 De mattia E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1009 De mattia E. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
1010 De mattia E. Next generation sequencing for i... Visualizza
3954 De mattia E. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
3955 De mattia E. Immunogenetics of prostate cance... Visualizza
3956 De metrio M. Vitamin D levels and Tissue Fact... Visualizza
1011 De Metrio S. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1012 De metrio S. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
1013 De Metrio S. UNRAVELING THE MECHANISM OF ACTI... Visualizza
1014 De nadai G. Phytochemical Investigation and ... Visualizza
1015 De nes M. A CLINICIAN NETWORK FOR SHARING ... Visualizza
1016 De nicola G. The chemopreventive effects of i... Visualizza
1017 De nicolò A. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3957 De nicolo' A. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
1018 De novellis V. Stimulation of CB2 receptor affe... Visualizza
1019 De novellis V. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
1020 De novellis V. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1021 De novellis V. Palmitoylethanolamide Reduces Ne... Visualizza
3958 De novellis V. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1022 De paoli A. Next generation sequencing for i... Visualizza
1023 De paoli A. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3959 De paoli A. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1024 De Pasquale D. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
1025 De ponti F. Occurrence of Liver Injury with ... Visualizza
1026 De Ponti F. Renal impairment in very low bir... Visualizza
1027 De ponti F. MYOPERICARDITIS AND VACCINES: GA... Visualizza
1028 De ponti F. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
1029 De ponti F. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
3960 De ponti F. In vitro effects of mediators de... Visualizza
3961 De ponti F. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
3962 De ponti F. Interactions between vaccines ag... Visualizza
1030 De salvia MA. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
3963 De salvia MA. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
1031 De Sarro C. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
1032 De sarro C. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
1033 De sarro C. MONITORING SAFETY AND USE OF OLD... Visualizza
1034 De sarro G. Myotrophin and miR-375 as pharma... Visualizza
1035 De sarro G. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
1036 De sarro G. Therapeutic benefits of methylxa... Visualizza
1037 De Sarro G. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
1038 De sarro G. TREND OF ADVERSE DRUG REACTION R... Visualizza
1039 De sarro G. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1040 De sarro G. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
1041 De sarro G. Intravitreal anti-VEGF injection... Visualizza
3964 De sarro G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1042 De Sarro GB. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
1043 De siena G. Central effects induced by syste... Visualizza
1044 De tommasi N. A multiple approach allowed unve... Visualizza
1045 De vita S. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1046 Deagostino A. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1047 Debetto, P. Antibiotic-induced dysbiosis aff... Visualizza
1048 Decimo I. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
1049 Decimo I. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
1050 Decimo I. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
3965 Decimo I. Meninges are a reservoir for new... Visualizza
1051 Decorti G. THE ROLE OF THE mRNA BINDING PRO... Visualizza
1052 Decorti G. Pharmacoepigenomic markers invol... Visualizza
1053 Decorti G. Surfaced-enhanced Raman spectros... Visualizza
1054 Deidda A. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
1055 Deidda A. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
1056 Del grosso E. Nicotinamide phosphoribosyltrans... Visualizza
1057 Del lungo M. FREQUENCY AND CHARACTERISTICS OF... Visualizza
1058 Del porto P. Development of hyaluronan/mannit... Visualizza
1059 Del Re M. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
1060 Del re M. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1061 Del re M. Monitoring of Epidermal Growth F... Visualizza
1062 Del re M. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
1063 Del rio D. Proatherosclerotic effect of tri... Visualizza
3966 Del Vecchio GC. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
1064 Del Zompo M. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
3967 Delfino DV. Artocarpus tonkinensis, a Vietna... Visualizza
1068 Dell'agli M. Cutaneous hypoxia: effect of oxy... Visualizza
3969 Dell'agli M. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
1070 Dell'omo G. Inhibition of SIRT1 Deacetylase ... Visualizza
1066 Della croce CM. Evaluation of protective effect ... Visualizza
1067 Della torre S. FROM METABOLIC FITNESS TO METABO... Visualizza
3968 Dell’Agli M. Thistles from Sardinia: evaluati... Visualizza
1069 Delle fratte C. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3550 Dell’Agli M. Nutraceuticals and gastro-intest... Visualizza
1071 Delodi G. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
1072 Delvecchio P. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
1075 Denaro M. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
1076 Denora N. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1077 Denora N. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
1079 Derudas M. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
3630 Desaphy J. Bench to patient side developmen... Visualizza
1080 Desaphy J.F. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1081 Desaphy JF. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
3971 Desiato G. Role of the inflammation in the ... Visualizza
1082 Dettori I. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1083 Dettori I. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1084 Dettori I. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1085 Devoto P. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3972 Devoto P. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
1086 Dewerchin M. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
3973 Dewerchin M. Meninges are a reservoir for new... Visualizza
1087 Di biase E. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
3974 Di cairano E. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
1088 Di cesare mannelli L. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1089 Di cesare mannelli L. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
1090 Di cesare mannelli L. Studying the mechanism of rat ad... Visualizza
1091 Di Cesare Mannelli L. Development of an in vitro model... Visualizza
1092 Di cesare mannelli L. Alteration of visceral sensitivi... Visualizza
1093 Di cesare mannelli L. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1094 Di cesare mannelli L. Into the unexplored pathophysiol... Visualizza
1095 Di cesare mannelli L. Prophylactic versus Therapeutic ... Visualizza
1096 Di cesare mannelli L. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
3975 Di Cesare Mannelli L. Brassicaceae as source of H2S-re... Visualizza
1097 Di Chio M. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
3976 Di chio M. METAPLASTIC TREATMENTS WITH KETA... Visualizza
3977 Di chio M. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
1098 Di cristo V. Pharmacokinetics of darunavir/co... Visualizza
1099 Di Desidero T. Colon cancer therapy beyond tumo... Visualizza
1100 Di Desidero T. Melanocortin receptor-4 as a nov... Visualizza
1101 Di Desidero T. Metronomic vinorelbine is active... Visualizza
3978 Di febbo C. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1102 Di filippo C. PHARMACOLOGICAL MODULATION OF CA... Visualizza
1103 Di filippo C. MODULATION OF DIABETIC RETINOPAT... Visualizza
3979 Di francesco L. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1104 Di gennaro P. Tryptophan 2,3-dioxygenase inhib... Visualizza
1105 Di Giacomo S. Antiviral and antioxidant activi... Visualizza
1106 Di giacomo S. Effects of the metronomic treatm... Visualizza
3980 Di Giacomo S. _-Caryophyllene oxide as a new c... Visualizza
1107 Di Giorgio FP. In vitro and in vivo antibacteri... Visualizza
1108 Di giulio S. Gamma-hydroxybutyrate intoxicati... Visualizza
1109 Di giulio S. Antidote treatment in Viper enve... Visualizza
1110 Di giulio S. Analytically confirmed post-inje... Visualizza
1111 Di giulio S. Methotrexate therapeutic error i... Visualizza
1112 Di guida F. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
1113 Di guida F. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
3981 Di guida F. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1114 Di iorio BR. Intestine as a Source of Inflamm... Visualizza
1115 Di lascio S. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
1116 Di lascio S. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
1117 Di lascio S. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
3982 Di lascio S. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1118 Di lieto M. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1119 Di lorenzo A. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1120 Di lorenzo D. Reporting of adverse drug reacti... Visualizza
3983 Di Marco R. Dopamine D3 receptor-dependent c... Visualizza
3465 Di Martino A. Kv7 channels are involved in hum... Visualizza
3984 Di martino MT. Identification and validation of... Visualizza
1121 Di marzo V. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
1122 Di marzo V. Hedonic eating in Prader-Willi s... Visualizza
1123 Di marzo V. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
1124 Di marzo V. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3454 Di Marzo V. The loss of Aristaless related h... Visualizza
1125 di Matteo A. In vitro and in vivo antibacteri... Visualizza
1126 Di matteo M. CM554, A NEW POTENT AND SELECTIV... Visualizza
1127 Di mauro G. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
3985 Di mauro G. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
3986 Di mauro G. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
1128 Di minno A. Fluoroscopy-associated oxidative... Visualizza
1129 Di minno A. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3987 Di minno G. Hydrogen sulfide pathway as a ne... Visualizza
3988 Di minno MN. Hydrogen sulfide pathway as a ne... Visualizza
1130 Di nisio C. Peripheral RVD-hemopressin(_) ad... Visualizza
1131 Di nisio C. Effects of Growth Hormone-Releas... Visualizza
1132 Di paola L. Role of P2X7 receptor in early d... Visualizza
3989 Di paola R. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1133 Di paola RD. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
1134 Di paola RD. Inhibition of inflammasome activ... Visualizza
1135 Di paola RD. Bergamot Juice extract treatment... Visualizza
1136 Di paolo A. The ABCB1 pharmacogenetics of R-... Visualizza
1137 Di paolo V. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
1138 Di perri G. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3990 Di perri G. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
3991 Di raimo T. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1139 Di renzo G. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1140 Di renzo L. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
1141 Di sabatino M. Development of microparticles fo... Visualizza
1142 Di silvestre A. THE ROLE OF THE mRNA BINDING PRO... Visualizza
1143 Di Silvestre A. Pharmacoepigenomic markers invol... Visualizza
1144 Di silvestre S. CM554, A NEW POTENT AND SELECTIV... Visualizza
1145 Di sotto A. Effects of the metronomic treatm... Visualizza
1146 Di Sotto A. Antiviral and antioxidant activi... Visualizza
3992 Di Sotto A. _-Caryophyllene oxide as a new c... Visualizza
1147 Di tommaso MD. Aromatase inhibitor-evoked pain ... Visualizza
1148 Diacciati S. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1149 Diana E. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1150 Dianzani C. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
3993 Dianzani C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
3994 Dianzani U. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1151 Diemberger I. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
1152 Diemeberger I. MYOPERICARDITIS AND VACCINES: GA... Visualizza
1153 Dietrich A. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1154 Difrancesco JC. Compound heterozygosis in the kc... Visualizza
1155 Dimiccoli V. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1156 Dimou L. GPR17-expressing oligodendrocyte... Visualizza
1157 Dini Del Lungo L. M. Isoform-selective blockade of HC... Visualizza
3995 Dini L. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3996 Dini L. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
3997 Diolaiuti L. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
1158 Diomede F. Conditioned medium of human peri... Visualizza
1159 Dionisi MD. Understanding the pathogenesis o... Visualizza
1160 Distasi CD. Understanding the pathogenesis o... Visualizza
1161 Dobrowolny G. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
1162 Dolci S. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
1163 Dolci S. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
1164 Doldo P. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
3998 Domi A. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
1165 Dominici C. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1166 Donghia R. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1167 Donnarumma E. 3-Mercaptopyruvate relaxes aorta... Visualizza
1168 Donnini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1169 Donnini S. The Impact Of ALDH-2 Activity On... Visualizza
1170 Donnini S. Tumor stemness and cancer drug-r... Visualizza
1171 Donnini S. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
2889 donnini S. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
3999 Donnini S. Interaction between mPGES-1 and ... Visualizza
4000 Donnini S. Hydroxytyrosol inhibits EGFR sig... Visualizza
4001 Donnini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4002 Dothel G. In vitro effects of mediators de... Visualizza
1172 Dovizio M. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
1173 Dovizio M. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
1174 Dovizio M. Targeting platelet purinergic si... Visualizza
1175 Dovizio M. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
1176 Dovizio M. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
1177 Dovizio M. Generation of 12- hydroxyeicosat... Visualizza
4003 Dovizio M. Platelet-derived microparticles ... Visualizza
4004 Dovizio M. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4005 Dovizio M. MICRORNA-574-5P MODULATES MICROS... Visualizza
4006 Dragani A. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
1178 Drago F. Autoregulation of retinal gangli... Visualizza
1179 Drago F. Off-label drug use at the Univer... Visualizza
1180 Drago F. Role of P2X7 receptor in early d... Visualizza
1181 Drago F. Effects of Taurine in dry eye mo... Visualizza
1182 Drago F. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
1183 Drago F. Role of TGF-_1 in age-related ma... Visualizza
1184 Drago F. Structure based approach for sea... Visualizza
1185 Drago F. Sulodexide prevents high glucose... Visualizza
3405 Drago F. Small molecules to treat diabeti... Visualizza
3406 Drago F. Off-label drug use and safety of... Visualizza
3407 Drago F. Off-label drug use at the Policl... Visualizza
3408 Drago F. Ensure patients access to invest... Visualizza
4007 Drago F. Retinal bioavailability of curcu... Visualizza
4008 Drago F. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
4009 Drago F. Buspirone rescues MK-801-induced... Visualizza
4010 Drago F. Dopamine D3 receptor-dependent c... Visualizza
4011 Drago F. Dopamine D3 receptors control dy... Visualizza
1186 Dreussi E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
4012 Dreussi E. Immunogenetics of prostate cance... Visualizza
4013 Drufuca L. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1187 Dugo P. Evaluation of protective effect ... Visualizza
1188 Durai V. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
1189 Durante M. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
1190 Durante M. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
1191 Durante M. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
1192 Durante M. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
1193 Duranti E. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
4014 Dyson P. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
3530 D’Addario C. Epigenetic regulation of CNR1 ge... Visualizza
3492 D’Agostino B. Nociceptin/orphanin FQ (N/OFQ) c... Visualizza
3502 D’Amario D. Microvascular dysfunction in acu... Visualizza
3606 D’Avolio A. The pharmacological difference o... Visualizza
1195 Eberini I. Inhibition of SIRT1 Deacetylase ... Visualizza
1196 Ecca F. Next generation sequencing for i... Visualizza
1197 Ecca F. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
1199 Edwards CH. IN VITRO AND IN VIVO MODELING OF... Visualizza
1200 Eiandi CM. Sulodexide prevents high glucose... Visualizza
4015 El-beshlawy A. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
1202 Ellis PR. IN VITRO AND IN VIVO MODELING OF... Visualizza
4016 Enghusen-poulsen H. Un-Suggested Prescriptions of No... Visualizza
1203 Ercolano G. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
1204 Ercolano G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
1205 Ercolano G. Modulation of the inflammatory r... Visualizza
4017 Ercolano GE. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
1207 Esposito E. Multiple mechanisms of dimethyl ... Visualizza
1208 Esposito E. Dimethyl fumarate attenuates neu... Visualizza
1209 Esposito E. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
1210 Esposito E. Absence of TLR4 reduces neuroinf... Visualizza
3490 Esposito E. Nuclear factor erythroid 2-relat... Visualizza
4018 Esposito E. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
4019 Esposito E. INHIBITION OF MAMMALIAN TARGET O... Visualizza
1211 Esposito G. Rifaximin induces a PXR-mediated... Visualizza
1212 Esposito G. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
1213 Esposito G. Effects of lung resident mesench... Visualizza
1214 Esposito G. Ranolazine attenuates adverse my... Visualizza
4020 Esposito G. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
4021 Esposito G. Cardio-renal positive effects of... Visualizza
4022 Esposito I. The high price of anticancer dru... Visualizza
1215 Esteller M. DNA METHYLATION: GENE PROFILING ... Visualizza
1216 Evangelista A. The ABCB1 pharmacogenetics of R-... Visualizza
4023 Evangelista V. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
3409 Everard A. Chronic Oleoylethanolamide Treat... Visualizza
1217 Fabio F. Targeting nicotinamide phosphory... Visualizza
1218 Facchinetti F. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
1219 Facchinetti R. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
1220 Facchinetti R. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
4024 Fadda AM. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
3483 Fadda P. The endocannabinoid system: poss... Visualizza
1757 faggi L. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
1221 Failli P. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1222 Failli P. Studying the mechanism of rat ad... Visualizza
1223 Falcicchia C. Sestrin 3 as a regulator of pro-... Visualizza
1224 Falcone A. Colon cancer therapy beyond tumo... Visualizza
1225 Falcone A. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
1226 Falcone A. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
1227 Fallarino F. Aryl hydrocarbon receptor: a nov... Visualizza
1228 Fallarino F. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
4025 Fallarino F. IDO1 activity in selected immune... Visualizza
4026 Fallarino F. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
4027 Fallarino F. REINSTALLING IMMUNE REGULATORY T... Visualizza
1229 Fallarino FF. CpG type-A induction of an early... Visualizza
3605 Falsini B. Neurodegeneration in retina and ... Visualizza
1230 Fancello S. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1231 Fanni S. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
4028 Fanni S. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
1232 Fantacuzzi ML. CM554, A NEW POTENT AND SELECTIV... Visualizza
1233 Fantin M. The protective effect of naringe... Visualizza
1234 Fantozzi R. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
1235 Fantozzi R. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
1236 Fantozzi R. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
4029 Fantozzi R. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
1237 Farina C. A PRECLINICAL SET UP OF A RAT MO... Visualizza
4030 Farina D. Real-time detection of ethanol i... Visualizza
1238 Farinato A. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
1239 Fattore C. OVERTREATMENT IN PHARMACORESISTA... Visualizza
4031 Fattore L. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
4032 Fava C. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4033 Favaretto A. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1240 Favata F. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
4034 Favata F. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
1241 Favoni RE. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
1242 Fedele E. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
1243 Fedele E. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
1244 Fedele E. cGMP MODULATES LONG-TERM POTENTI... Visualizza
1246 Fehrentz J. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
1247 Fehrentz JA. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
1248 Feligioni M. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
1249 Felisi M. Failures to further developing o... Visualizza
4035 Felisi MG. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
4036 Femia AP. INHIBITION OF SPONTANEOUS COLON ... Visualizza
4037 Femia AP. Potential of a flavonoid-rich ex... Visualizza
4038 Ferketich AK. Results from an e-learning cours... Visualizza
1250 Ferland-mccollough D. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1251 Ferlazzo N. Growth inhibition, cell-cycle ar... Visualizza
4039 Ferlazzo N. Potential of a flavonoid-rich ex... Visualizza
1252 Ferrajolo C. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
1253 Ferrajolo C. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
1254 Ferrante C. Peripheral RVD-hemopressin(_) ad... Visualizza
1255 Ferrante C. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1256 Ferrante C. Effects of Growth Hormone-Releas... Visualizza
4040 Ferrante C. Emotional Disorders Induced by H... Visualizza
1257 Ferrara B. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
1258 Ferrara B. ANALYSIS OF TOPOLOGICAL FEATURES... Visualizza
4041 Ferrara B. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1259 Ferrari D. In Vitro Protective Effects of C... Visualizza
1260 Ferrari F. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
1261 Ferrari F. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4042 Ferrari F. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
1262 Ferrari M. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
1263 Ferrari S. Phytochemical Investigation and ... Visualizza
3504 Ferraro E. Cachexia and heart failure: meta... Visualizza
3597 Ferraro L. Evaluation of the possible thera... Visualizza
4043 Ferraro L. Gestational cannabinoid exposure... Visualizza
1264 Ferreira LM. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
1265 Ferreira LM. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
1266 Ferrero S. The ABCB1 pharmacogenetics of R-... Visualizza
1267 Ferri N. G-protein coupled estrogen recep... Visualizza
4044 Ferri N. Geranylgeraniol prevents the sim... Visualizza
4045 Ferri N. High density lipoproteins inhibi... Visualizza
4046 Ferri N. Shedding light on PCSK9 function... Visualizza
1268 Ferri NF. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
1269 Ferro S. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
1270 Ferrocino I. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
1271 Fertonani affini L. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
1272 Festuccia C. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1273 Festuccia C. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
4047 Festuccia C. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
1274 Fiaschi AI. NO level and oxidative stress in... Visualizza
1275 Fidilio A. Effects of Taurine in dry eye mo... Visualizza
1276 Fidilio A. Role of TGF-_1 in age-related ma... Visualizza
4048 Fidilio A. Retinal bioavailability of curcu... Visualizza
1277 Fiengo L. A multiple approach allowed unve... Visualizza
4049 Filipello F. Role of the inflammation in the ... Visualizza
1278 Filippelli A. Health status and concomitant pr... Visualizza
1279 Filippelli A. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1280 Filippelli A. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1281 Filippelli A. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
3411 Filippelli A. A novel methodology for the dosa... Visualizza
4050 Filippelli A. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
1282 Filippelli W. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1283 Filippelli W. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1284 Filippi L. Enhancement of cardiac different... Visualizza
1285 Filippone A. Absence of TLR4 reduces neuroinf... Visualizza
1286 Filippone A. Dimethyl fumarate attenuates neu... Visualizza
1287 Filippone A. Multiple mechanisms of dimethyl ... Visualizza
1288 Filocamo A. Evaluation of protective effect ... Visualizza
4051 Filosa A. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
1289 Fimognari C. Creatine preserves the myogenic ... Visualizza
1290 Fimognari C. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
4052 Fimognari C. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1291 Finelli A. Health status and concomitant pr... Visualizza
1292 Finesso N. Cutaneous hypoxia: effect of oxy... Visualizza
1293 Fini M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1294 Finizio S. A COMPARISON BETWEEN A CANNABIS ... Visualizza
1295 Finocchio E. A prospective observational stud... Visualizza
1296 Fioravanti A. Colon cancer therapy beyond tumo... Visualizza
1297 Fiore D. RIMONABANT KILLS COLON CANCER ST... Visualizza
1300 Fiorentino M. The importance of Integrated Car... Visualizza
1301 Fiorentino S. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
1302 Fiorini G. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
4053 Fiorucci S. The bile acid receptor GPBAR1 re... Visualizza
1303 Fisichella V. Role of TGF-_1 in age-related ma... Visualizza
1304 Flacco ME. Increasing trend in admission ra... Visualizza
1305 Flamini S. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
1306 Flamini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4054 Flamini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1307 Flammini L. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
1308 Florio C. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
1309 Florio L. TREND OF ADVERSE DRUG REACTION R... Visualizza
1310 Florio T. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
1311 Florio T. Subcutaneous slow-release metfor... Visualizza
1312 Florio T. PRION PROTEIN SIGNALLING CONTROL... Visualizza
1313 Focà E. Pharmacokinetics of darunavir/co... Visualizza
4055 Focchi E. ATM INHIBITION AS INNOVATIVE STR... Visualizza
1314 Fogli S. Potential relationship between t... Visualizza
1315 Fogli S. Role of miR-34a as biomarker and... Visualizza
4056 Foltran L. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1316 Fonzino A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
1317 Fonzino A. Gender-dependent involvement of ... Visualizza
1318 Fonzino A. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
1319 Fonzino A. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
1320 Fonzino A. EFFECT OF A LONG TERM TREATMENT ... Visualizza
1321 Fonzino A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
1322 Forcesi E. Occurrence of Liver Injury with ... Visualizza
1323 Forcesi E. MYOPERICARDITIS AND VACCINES: GA... Visualizza
1324 Forcesi E. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
4057 Forcesi E. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
1325 Forgiarini A. The protective effect of naringe... Visualizza
1326 Formica D. EVALUATION OF HEALTH DIRECT COST... Visualizza
1327 Formica D. Access to the market of medicine... Visualizza
1328 Formisano L. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
3495 Formisano L. Epigenetic Regulation of NCXs (s... Visualizza
1329 Fornai M. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
1330 Fornai M. Enteric glia is involved in colo... Visualizza
1331 Fornai M. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
1332 Fornai M. Bifidobacterium Longum and Lacto... Visualizza
1333 Fornai M. Alteration of visceral sensitivi... Visualizza
4058 Fornai M. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
1334 Fornaro L. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
1335 Fornasari D. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
1336 Fornasari D. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
3560 Fornasari D. Opioid medications: indispensabl... Visualizza
4059 Fornasari D. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1337 Fornasaro S. Surfaced-enhanced Raman spectros... Visualizza
1338 Fornasero S. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
1339 Forni M. Effects of ethanolic extracts of... Visualizza
4060 Forni M. In vitro effects of mediators de... Visualizza
4061 Fotia Y. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
1340 Fotio Y. PPAR gamma Activation reduces al... Visualizza
1341 Fragni M. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
1342 Fragni M. In vitro identification of molec... Visualizza
1343 Frammartino T. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1344 Francescato S. Phytochemical Investigation and ... Visualizza
1345 Francescato S. HPLC-MS Analysis of Glucosinolat... Visualizza
1346 Franceschini G. Recombinant LCAT rescues defecti... Visualizza
4062 Franceschini G. High density lipoproteins inhibi... Visualizza
1349 Francesco Rossi NOCICEPTIN/ORPHANINFQ (N/OFQ) CO... Visualizza
1348 Francesco rossi FR. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
1350 Franchi S. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
1351 Franchin G. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
1352 Franchin G. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
4063 Franchina T. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
1353 Francia G. Metronomic vinorelbine is active... Visualizza
4064 Francisci D. The bile acid receptor GPBAR1 re... Visualizza
1354 Franco M. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1355 Franco V. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1356 Frassoldati A. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1357 Fratantonio D. Curcumin Potentiates Antitumor A... Visualizza
4065 Fratantonio D. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
4066 Fratta W. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
1358 Frau R. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3528 Frau R. The Neurosteroidogenic Enzyme 5?... Visualizza
4067 Frau R. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
1359 Freri E. Compound heterozygosis in the kc... Visualizza
1360 Frezza C. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
1361 Frión herrera Y. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
1362 Frión-herrera Y. Antiproliferative effect of Cuba... Visualizza
1363 Frigerio B. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
1364 Frigerio B. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
1365 Froldi G. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
1366 Frosini M. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
1367 Fruttero R. UNRAVELING THE MECHANISM OF ACTI... Visualizza
1368 Fucile C. Subcutaneous slow-release metfor... Visualizza
1369 Fucile C. Measurement of deferasirox plasm... Visualizza
1370 Fugazzotto F. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
4068 Fulceri F. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
1371 Fullone R. Generation of 12- hydroxyeicosat... Visualizza
1372 Fullone R. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
4069 Fullone R. Platelet-derived microparticles ... Visualizza
1373 Fumagalli F. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
1374 Fumagalli F. Acute behavioral and molecular e... Visualizza
1375 Fumagalli F. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
4070 Fumagalli F. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
1376 Fumagalli GF. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
1377 Fumagalli M. Multiple sclerosis and depressio... Visualizza
1378 Fumagalli M. GPR17-expressing oligodendrocyte... Visualizza
1379 Fumagalli M. Cutaneous hypoxia: effect of oxy... Visualizza
3627 Fumagalli M. Investigating microglia and olig... Visualizza
4071 Fumagalli M. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
4072 Fumagalli M. Thistles from Sardinia: evaluati... Visualizza
1380 Furlan R. GPR17-expressing oligodendrocyte... Visualizza
1381 Fusco I. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1382 Fusco I. Involvement of the Prokineticin ... Visualizza
4073 Fusco I. Molecular basis of adenosine A3 ... Visualizza
1383 Fusco L. CHARACTERIZATION OF THE MECHANIS... Visualizza
4074 Fusco R. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1384 Fusco RF. Inhibition of inflammasome activ... Visualizza
1385 Fusco RF. Bergamot Juice extract treatment... Visualizza
1386 Fusco RF. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
1387 Fusi CF. Aromatase inhibitor-evoked pain ... Visualizza
1388 Fusi F. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
4075 Fuxe K. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
1391 Gabaglio M. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
1392 Gabbia D. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
1393 Gabbia D. Antiproliferative effect of Cuba... Visualizza
4076 Gabrielli E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1394 Gaetani S. Chronic Oleoylethanolamide Treat... Visualizza
1395 Gaetani S. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1396 Gaetani S. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1397 Gaetano malgieri GM. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
1398 Gagliardi A. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4077 Gagliardi A. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4078 Gagno S. Immunogenetics of prostate cance... Visualizza
4079 Galati E. M. Aldose Reductase Inhibitors from... Visualizza
4080 Galeano T. Identification and validation of... Visualizza
1399 Galfo F. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
1400 Galfo F. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
4081 Galfo F. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
4082 Galfo F. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4083 Galfo F. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
1401 Galimberti CA. OVERTREATMENT IN PHARMACORESISTA... Visualizza
4084 Galimberti F. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
1402 Galimberti S. The ABCB1 pharmacogenetics of R-... Visualizza
1403 Galiulo M. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1404 Galiulo M. INTENSIVE MONITORING PROGRAM OF ... Visualizza
1405 Galiulo M. A CLINICIAN NETWORK FOR SHARING ... Visualizza
4085 Galiulo M. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
1406 Gallelli CA. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1407 Gallelli CA. Chronic Oleoylethanolamide Treat... Visualizza
1408 Gallelli CA. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1409 Gallelli L. Myotrophin and miR-375 as pharma... Visualizza
1410 Gallelli L. Therapeutic benefits of methylxa... Visualizza
1411 Galleri G. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1412 Galletti P. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
1413 Galletti S. Renal impairment in very low bir... Visualizza
1414 Galli D. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
1415 Galli L. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
1416 Gallia E. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
1417 Gallia E. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
1418 Gallia E. Altered Mechanisms Underlying th... Visualizza
1419 Gallicchio M. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
1420 Gallicchio M. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1421 Gallicchio M. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
4086 Gallipoli S. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
1422 Gallo A. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
1423 Galloni C. FREQUENCY AND CHARACTERISTICS OF... Visualizza
1424 Gallorini M. CM554, A NEW POTENT AND SELECTIV... Visualizza
1425 Galuppini F. Involvement of catechol-O-methyl... Visualizza
1426 Gani A. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1427 Garau D. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
1428 Garavaglia S. Nicotinamide phosphoribosyltrans... Visualizza
1429 Garbi M. Analytically confirmed post-inje... Visualizza
1430 Garbi M. Gamma-hydroxybutyrate intoxicati... Visualizza
1431 Garcia-serna R. In search of biological substant... Visualizza
3596 Gardoni F. Targeting GluN2A-containing N-Me... Visualizza
1432 Gargaro M. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
1433 Gargaro M. Aryl hydrocarbon receptor: a nov... Visualizza
4087 Gargaro M. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
4088 Gargaro M. IDO1 activity in selected immune... Visualizza
1434 Gargaro MG. CpG type-A induction of an early... Visualizza
1435 Gargini M. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
4089 Gargini M.C. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
1436 Gargini MC. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
1437 Gargiulo A. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1438 Garibaldi G. Cutaneous hypoxia: effect of oxy... Visualizza
1439 Garlaschelli K. Apolipoprotein E modulates adapt... Visualizza
1440 Garofalo P. Characterization of adipokines s... Visualizza
1441 Gasco A. UNRAVELING THE MECHANISM OF ACTI... Visualizza
1442 Gasperoni L. DRUGS - INDUCED DISSEMINATED INT... Visualizza
1443 Gasperoni L. Reporting of adverse drug reacti... Visualizza
1444 Gaude E. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
3669 Gaviani P. Liposomal cytarabine in leptomen... Visualizza
1445 Gaviano L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1446 Gaviano L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1447 Gaviano L. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1448 Gavini E. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1449 Gazzano E. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
1450 Gazzerro P. RIMONABANT KILLS COLON CANCER ST... Visualizza
1451 Gellera C. Compound heterozygosis in the kc... Visualizza
4090 Gelmini S. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
1452 Genazzani AA. Nicotinamide phosphoribosyltrans... Visualizza
1453 Genazzani AA. INVESTIGATION OF A PUTATIVE NICO... Visualizza
1454 Genazzani AA. The pharmacogenetics of the resp... Visualizza
1455 Genazzani AA. Real world data about biosimilar... Visualizza
1456 Genazzani AG. Understanding the pathogenesis o... Visualizza
4091 Genedani S. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
1457 Gennazzani A. EVALUATION OF HEALTH DIRECT COST... Visualizza
1458 Genova E. Surfaced-enhanced Raman spectros... Visualizza
3582 Gentile A. Exercise attenuates myelin loss ... Visualizza
1459 Gentile D. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
1460 Gentile D. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
1461 Gentile D. Enteric glia is involved in colo... Visualizza
1462 Gentile D. Bifidobacterium Longum and Lacto... Visualizza
4092 Gentile D. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
1463 Gentili M. Stimulation of CB2 receptor affe... Visualizza
1464 Gentili M. MARKAR survey: influence of dire... Visualizza
1465 Gentili M. On the possible relationship bet... Visualizza
4093 Gentili M. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4094 Gentili M. Interactions between vaccines ag... Visualizza
1466 Gentilucci L. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
1467 Georgescu T. Hypothalamic Circuit Mediates Th... Visualizza
1468 Geppetti P. The antimigraine butterbur ingre... Visualizza
1469 Geppetti PG. Aromatase inhibitor-evoked pain ... Visualizza
4095 Gerace E. METAPLASTIC TREATMENTS WITH KETA... Visualizza
1470 Geraci F. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
1471 Geraci F. Effects of Taurine in dry eye mo... Visualizza
1472 Geraci F. Role of TGF-_1 in age-related ma... Visualizza
4096 Geraci F. Retinal bioavailability of curcu... Visualizza
4097 Geraci F. Buspirone rescues MK-801-induced... Visualizza
4098 Gerdol M. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
1473 Gerhard C. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
1474 Gerlini G. Tryptophan 2,3-dioxygenase inhib... Visualizza
1475 Gessi S. A2B adenosine receptors stimulat... Visualizza
1476 Gessi S. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
1477 Gessi S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
1478 Gesualdo C. MODULATION OF DIABETIC RETINOPAT... Visualizza
1479 Ghalardini C. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
1480 Ghelardini C. Studying the mechanism of rat ad... Visualizza
1481 Ghelardini C. Development of an in vitro model... Visualizza
1482 Ghelardini C. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1483 Ghelardini C. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
1484 Ghelardini C. Into the unexplored pathophysiol... Visualizza
1485 Ghelardini C. Alteration of visceral sensitivi... Visualizza
1486 Ghelardini C. Prophylactic versus Therapeutic ... Visualizza
1487 Ghelardini C. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
1488 Ghelardini C. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
4099 Ghelardini C. Brassicaceae as source of H2S-re... Visualizza
4100 Gherardi M. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1489 Ghibaudi E. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
4101 Giachetti A. Interaction between mPGES-1 and ... Visualizza
1490 Giacomini D. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
1491 Giambelli R. Characterization of adipokines s... Visualizza
1492 Giampietro L. CM554, A NEW POTENT AND SELECTIV... Visualizza
1493 Giancotta C. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
1494 Giancotta C. Early up-regulation of hepatic m... Visualizza
1495 Giancotta C. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1496 Giancotta GC. Sildenafil improves cardiac func... Visualizza
1497 Giancotti LA. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1498 Giannasi C. Bisphosphonates modulate bone bi... Visualizza
3455 Giannasi C. ASC-DERIVED CONDITIONED MEDIUM (... Visualizza
1499 Giannotti G. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
1500 Giannotti G. Acute behavioral and molecular e... Visualizza
4102 Giannotti G. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
1501 Giannuzzi F. Failures to further developing o... Visualizza
1502 Giannuzzi V. Failures to further developing o... Visualizza
3469 Giannuzzi V. The European Regulation for the ... Visualizza
1503 Giardina C. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
4103 Giardina C. Facilitation Of Reporting in hos... Visualizza
1504 Giaroni C. Involvement of catechol-O-methyl... Visualizza
1505 Giaroni, C. Antibiotic-induced dysbiosis aff... Visualizza
1506 Gigli S. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
1507 Gigli S. Rifaximin induces a PXR-mediated... Visualizza
4104 Gigli S. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
4105 Gigliotti CL. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1508 Ginestra G. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
1509 Gini R. Utilization of biological drugs ... Visualizza
1510 Gini R. Real world data about biosimilar... Visualizza
1511 Gini R. EVALUATION OF HEALTH DIRECT COST... Visualizza
1512 Gini R. NSAIDs utilization in a large co... Visualizza
4106 Gini R. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
1513 Ginobbi P. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
4107 Giofrè S. Aldose Reductase Inhibitors from... Visualizza
1514 Gioia tartaglione GT. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
1515 Gioia tartaglione GT. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
1516 Giordano C. Palmitoylethanolamide Reduces Ne... Visualizza
4108 Giordano G. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1517 Giorgi G. NO level and oxidative stress in... Visualizza
1518 Giorgi G. Evaluation of salivary catalase ... Visualizza
1519 Giorgia G. Targeting nicotinamide phosphory... Visualizza
1520 Giorgianni F. WHAT IS THE EFFECT OF RISK MINIM... Visualizza
1521 Giorgianni F. Real world data about biosimilar... Visualizza
1522 Giorgianni F. EVALUATION OF HEALTH DIRECT COST... Visualizza
1523 Giorgianni F. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
1524 Giorgianni F. Intravitreal anti-VEGF injection... Visualizza
1525 Giorgio C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4109 Giorgio C. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
4110 Giorgio E. High density lipoproteins inhibi... Visualizza
1526 Giorgio V. The Impact Of ALDH-2 Activity On... Visualizza
4111 Giovannelli L. INHIBITION OF SPONTANEOUS COLON ... Visualizza
1527 Giovannini MG. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1528 Giovannoni MP. Development of an in vitro model... Visualizza
1529 Girardi A. Renal impairment in very low bir... Visualizza
1530 Girardi A. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
1531 Giron MC. Antibiotic-induced dysbiosis aff... Visualizza
1532 Giron MC. Involvement of catechol-O-methyl... Visualizza
1533 Giron MC. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
1534 Giron MC. Enteric glia is involved in colo... Visualizza
1535 Giron MC. The protective effect of naringe... Visualizza
1536 Giron, MC. Changes of small bowel inhibitor... Visualizza
4112 Gislason G. Un-Suggested Prescriptions of No... Visualizza
1537 Giugliano M. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4113 Giugliano M. Meninges are a reservoir for new... Visualizza
1538 Giuliani D. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
1539 Giuliani D. Melanocortin receptor-4 as a nov... Visualizza
4114 Giuliani D. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
4115 Giuliani D. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4116 Giuliani D. MECHANISM OF HYDROGEN SULFIDE AG... Visualizza
3628 Giuliani P. Influence of P2X7 receptors (pur... Visualizza
1540 Giulivi, C. Changes of small bowel inhibitor... Visualizza
1541 Giurdanella G. Sulodexide prevents high glucose... Visualizza
1542 Giurdanella G. Role of P2X7 receptor in early d... Visualizza
4117 Giurdanella G. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
4118 Giurdanella G. Dopamine D3 receptor-dependent c... Visualizza
1547 Giusepponi ME. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1548 Giusti P. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1549 Giusti P. CLINICAL VALIDATION OF THE REALQ... Visualizza
1550 Giusti P. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
1551 Giusti P. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
1552 Giustino A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
4119 Giva LB. Sphingosine 1-Phosphate And Athe... Visualizza
1553 Gliozzi GM. Sildenafil improves cardiac func... Visualizza
1554 Gliozzi M. Impaired glucose and lipid metab... Visualizza
1555 Gliozzi M. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
1556 Gliozzi M. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1557 Gliozzi M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1558 Gliozzi M. Early up-regulation of hepatic m... Visualizza
1559 Gomaraschi M. Recombinant LCAT rescues defecti... Visualizza
4120 Gomaraschi M. High density lipoproteins inhibi... Visualizza
1560 Gonella L. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4121 Gonella LA. WEB-BASED REPORTING OF ADVERSE D... Visualizza
1561 Gontero E. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
1562 Gonzalez Ruiz P. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1563 Gori A. Pharmacokinetics of darunavir/co... Visualizza
1564 Gori A. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
1565 Gorini A. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
3535 Govoni S. Targeting pathologic amyloid wit... Visualizza
1566 Gozzo L. Off-label drug use and safety of... Visualizza
1567 Gozzo L. Off-label drug use at the Policl... Visualizza
1568 Gozzo L. Off-label drug use at the Univer... Visualizza
3414 Gozzo L. Ensure patients access to invest... Visualizza
1569 Gran BG. CpG type-A induction of an early... Visualizza
1570 Granata A. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
1571 Granata A. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1572 Granata A. UNRAVELING THE MECHANISM OF ACTI... Visualizza
4122 Granchi C. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
1573 Grande R. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
1574 Grande R. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
1575 Grande R. Generation of 12- hydroxyeicosat... Visualizza
1576 Grande R. Targeting platelet purinergic si... Visualizza
4123 Grande R. Platelet-derived microparticles ... Visualizza
1577 Grandi A. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
1578 Grandi A. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
1579 Grandi S. Reporting of adverse drug reacti... Visualizza
1580 Grandi S. DRUGS - INDUCED DISSEMINATED INT... Visualizza
1581 Grandi S. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
4124 Grange C. Megalin and Sodium-Hydrogen Exch... Visualizza
1582 Grassby T. IN VITRO AND IN VIVO MODELING OF... Visualizza
4125 Grassi G. Aldose Reductase Inhibitors from... Visualizza
4126 Grassi MC. Results from an e-learning cours... Visualizza
1583 Gravina GL. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1584 Gravina GL. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
4127 Gravina GL. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
1585 Graziani V. CM554, A NEW POTENT AND SELECTIV... Visualizza
1586 Graziano A. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
1587 Graziella turato GT. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
1588 Graziosi A. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
4128 Graziosi A. NEUROPROTECTIVE EFFECT OF CAFFEI... Visualizza
1589 Greco D. Vitamin D replacement in pre-men... Visualizza
1590 Greco G. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
4129 Greco G. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1591 Gregori M. Measurement of deferasirox plasm... Visualizza
1592 Grieco P. MODULATION OF DIABETIC RETINOPAT... Visualizza
1593 Grigore L. Apolipoprotein E modulates adapt... Visualizza
1594 Grilli M. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
1595 Grilli M. SALMETEROL, A SELECTIVE AND LONG... Visualizza
1596 Grilli M. Functional interaction between n... Visualizza
1597 Grilli M. Prophylactic versus Therapeutic ... Visualizza
4130 Grilli M. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
3415 Grimaldi A. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
1598 Gritti L. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
4131 Grohmann G. REINSTALLING IMMUNE REGULATORY T... Visualizza
4132 Grohmann U. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
1599 Grolla AA. Nicotinamide phosphoribosyltrans... Visualizza
1600 Groppuzzo M. Tacrolimus Therapeutic Drug Moni... Visualizza
1601 Grotti A. Characterization of adipokines s... Visualizza
1602 Grugni G. Hedonic eating in Prader-Willi s... Visualizza
1603 Grundy MM. IN VITRO AND IN VIVO MODELING OF... Visualizza
1604 Gualtieri P. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
4133 Guardascione M. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1605 Guarini S. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
1606 Guarini S. Melanocortin receptor-4 as a nov... Visualizza
4134 Guarini S. MECHANISM OF HYDROGEN SULFIDE AG... Visualizza
4135 Guarini S. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
4136 Guarini S. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
1607 Guerini R. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1608 Guerra A. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
1609 Guerrini R. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4137 Guerrini R. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
4138 Guerrini R. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
4139 Gugliandolo E. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1610 Gugliandolo EG. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
1611 Gugliandolo EG. Bergamot Juice extract treatment... Visualizza
1612 Gugliandolo EG. Inhibition of inflammasome activ... Visualizza
4140 Guglielmi VG. Drug interactions with levothyro... Visualizza
1613 Guglielmo L. Curcumin Ameliorates the In Vitr... Visualizza
1614 Guida F. Pathological gambling new therap... Visualizza
1615 Guida F. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1616 Guida F. Palmitoylethanolamide Reduces Ne... Visualizza
1617 Guida F. Stimulation of CB2 receptor affe... Visualizza
4141 Guida F. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1618 Guida N. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1619 Guido mannaioni GM. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
4142 Guidolin D. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
1621 Guillem-llobat P. Targeting platelet purinergic si... Visualizza
1620 Guillemette C. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1622 Gulisano M. Into the unexplored pathophysiol... Visualizza
1623 Gulisano W. cGMP MODULATES LONG-TERM POTENTI... Visualizza
1624 Gumeni S. The protective effect of naringe... Visualizza
1625 Gurgone D. 3-Mercaptopyruvate relaxes aorta... Visualizza
4143 Gurgone D. Hydrogen sulfide pathway as a ne... Visualizza
1626 Gurlek A. Vitamin D replacement in pre-men... Visualizza
1627 Gurses KM. Vitamin D replacement in pre-men... Visualizza
1628 Gustavo provensi GP. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
1629 Guzzo G. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
4144 Hauben M. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
1630 Haxhi J. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
1631 Heilbronner U. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
1632 Heisler LK. Hypothalamic Circuit Mediates Th... Visualizza
4145 Hilgemann DW. Calcium and ATP-Dependent Potent... Visualizza
1633 Hinz C. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
1634 Hinz C. Generation of 12- hydroxyeicosat... Visualizza
1635 Hla T. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1636 Hope BT. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
1637 Hossain F. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
1638 Hou L. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
1639 Howell LA. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1640 Hoxha M. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
1641 Hrelia P. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
1642 Hrelia P. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
1643 Hrelia P. 6-(METHYLSULFINYL)HEXYLISOTHIOCY... Visualizza
1644 Hrelia P. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
1645 Hrelia P. DNA METHYLATION: GENE PROFILING ... Visualizza
1646 Hrelia P. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
1647 Hrelia P. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3484 Hrelia P. Exposome, genetic traits and fun... Visualizza
4146 Hrelia P. NEUROPROTECTIVE EFFECT OF CAFFEI... Visualizza
4147 Hrelia P. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1648 Hrelia S. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
3655 Hrelia S. Biochemical mechanisms of nutrac... Visualizza
4148 Hu H. Chronic treatment with fluoxetin... Visualizza
1649 Huang X. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
1650 Huber V. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
1651 Iaccarino G. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
1652 Iacobelli C. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
4149 Ialenti A. A ROLE FOR FIBROBLAST GROWTH FAC... Visualizza
1653 Ianaro A. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
1654 Ianaro A. Modulation of the inflammatory r... Visualizza
1655 Ianaro A. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
4150 Ianaro AI. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
1656 Iannaccone T. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1657 Iannaccone T. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1658 Iannaccone T. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
4151 Iannaccone T. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
4152 Iannello F. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
4153 Iannone M. Identification and validation of... Visualizza
1659 Iannopollo M. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1660 Iannotta M. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
1661 Iannotta M. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1662 Iannotta M. Palmitoylethanolamide Reduces Ne... Visualizza
1663 Iannotti F. TRPM8 and experimental colorecta... Visualizza
1664 Iannotti FA. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
1665 Iannotti Fabio Arturo The loss of Aristaless related h... Visualizza
1666 Iannuzzi F. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
1667 Idborg H. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
1668 Ientile V. Real world data about biosimilar... Visualizza
1669 Ientile V. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
1670 Ientile V. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
1671 Ieraci A. Environmental Chronic Stress Ind... Visualizza
1672 Ignazzi A. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1673 Ilari S. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1674 Ilari S. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
4154 Illiano M. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
4155 Ilvento L. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
1675 Imbrici P. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
1676 Imbrici P. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1677 Imitazione P. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
1678 Impellizzeri D. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
4156 Impellizzeri D. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
4157 Impellizzeri P. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
1679 Imperi F. Development of hyaluronan/mannit... Visualizza
1680 Incerti M. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
1681 Indraccolo S. Anti-angiogenic effect of therap... Visualizza
4158 Inferrera A. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1682 Ingrasciotta Y. Real world data about biosimilar... Visualizza
1683 Ingrasciotta Y. EVALUATION OF HEALTH DIRECT COST... Visualizza
4159 Intelisano R. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
1684 Iori R. The chemopreventive effects of i... Visualizza
1685 Iorio A. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
4160 Iorio A. IDO1 activity in selected immune... Visualizza
1686 Ipavec V. EFFECTS OF TETRAETHYLAMMONIUM ON... Visualizza
1687 Ippolito C. Enteric glia is involved in colo... Visualizza
1688 Ippolito C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
1689 Ippolito C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
1690 Irace C. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1691 Irrera N. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
1692 Irrera N. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
1693 Irrera N. Survivin and NAIP in Human Benig... Visualizza
1694 Irrera N. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
1695 Irrera N. Cadmium and its role in brain dy... Visualizza
1696 Irrera N. Activation of the EPOR-b common ... Visualizza
1697 Irrera N. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
4161 Irrera N. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4162 Irrera N. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4163 Irrera N. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
1698 Iudici M. Health status and concomitant pr... Visualizza
4164 Iuliano E. Identification and validation of... Visualizza
4165 Izzo A.A. Herbal dietary supplements for e... Visualizza
1699 Izzo AA. A COMPARISON BETWEEN A CANNABIS ... Visualizza
1700 Izzo AA. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
1701 Izzo AA. TRPM8 and experimental colorecta... Visualizza
1702 Izzo AA. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
1703 Izzo RI. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
1704 Izzo V. Health status and concomitant pr... Visualizza
1705 Jakobsson PJ. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4166 Jakobsson PJ. MICRORNA-574-5P MODULATES MICROS... Visualizza
1706 Johnson MR. Sestrin 3 as a regulator of pro-... Visualizza
1707 Jonker D. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1708 Kagechika H. Myotrophin and miR-375 as pharma... Visualizza
1709 Kannan R. MODELING ROS1 TRANSLOCATION IN L... Visualizza
1710 Karathanasis S. Recombinant LCAT rescues defecti... Visualizza
4167 Kattamis A. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
4168 Keller C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1711 Kern M. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
4169 Khatib M. INHIBITION OF SPONTANEOUS COLON ... Visualizza
1712 Kirchmayer U. NSAIDs utilization in a large co... Visualizza
3585 Kirchmayer U. The role of data sources in Real... Visualizza
1713 Kleinau G. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1714 Kloting N. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1715 Knezevic T. A CLINICIAN NETWORK FOR SHARING ... Visualizza
4170 Knezevic T. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
1716 Kocyigit D. Vitamin D replacement in pre-men... Visualizza
1717 Koczwara JB. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1718 Koczwara JB. Chronic Oleoylethanolamide Treat... Visualizza
1719 Koczwara JB. ROLE OF THE AREA POSTREMA IN THE... Visualizza
4171 Kolachalam S. Clozapine as the most efficaciou... Visualizza
1720 Korotkova M. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4172 Korotkova M. MICRORNA-574-5P MODULATES MICROS... Visualizza
4173 Korpi ER. Dopamine D3 receptor-dependent c... Visualizza
1721 Kreek MJ. EFFECTS OF A NOVEL SELECTIVE SHO... Visualizza
4174 Kreka M. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
1740 L'Andolina M. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
1722 La neve A. OVERTREATMENT IN PHARMACORESISTA... Visualizza
4175 La placa M. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
1723 La Rana G. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
1724 La Rana G. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
1726 Labasque M. Sestrin 3 as a regulator of pro-... Visualizza
1727 Labbozzetta M. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
1728 Labriet A. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1729 Ladetto M. The ABCB1 pharmacogenetics of R-... Visualizza
1730 Lama A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
1731 Lama A. Behavioral and Metabolic Charact... Visualizza
1732 Lama A. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
4176 Lama A. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1733 Lambiase C. Analytically confirmed post-inje... Visualizza
1734 Lana D. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1735 Lanati E. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
1736 Lanati EP. REtrospective study on ItaliaN A... Visualizza
1737 Lancioni M. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
1738 Landi A. Failures to further developing o... Visualizza
1739 Landini I. SELECTION AND CHARACTERIZATION O... Visualizza
4177 Landini I. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
1741 Landonio S. MARKAR survey: influence of dire... Visualizza
1742 Landucci E. Central effects induced by syste... Visualizza
1743 Langasco R. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1744 Lange C. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4178 Lange C. Meninges are a reservoir for new... Visualizza
1745 Langhans W. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1746 Lanni C. MODULATION OF OXIDATIVE AND INFL... Visualizza
1747 Lanuti P. Generation of 12- hydroxyeicosat... Visualizza
4179 Lanuti P. Platelet-derived microparticles ... Visualizza
1748 Lanza M. Multiple mechanisms of dimethyl ... Visualizza
1749 Lanza M. Absence of TLR4 reduces neuroinf... Visualizza
1750 Lanza M. Dimethyl fumarate attenuates neu... Visualizza
1751 Lanzi C. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
1752 Lanzi C. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
1753 Lanzi C. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
81 lanzillotta A. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
1754 Lapi F. NSAIDs utilization in a large co... Visualizza
4180 Lapi FL. Drug interactions with levothyro... Visualizza
1755 Lapucci A. SELECTION AND CHARACTERIZATION O... Visualizza
4181 Lapucci A. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
1756 Laquintana A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1758 Larato A. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
1759 Larato A. ESTIMATING INCIDENCE RATES OF AD... Visualizza
1760 Larato A. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
1761 Lariccia V. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
4182 Lariccia V. Calcium and ATP-Dependent Potent... Visualizza
4183 Lariccia V. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
1762 Larussa T. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
1763 Lattanzi R. Involvement of the Prokineticin ... Visualizza
1764 Lattanzi R. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
1765 Laudati G. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1766 Laufkötter O. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
1767 Laurenti E. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1768 Lauria M. Cross-Disease Analysis of Alzhei... Visualizza
1769 Laurino A. Central effects induced by syste... Visualizza
1770 Laurino A. Angiotensin-II activates p-38 an... Visualizza
1771 Laurino A. Enhancement of cardiac different... Visualizza
1772 Laurino A. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
3417 Laurino A. Isoform-selective blockade of HC... Visualizza
4184 Laurita R. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1773 Lauritano A. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
1774 Lauritano A. Hedonic eating in Prader-Willi s... Visualizza
1775 Lauritano A. A COMPARISON BETWEEN A CANNABIS ... Visualizza
1776 Lauro F. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1777 Lavecchia AM. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
1778 Lazzara A. Off-label drug use at the Univer... Visualizza
3418 Lazzara A. Off-label drug use and safety of... Visualizza
3419 Lazzara A. Off-label drug use at the Policl... Visualizza
3420 Lazzara A. Ensure patients access to invest... Visualizza
1779 Lazzara F. Role of TGF-_1 in age-related ma... Visualizza
1780 Lazzara F. Effects of Taurine in dry eye mo... Visualizza
1781 Lazzara F. Sulodexide prevents high glucose... Visualizza
4185 Lazzara F. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
4186 Lazzara F. Retinal bioavailability of curcu... Visualizza
1782 Lazzara S. Phytochemical Profile and Photot... Visualizza
1783 Lazzarato L. UNRAVELING THE MECHANISM OF ACTI... Visualizza
4187 Lazzeri L. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
1725 Lévesque E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
4188 Le Grand B. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
1784 Lecca D. GPR17-expressing oligodendrocyte... Visualizza
1785 Lecca D. Multiple sclerosis and depressio... Visualizza
1786 Lechi A. A prospective observational stud... Visualizza
1787 Leggio GM. Role of P2X7 receptor in early d... Visualizza
1788 Leggio GM. Role of TGF-_1 in age-related ma... Visualizza
1789 Leggio GM. Sulodexide prevents high glucose... Visualizza
4189 Leggio GM. Dopamine D3 receptors control dy... Visualizza
4190 Leggio GM. Dopamine D3 receptor-dependent c... Visualizza
4191 Leggio GM. Buspirone rescues MK-801-induced... Visualizza
1790 Lembo F. Behavioral and Metabolic Charact... Visualizza
1791 Lenti MC. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
1792 Lentini G. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
1793 Lenzi M. 6-(METHYLSULFINYL)HEXYLISOTHIOCY... Visualizza
1794 Lenzi M. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
1795 Leo A. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
1796 Leo A. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
1797 Leo A. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
1798 Leo A. TREND OF ADVERSE DRUG REACTION R... Visualizza
1799 Leo A. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
1800 Leo V. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
1801 Leonardi L. Renal impairment in very low bir... Visualizza
4192 Leonardi L. Interactions between vaccines ag... Visualizza
1802 Leone R. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
1803 Leone R. A prospective observational stud... Visualizza
3511 Leone R. Frontiers in signal detection: f... Visualizza
4193 Leone R. WEB-BASED REPORTING OF ADVERSE D... Visualizza
1804 Leone S. Peripheral RVD-hemopressin(_) ad... Visualizza
1805 Leone S. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1806 Leone S. Effects of Growth Hormone-Releas... Visualizza
4194 Leone S. Emotional Disorders Induced by H... Visualizza
1807 Leoni L. Development of hyaluronan/mannit... Visualizza
1808 Lepore SM. Anti-proliferative effects of Cy... Visualizza
1809 Lepore SM. Evaluation of protective effect ... Visualizza
1810 Leporini C. MONITORING SAFETY AND USE OF OLD... Visualizza
1811 Leporini C. TREND OF ADVERSE DRUG REACTION R... Visualizza
1812 Leporini C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
1813 Leporini L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1814 Letizia A. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
1815 Letizia A. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
1816 Levandis G. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
4196 Levantesi G. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1817 Leybaert L. Into the unexplored pathophysiol... Visualizza
1818 Li puma S. The antimigraine butterbur ingre... Visualizza
1819 Li puma SL. Aromatase inhibitor-evoked pain ... Visualizza
1820 Liantonio A. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
1821 Liantonio A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
1822 Liantonio A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
1823 Liberto E. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
1824 Liberto E. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
1825 Liedtke W. The antimigraine butterbur ingre... Visualizza
4197 Liepe J. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1826 Lim DL. Understanding the pathogenesis o... Visualizza
4198 Limanaqi F. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
4199 Lin MJ. Calcium and ATP-Dependent Potent... Visualizza
1827 Liparulo A. Effects of lung resident mesench... Visualizza
1828 Lippiello P. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1829 Lisi L. Interactions between antiretrovi... Visualizza
1830 Liu C. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1831 Liu N. Myotrophin and miR-375 as pharma... Visualizza
1832 Llorens-bobadilla E. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4200 Llorens-bobadilla E. Meninges are a reservoir for new... Visualizza
1833 Lo giudice I. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
1834 Lo Monaco M. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
4201 Lo Re G. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
1835 Lo schirico M. The ABCB1 pharmacogenetics of R-... Visualizza
1836 Locatelli CA. Gamma-hydroxybutyrate intoxicati... Visualizza
1837 Locatelli CA. Analytically confirmed post-inje... Visualizza
1838 Locatelli CA. Antidote treatment in Viper enve... Visualizza
1839 Locatelli CA. Methotrexate therapeutic error i... Visualizza
1840 Locatelli M. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1841 Locatelli V. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
1842 Locatelli V. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
1843 Locati M. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
4202 Locati M. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
4203 Locci V. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
1844 Lodola A. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4204 Lodola A. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
1845 Lodovici M. Effects of electronic cigarette ... Visualizza
4205 Lodovici M. Nutraceutical properties of Arth... Visualizza
1846 Lodrini G. Methotrexate therapeutic error i... Visualizza
1847 Lodrini G. Analytically confirmed post-inje... Visualizza
1848 Lolli F. FROM METABOLIC FITNESS TO METABO... Visualizza
1849 Lolli M. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
962 lomas DL. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3624 Lombardi M. Proteomic analysis of ectosomes ... Visualizza
1850 Lombardi N. Risk of bone fractures among use... Visualizza
1851 Lombardi N. Drug-utilization of new oral ant... Visualizza
1852 Lombardi N. Pharmacoutilization of Antidiabe... Visualizza
1853 Lombardi N. Adverse drug reactions in paedia... Visualizza
1854 Lombardi N. FREQUENCY AND CHARACTERISTICS OF... Visualizza
4206 Lombardi N. Incidence of ticagrelor-related ... Visualizza
4207 Lombardi N. Real-world evidence on the risk ... Visualizza
1855 Lombardi S. Identification of a novel, funct... Visualizza
1856 Lombardo GE. Evaluation of protective effect ... Visualizza
1857 Lombardo GE. Growth inhibition, cell-cycle ar... Visualizza
1858 Lombardo GE. Anti-proliferative effects of Cy... Visualizza
1859 Lonati D. Methotrexate therapeutic error i... Visualizza
1860 Lonati D. Antidote treatment in Viper enve... Visualizza
1861 Longo L. Ensure patients access to invest... Visualizza
1862 Longo L. Off-label drug use at the Univer... Visualizza
1863 Longo L. LONG-LASTING EFFECTS OF STRESS I... Visualizza
1864 Longo L. Trends in Spontaneous Adverse Dr... Visualizza
3422 Longo L. Off-label drug use and safety of... Visualizza
3423 Longo L. Off-label drug use at the Policl... Visualizza
1865 Longo V. Evaluation of protective effect ... Visualizza
1866 Lopedota A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1867 Lora R. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4208 Lora R. WEB-BASED REPORTING OF ADVERSE D... Visualizza
1868 Loré F. Evaluation of salivary catalase ... Visualizza
1869 Lorusso D. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1870 Loupakis F. Colon cancer therapy beyond tumo... Visualizza
1871 Lovisari F. Sestrin 3 as a regulator of pro-... Visualizza
1872 Lucafò M. THE ROLE OF THE mRNA BINDING PRO... Visualizza
1873 Lucafo' M. Pharmacoepigenomic markers invol... Visualizza
1874 Lucarini E. Alteration of visceral sensitivi... Visualizza
1875 Lucarini E. Studying the mechanism of rat ad... Visualizza
1876 Lucarini E. Development of an in vitro model... Visualizza
1877 Lucarini E. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1878 Lucarini E. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1879 Lucarini E. Into the unexplored pathophysiol... Visualizza
4209 Lucarini E. Brassicaceae as source of H2S-re... Visualizza
1880 Lucarini L. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
1881 Lucarini L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1882 Lucarini L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1883 Lucarini L. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
1884 Lucarini L. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
4210 Lucchesi S. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
1885 Lucchetti E. Hedonic eating in Prader-Willi s... Visualizza
1886 Lucenteforte E. Risk of bone fractures among use... Visualizza
1887 Lucenteforte E. Adverse drug reactions in paedia... Visualizza
1888 Lucenteforte E. Drug-utilization of new oral ant... Visualizza
1889 Lucenteforte E. Pharmacoutilization of Antidiabe... Visualizza
1890 Lucenteforte E. NSAIDs utilization in a large co... Visualizza
4211 Lucenteforte E. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
4212 Lucenteforte E. Incidence of ticagrelor-related ... Visualizza
4213 Lucenteforte E. Real-world evidence on the risk ... Visualizza
1891 Luceri C. AN IN VITRO MODEL FOR SCREENING ... Visualizza
1892 Luceri C. Effects of NO and H2S releasing ... Visualizza
4214 Luceri C. Nutraceutical properties of Arth... Visualizza
4215 Luceri C. Potential of a flavonoid-rich ex... Visualizza
4216 Luceri C. INHIBITION OF SPONTANEOUS COLON ... Visualizza
1893 Lucia M. TREND OF ADVERSE DRUG REACTION R... Visualizza
1896 Luongo L. Palmitoylethanolamide Reduces Ne... Visualizza
1897 Luongo L. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
1898 Luongo L. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1899 Lupo G. Sulodexide prevents high glucose... Visualizza
1900 Lupo ML. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
1901 Luppi B. Development of microparticles fo... Visualizza
1902 Lutz T. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1903 Luzza F. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
1906 Mabou Tagne A. Tithonia diversifolia (Hemsl.) A... Visualizza
1907 Macallini C. CM554, A NEW POTENT AND SELECTIV... Visualizza
4217 Maccariello A. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
4218 Maccherini M. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
4219 Macchi C. High density lipoproteins inhibi... Visualizza
1908 Macedonio G. Peripheral RVD-hemopressin(_) ad... Visualizza
1909 Macrì ML. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
1910 Madeddu P. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
3456 Madonna G. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
1911 Maestrelli P. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
3552 Maffei F. Sport and Dietary supplements: e... Visualizza
1912 Maftei D. Involvement of the Prokineticin ... Visualizza
1913 Magarò G. In vitro and in vivo antibacteri... Visualizza
1914 Maggi A. FROM METABOLIC FITNESS TO METABO... Visualizza
1915 Maggi A. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
1916 Maggi A. STUDY OF MICROGLIA PROLIFERATION... Visualizza
1917 Maggi A. Inhibition of SIRT1 Deacetylase ... Visualizza
4220 Maggio A. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
1918 Maggio R. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
1919 Maggio R. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1920 Maggisano V. Anti-proliferative effects of Cy... Visualizza
4221 Magi A. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
1921 Magi S. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
4222 Magi S. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
1922 Magni C. MARKAR survey: influence of dire... Visualizza
4223 Magni P. High density lipoproteins inhibi... Visualizza
1923 Magro L. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
1924 Magro L. A prospective observational stud... Visualizza
4224 Magro L. WEB-BASED REPORTING OF ADVERSE D... Visualizza
1925 Maida F. MONITORING SAFETY AND USE OF OLD... Visualizza
1926 Maino B. Involvement of bradykinin B2 rec... Visualizza
1927 Maioli S. Cross-Disease Analysis of Alzhei... Visualizza
4225 Maiolino M. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
1928 Maione F. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1929 Maione S. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
1930 Maione S. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1931 Maione S. Stimulation of CB2 receptor affe... Visualizza
1932 Maione S. Pathological gambling new therap... Visualizza
1933 Maione S. Palmitoylethanolamide Reduces Ne... Visualizza
4226 Maione S. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1934 Maisto R. MODULATION OF DIABETIC RETINOPAT... Visualizza
1935 Maisto R. PHARMACOLOGICAL MODULATION OF CA... Visualizza
1936 Maiuolo J. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1937 Maiuolo J. Impaired glucose and lipid metab... Visualizza
1938 Maiuolo J. Anti-proliferative effects of Cy... Visualizza
1939 Maiuolo J. Early up-regulation of hepatic m... Visualizza
1940 Maiuolo MJ. Sildenafil improves cardiac func... Visualizza
1941 Malafoglia V. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
4227 Malaguti L. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
1942 Malaguti M. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
4228 Malangone P. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
3613 Maldonado R. The endocannabinoid system as th... Visualizza
1943 Malfacini D. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4229 Malfacini D. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
3401 Mallardo D. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
1944 Maloy K. Modulation of the inflammatory r... Visualizza
1945 Mammola CL. Effects of the metronomic treatm... Visualizza
4230 Managò F. A precision medicine genetic mar... Visualizza
4231 Managò F. Dopamine D3 receptors control dy... Visualizza
4232 Manarini S. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4233 Manca ML. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
1946 Mancinelli R. Effects of the metronomic treatm... Visualizza
1947 Mancini A. Kv7 channels are involved in hum... Visualizza
1948 Mancini G.F. AMPHETAMINE AND THE 3,4-METHYLE... Visualizza
4234 Mancini I. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
4235 Mancini T. Sphingosine 1-Phosphate And Athe... Visualizza
1949 Mancusi D. Pharmacokinetics of darunavir/co... Visualizza
1950 Mancuso C. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
3598 Mancuso C. A preclinical study on the nootr... Visualizza
1951 Mandalari G. IN VITRO AND IN VIVO MODELING OF... Visualizza
1952 Mandrioli R. Effects of ethanolic extracts of... Visualizza
1953 Manduca A. CHANGES IN THE ENDOCANNABINOID S... Visualizza
3522 Manduca A. Nutritional omega-3 deficiency s... Visualizza
1954 Manega CM. Fluoroscopy-associated oxidative... Visualizza
4236 Manfredi C. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
1955 Manfredi M. INVESTIGATION OF A PUTATIVE NICO... Visualizza
4237 Manfredi M. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
1956 Mangano G. MONITORING SAFETY AND USE OF OLD... Visualizza
1957 Mangialardi G. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1958 Mangiatordi G.F. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1959 Mangiatordi GF. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
1960 Mango D. ACID-SENSING ION CHANNEL 1A IS R... Visualizza
1961 Mannaioni G. Central effects induced by syste... Visualizza
3457 Mannaioni G. Isoform-selective blockade of HC... Visualizza
1962 Manni G. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
1963 Manni GM. CpG type-A induction of an early... Visualizza
1964 Manning M. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1965 Mannino F. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
1966 Mannino F. Activation of the EPOR-b common ... Visualizza
1967 Mannino F. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
4238 Mannino F. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4239 Mannino F. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
4240 Mannino F. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
1968 Mannucci C. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
1969 Mannucci C. NABILONE AND THC/CBD FOR THE TRE... Visualizza
1970 Manocchio L. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
1971 Mansueto S. Off-label drug use at the Univer... Visualizza
1972 Mansueto S. Trends in Spontaneous Adverse Dr... Visualizza
3425 Mansueto S. Off-label drug use and safety of... Visualizza
3426 Mansueto S. Off-label drug use at the Policl... Visualizza
3427 Mansueto S. Ensure patients access to invest... Visualizza
1973 Mantarro S. INTENSIVE MONITORING PROGRAM OF ... Visualizza
4241 Mantarro S. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
1974 Mantegazza R. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1975 Mantuano P. EFFECT OF A LONG TERM TREATMENT ... Visualizza
1976 Mantuano P. A LONG TERM TREATMENT WITH TAURI... Visualizza
1977 Mantuano P. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
1982 Manzo V. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
1983 Manzo V. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1984 Manzo V. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
4242 Manzo V. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
1985 Manzoli L. Increasing trend in admission ra... Visualizza
1986 Maqoud F. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1987 Maqoud F. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
1988 Maqoud F. Gender-dependent involvement of ... Visualizza
1989 Maqoud F. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
1990 Marabello D. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1991 Marabese I. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1992 Marampon F. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1993 Marampon F. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
1994 Marangon D. GPR17-expressing oligodendrocyte... Visualizza
1995 Marangon D. Multiple sclerosis and depressio... Visualizza
4243 Marín JJ. G. _-Caryophyllene oxide as a new c... Visualizza
1996 Marcelli A. REtrospective study on ItaliaN A... Visualizza
1997 Marchesi N. MODULATION OF OXIDATIVE AND INFL... Visualizza
4244 Marchesini G. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
1998 Marchi C. Vitamin D replacement in pre-men... Visualizza
1999 Marchi M. Functional interaction between n... Visualizza
2000 Marchi M. Prophylactic versus Therapeutic ... Visualizza
4245 Marchianò S. Geranylgeraniol prevents the sim... Visualizza
4246 Marchianò S. Shedding light on PCSK9 function... Visualizza
4247 Marchianò S. The bile acid receptor GPBAR1 re... Visualizza
2001 Marchianò SM. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
2002 Marchione P. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
2003 Marchisio M. Generation of 12- hydroxyeicosat... Visualizza
4248 Marchisio M. Platelet-derived microparticles ... Visualizza
2004 Marcianò I. Intravitreal anti-VEGF injection... Visualizza
2005 Marcianò I. Real world data about biosimilar... Visualizza
4249 Marcianò I. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
2006 Marcoli M. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
2007 Marcoli M. VULNERABILITY TO SEIZURES AND AS... Visualizza
4250 Marcoli M. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
2008 Marconi E. Drug-utilization of new oral ant... Visualizza
2009 Marconi E. Pharmacoutilization of Antidiabe... Visualizza
2010 Marconi E. Adverse drug reactions in paedia... Visualizza
2011 Marelli-berg F. Apolipoprotein E modulates adapt... Visualizza
4251 Marengo A. Thistles from Sardinia: evaluati... Visualizza
4252 Marengo E. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
4253 Marenzi GC. Vitamin D levels and Tissue Fact... Visualizza
2012 Maresca M. Into the unexplored pathophysiol... Visualizza
2013 Maresca M. Studying the mechanism of rat ad... Visualizza
2014 Maresca M. Alteration of visceral sensitivi... Visualizza
2015 Maresca M. Development of an in vitro model... Visualizza
2016 Maresca M. A PRECLINICAL SET UP OF A RAT MO... Visualizza
4254 Maresca M. Brassicaceae as source of H2S-re... Visualizza
2017 Maretta A. Early up-regulation of hepatic m... Visualizza
2018 Maretta A. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2019 Maretta A. Impaired glucose and lipid metab... Visualizza
2020 Maretta MA. Sildenafil improves cardiac func... Visualizza
2024 Marin E. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
2029 Marini H. Cadmium and its role in brain dy... Visualizza
2030 Marini H. Survivin and NAIP in Human Benig... Visualizza
2031 Marini V. Measurement of deferasirox plasm... Visualizza
2032 Marini V. Subcutaneous slow-release metfor... Visualizza
2033 Marino A. A CLINICIAN NETWORK FOR SHARING ... Visualizza
2034 Marino A. INTENSIVE MONITORING PROGRAM OF ... Visualizza
2035 Marino A. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
4255 Marino A. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
3431 Marino F. Tithonia diversifolia (Hemsl.) A... Visualizza
2036 Marino R. The importance of Integrated Car... Visualizza
4256 Marino R. Insulin analogue glargine 300 U/... Visualizza
2037 Mariottini P. VULNERABILITY TO SEIZURES AND AS... Visualizza
4257 Maroli A. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
2038 Marone I. The antimigraine butterbur ingre... Visualizza
2039 Marone IM. Aromatase inhibitor-evoked pain ... Visualizza
2040 Marongiu M.B. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
2041 Marongiu M.B. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
2042 Marrosu F. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
2043 Marshall J. THE ROLE OF THE mRNA BINDING PRO... Visualizza
2044 Marsilio I. Involvement of catechol-O-methyl... Visualizza
2045 Marsilio, I. Changes of small bowel inhibitor... Visualizza
2046 Marsilio, I. Antibiotic-induced dysbiosis aff... Visualizza
2047 Martín C. CHARACTERIZATION OF THE MECHANIS... Visualizza
2048 Marte A. Altered Mechanisms Underlying th... Visualizza
2049 Martelli A. Measurement of deferasirox plasm... Visualizza
2050 Martelli A. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
2051 Martelli A. Kv7 channels are involved in hum... Visualizza
2052 Martelli A. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
4258 Martelli A. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
4259 Martelli A. Brassicaceae as source of H2S-re... Visualizza
4260 Martelli A. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
4261 Martelli A. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
2053 Martelossi S. Pharmacoepigenomic markers invol... Visualizza
2054 Martelossi S. THE ROLE OF THE mRNA BINDING PRO... Visualizza
2055 Marti M. Acute behavioral and molecular e... Visualizza
4262 Martin L. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
2061 Martin-villalba A. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4266 Martin-villalba A. Meninges are a reservoir for new... Visualizza
2056 Martinez J. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
2057 Martinez J. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
4263 Martini C. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
4264 Martini N. The high price of anticancer dru... Visualizza
2058 Martinotti S. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
2059 Martinotti S. Peripheral RVD-hemopressin(_) ad... Visualizza
4265 Martinotti S. Emotional Disorders Induced by H... Visualizza
2060 Martinuzzi A. The protective effect of naringe... Visualizza
2062 Marzocco S. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
2063 Marzocco S. Intestine as a Source of Inflamm... Visualizza
2064 Marzola E. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4267 Mascolo A. Effect of Chronic Kidney Disease... Visualizza
4268 Mascolo A. Un-Suggested Prescriptions of No... Visualizza
4269 Mascolo A. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
4270 Mascolo A. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
2065 Mascolo L. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
2066 Mascolo N. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
2067 Maselli D. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
2068 Maselli M.A. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
2069 Maselli R. Therapeutic benefits of methylxa... Visualizza
2070 Maserati R. Pharmacokinetics of darunavir/co... Visualizza
30 masi A. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
2071 Masi A. Central effects induced by syste... Visualizza
2072 Masini E. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
2073 Masini E. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
2074 Masini E. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
2075 Masini E. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
2076 Masini E. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
2077 Masini E. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
2078 Mason S. MOLECULAR MONITORING OF CHRONIC ... Visualizza
2079 Mason S. CLINICAL VALIDATION OF THE REALQ... Visualizza
2080 Massai L. SELECTION AND CHARACTERIZATION O... Visualizza
2081 Mastrocola R. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
2082 Mastrocola R. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
2083 Mastrocola R. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
4271 Mastrocola R. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
4272 Mastrogiacomo R. A precision medicine genetic mar... Visualizza
4273 Mastrogiacomo R. Dopamine D3 receptors control dy... Visualizza
2084 Materazzi S. The antimigraine butterbur ingre... Visualizza
2085 Matii L. Potential relationship between t... Visualizza
4274 Matino D. IDO1 activity in selected immune... Visualizza
4275 Matino D. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
2086 Matino DM. CpG type-A induction of an early... Visualizza
4276 Mattace G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2087 Mattace raso G. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
2088 Mattace raso G. Behavioral and Metabolic Charact... Visualizza
2089 Mattace raso G. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
2090 Mattace raso G. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
2022 matteis M. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
4277 Matteoli M. Role of the inflammation in the ... Visualizza
2091 Mattera iacono V. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
2092 Mattioli F. Subcutaneous slow-release metfor... Visualizza
2093 Mattioli F. Measurement of deferasirox plasm... Visualizza
4278 Mattivi F. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
2094 Maugeri A. Growth inhibition, cell-cycle ar... Visualizza
4279 Maugeri A. Potential of a flavonoid-rich ex... Visualizza
2095 Maura G. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
2096 Maura G. VULNERABILITY TO SEIZURES AND AS... Visualizza
4280 Maura G. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
4281 Maurel OM. Buspirone rescues MK-801-induced... Visualizza
4282 Maxia A. Thistles from Sardinia: evaluati... Visualizza
2097 Maximova N. Measurement of deferasirox plasm... Visualizza
4283 Mayer F. The high price of anticancer dru... Visualizza
2098 Mazzanti G. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
2099 Mazzanti G. Antiviral and antioxidant activi... Visualizza
2100 Mazzanti G. Effects of the metronomic treatm... Visualizza
4284 Mazzanti G. Suspected adverse reactions to h... Visualizza
4286 Mazzanti G. _-Caryophyllene oxide as a new c... Visualizza
4287 Mazzarella A. In vitro effects of mediators de... Visualizza
2101 Mazzei T. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
4288 Mazzei T. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
4289 Mazzei T. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
2102 Mazzini G. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
2103 Mazzitelli M. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
4290 Mazzitelli M. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
2104 Mccormick PJ. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
2105 Mcdowell HP. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
4291 Mcgreevy KS. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
2106 Mcmahon FJ. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
4292 Mecchio A. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
4293 Mecchio A. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
2107 Meconi A. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
2108 Meda C. FROM METABOLIC FITNESS TO METABO... Visualizza
2109 Medema JP. RIMONABANT KILLS COLON CANCER ST... Visualizza
2110 Megiorni F. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
2111 Mei R. MYOPERICARDITIS AND VACCINES: GA... Visualizza
2112 Melancia F. CHANGES IN THE ENDOCANNABINOID S... Visualizza
2113 Melancia F. AUTISTIC-LIKE BEHAVIORAL ABNORMA... Visualizza
2114 Melani A. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
2115 Melani A. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
3458 Melchiorre M. Isoform-selective blockade of HC... Visualizza
2116 Mele A. Gender-dependent involvement of ... Visualizza
2117 Mele A. A LONG TERM TREATMENT WITH TAURI... Visualizza
2118 Mele A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
2119 Mele A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
2120 Mele A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
2121 Mele L. Proatherosclerotic effect of tri... Visualizza
2122 Meli R. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
2123 Meli R. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
2124 Meli R. Behavioral and Metabolic Charact... Visualizza
3432 Meli R. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
4294 Meli R. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2125 Melis M. DRUGS - INDUCED DISSEMINATED INT... Visualizza
2126 Melis M. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
4295 Melis M. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2127 Mellai M. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
2128 Melone M. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
2129 Memo M. In vitro identification of molec... Visualizza
2130 Memo M. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
2131 Menchiari A. Evaluation of salivary catalase ... Visualizza
2132 Menchini M. Evaluation of protective effect ... Visualizza
4296 Meneguzzi A. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
2133 Menghini L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
4297 Menna E. ATM INHIBITION AS INNOVATIVE STR... Visualizza
4298 Menniti F. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
2134 Menniti-ippolito F. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
4299 Menniti-Ippolito F. Suspected adverse reactions to h... Visualizza
2135 Merciaro I. Conditioned medium of human peri... Visualizza
2136 Merelli M. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
2137 Mereu M. Involvement of catechol-O-methyl... Visualizza
2138 Mereu M. CANNABINOID INVOLVMENT IN THE DE... Visualizza
2139 Mereu M. Effect of amphetamine on choroid... Visualizza
4300 Mereu M. Dopamine D3 receptors control dy... Visualizza
4301 Mereu M. A precision medicine genetic mar... Visualizza
2140 Merighi S. A2B adenosine receptors stimulat... Visualizza
2141 Merighi S. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
2142 Merighi S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
2143 Merlino F. MODULATION OF DIABETIC RETINOPAT... Visualizza
4302 Merlo E. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
2144 Merlo S. THE CONTRIBUTION OF MICROGLIA TO... Visualizza
4303 Merlo S. Chronic treatment with fluoxetin... Visualizza
2145 Messa G. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
2146 Messa G. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
2147 Messori L. SELECTION AND CHARACTERIZATION O... Visualizza
2148 Mestres J. In search of biological substant... Visualizza
2149 Mhillaj E. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
2150 Miano M. The loss of Aristaless related h... Visualizza
2151 Micali A. Survivin and NAIP in Human Benig... Visualizza
2152 Miceli F. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
2153 Miceli N. Evaluation of protective effect ... Visualizza
2154 Michela terlizzi MT. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2155 Micheli L. A PRECLINICAL SET UP OF A RAT MO... Visualizza
2156 Micheli L. Evaluation of salivary catalase ... Visualizza
2157 Micheli L. Into the unexplored pathophysiol... Visualizza
2158 Micheli L. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
2159 Micheli L. NO level and oxidative stress in... Visualizza
2160 Micheli L. Studying the mechanism of rat ad... Visualizza
2161 Micheli L. Alteration of visceral sensitivi... Visualizza
2162 Micheli L. Development of an in vitro model... Visualizza
2163 Micheli L. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
4304 Micheli L. Brassicaceae as source of H2S-re... Visualizza
2164 Michl C. The chemopreventive effects of i... Visualizza
3480 Micioni Di Bonaventura M. V. Genetic and epigenetic regulatio... Visualizza
2165 Micioni di bonaventura MV. ROLE OF THE AREA POSTREMA IN THE... Visualizza
2166 Micioni di bonaventura MV. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
2167 Miele L. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
2168 Migheli R. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
4305 Migheli R. Real-time detection of ethanol i... Visualizza
4306 Migheli R. Real-time monitoring of MPTP-ind... Visualizza
1390 Migliardi G. Safety profile of antipsychotic ... Visualizza
2169 Migliardi G. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
2170 Migliaro V. Hypoxia regulates ANXA1 expressi... Visualizza
2171 Miglio G. ANALYSIS OF TOPOLOGICAL FEATURES... Visualizza
4307 Migliorati G. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2172 Milanese C. In vitro and in vivo antibacteri... Visualizza
2173 Milanese M. Prophylactic versus Therapeutic ... Visualizza
2174 Milanese M. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
2175 Milanese M. Altered Mechanisms Underlying th... Visualizza
2176 Milanese M. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
3576 Milanese M. Targeting Group I metabotropic g... Visualizza
2177 Milano W. HYPERPROLACTINEMIA INDUCED BY AN... Visualizza
2178 Milano W. DO CANNABINOIDS CONFER NEUROPROT... Visualizza
2179 Milano W. THE PSYCHOBIOLOGY OF ENDOCANNABI... Visualizza
2180 Milano W. BENEFICAL EFFECTS OF POLYPHENOLS... Visualizza
2181 Milano W. PROTECTIVE EFFECT OF HDAC INHIBI... Visualizza
2182 Milano W. CANNABINOIDS INVOLVEMENT IN NEUR... Visualizza
2183 Milelli A. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
2184 Milla M. Alteration of visceral sensitivi... Visualizza
4308 Millan MJ. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
2185 Minetto M. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
3654 Minghetti P. Nutrients: when are they markete... Visualizza
4309 Mingrone G. Platelet-derived microparticles ... Visualizza
2186 Mini E. SELECTION AND CHARACTERIZATION O... Visualizza
2187 Mini E. Next generation sequencing for i... Visualizza
2188 Mini E. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
2189 Mini E. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
4310 Mini E. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
4311 Mini E. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
2190 Miniaci MC. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
2191 Minore C. Trends in Spontaneous Adverse Dr... Visualizza
3617 Minotti G. Beyond anthracyclines: new drugs... Visualizza
2192 Minutoli L. Survivin and NAIP in Human Benig... Visualizza
2193 Minutoli L. Cadmium and its role in brain dy... Visualizza
2194 Minutoli L. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
2195 Minutoli L. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
2196 Minutoli L. Activation of the EPOR-b common ... Visualizza
2197 Minutoli L. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
4312 Minutoli L. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4313 Minutoli L. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
4314 Minutoli L. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4315 Minutolo F. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
4316 Minuz P. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4317 Mirabella F. Role of the inflammation in the ... Visualizza
1201 miranda E. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
2198 Miranda R. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
2199 Miro A. Development of hyaluronan/mannit... Visualizza
2200 Miroddi M. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
2201 Miscioscia F. Interactions between antiretrovi... Visualizza
4318 Mishto M. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
2202 Mitidieri E. Development of hyaluronan/mannit... Visualizza
2203 Mitidieri E. 3-Mercaptopyruvate relaxes aorta... Visualizza
4319 Mitidieri E. Hydrogen sulfide pathway as a ne... Visualizza
2204 Mitro N. Fatty acid synthesis is crucial ... Visualizza
2205 Mitro N. Fatty acid synthesis is crucial ... Visualizza
2206 Mocciaro E. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
4320 Mocciaro E. Facilitation Of Reporting in hos... Visualizza
2207 Modugno M. Functional interaction between n... Visualizza
2208 Molinaro P. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
2209 Molino A. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
4321 Molino AM. Human Peripheral blood mononucle... Visualizza
2210 Mollace MV. Sildenafil improves cardiac func... Visualizza
2211 Mollace R. Early up-regulation of hepatic m... Visualizza
2212 Mollace V. Impaired glucose and lipid metab... Visualizza
2213 Mollace V. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2214 Mollace V. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2215 Mollace V. Early up-regulation of hepatic m... Visualizza
2216 Mollace V. Anti-proliferative effects of Cy... Visualizza
2217 Mollace V. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2218 Mollica A. Peripheral RVD-hemopressin(_) ad... Visualizza
4322 Mollica A. Emotional Disorders Induced by H... Visualizza
2219 Mollica MP. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
4323 Mollica MP. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2220 Molonia MS. Curcumin Ameliorates the In Vitr... Visualizza
2221 Molonia MS. In Vitro Protective Effects of C... Visualizza
2222 Molonia MS. Curcumin Potentiates Antitumor A... Visualizza
4324 Molonia MS. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
2223 Molteni L. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
2224 Molteni L. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
2225 Molteni R. Multiple sclerosis and depressio... Visualizza
2226 Moltoni L. NO level and oxidative stress in... Visualizza
4325 Mondanelli G. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
4326 Mondanelli G. REINSTALLING IMMUNE REGULATORY T... Visualizza
2227 Mondello C. NABILONE AND THC/CBD FOR THE TRE... Visualizza
2228 Mondello E. NABILONE AND THC/CBD FOR THE TRE... Visualizza
4327 Mondillo S. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
4328 Monforte M.T. Aldose Reductase Inhibitors from... Visualizza
2229 Montagnani M. POTENTIAL MECHANISMS LINKING DEF... Visualizza
2230 Montagnani M. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
2231 Montagnani M. CM554, A NEW POTENT AND SELECTIV... Visualizza
4329 Montagnani M. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
2232 Montanaro G. Tacrolimus Therapeutic Drug Moni... Visualizza
2233 Montanucci P. Prevention of diabetes in NOD mi... Visualizza
4330 Monte MJ _-Caryophyllene oxide as a new c... Visualizza
2234 Montopoli M. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
2235 Montopoli M. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2236 Montopoli M. The protective effect of naringe... Visualizza
3488 Montuschi P. Breathomics for assessing pharma... Visualizza
2237 Morabito C. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2238 Moran S. DNA METHYLATION: GENE PROFILING ... Visualizza
1894 morbidelli L. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
2239 Morbidelli L. Tumor stemness and cancer drug-r... Visualizza
2240 Morbidelli L. TARGETING THE CANCER RESISTOME T... Visualizza
2241 Morbioli L. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
2242 Morello S. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
3544 Morena M. Impact of different stress inten... Visualizza
2243 Mores N. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
2244 Moretti E. NO level and oxidative stress in... Visualizza
2245 Moretti U. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
2246 Moretti U. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4331 Moretti U. WEB-BASED REPORTING OF ADVERSE D... Visualizza
4332 Moretti U. Interactions between vaccines ag... Visualizza
3534 Morgese M. G. Soluble beta amyloid as bridge b... Visualizza
2247 Morgese MG. A LONG TERM TREATMENT WITH TAURI... Visualizza
2248 Morgia G. Survivin and NAIP in Human Benig... Visualizza
2249 Morice AM. Aromatase inhibitor-evoked pain ... Visualizza
2250 Morici N. Recombinant LCAT rescues defecti... Visualizza
4333 Mornese S. PHARMACOGENETICS OF SOFOSBUVIR ,... Visualizza
2251 Moro PA. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
2252 Moro S. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
2253 Morreale I. Trends in Spontaneous Adverse Dr... Visualizza
2254 Morroni F. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
2255 Morroni F. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
2256 Morroni F. Cross-Disease Analysis of Alzhei... Visualizza
4334 Morroni F. NEUROPROTECTIVE EFFECT OF CAFFEI... Visualizza
4335 Mortensen R. Un-Suggested Prescriptions of No... Visualizza
2257 Morucci G. Into the unexplored pathophysiol... Visualizza
2258 Mosca I. Compound heterozygosis in the kc... Visualizza
2259 Mosca I. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
4336 Moscatelli V. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
2260 Moscato S. Potential relationship between t... Visualizza
2261 Moschetti G. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
2262 Moschetti G. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
4337 Mostallino MC. PGE1 DELIVERED BY LIPOSOMES ANTA... Visualizza
2023 mota M. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2263 Motola D. DRUGS - INDUCED DISSEMINATED INT... Visualizza
2264 Motola D. Reporting of adverse drug reacti... Visualizza
2265 Motola D. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
2266 Mottarlini F. Acute behavioral and molecular e... Visualizza
2267 Mottarlini F. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
4338 Mottarlini F. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
2268 Mozzanica F. USE OF PROTON PUMP INHIBITORS AN... Visualizza
4339 Mozzanica F. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
2269 Mugelli A. Risk of bone fractures among use... Visualizza
2270 Mugelli A. Angiotensin-II activates p-38 an... Visualizza
2271 Mugelli A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
2272 Mugelli A. Enhancement of cardiac different... Visualizza
2273 Mugelli A. Drug-utilization of new oral ant... Visualizza
2274 Mugelli A. Pharmacoutilization of Antidiabe... Visualizza
2275 Mugelli A. Adverse drug reactions in paedia... Visualizza
2276 Mugelli A. NSAIDs utilization in a large co... Visualizza
3433 Mugelli A. Isoform-selective blockade of HC... Visualizza
4340 Mugelli A. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
4341 Mugelli A. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
4342 Mugelli A. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
4343 Mugelli A. Real-world evidence on the risk ... Visualizza
4344 Mugelli A. Incidence of ticagrelor-related ... Visualizza
4345 Mulinacci N. INHIBITION OF SPONTANEOUS COLON ... Visualizza
4346 Muntoni AL. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2277 Muntoni E. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
2278 Murphy KM. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
4347 Murphy KM. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
2279 Murphy TL. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
2280 Musaro' A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
2281 Musazzi L. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
2282 Musazzi L. Altered Mechanisms Underlying th... Visualizza
3482 Musazzi L. Acute stress rapidly increases e... Visualizza
2283 Muscarà Curcumin Potentiates Antitumor A... Visualizza
2284 Muscarà C. In Vitro Protective Effects of C... Visualizza
4348 Muscarà C. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
4349 Muscari I. Artocarpus tonkinensis, a Vietna... Visualizza
2285 Muscatello B. Metronomic vinorelbine is active... Visualizza
2286 Muscatello M. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
2287 Muscoli C. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
2288 Muscoli C. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2289 Muscoli C. Impaired glucose and lipid metab... Visualizza
2290 Muscoli C. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2291 Muscoli C. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2292 Muscoli C. Early up-regulation of hepatic m... Visualizza
2293 Muscoli MC. Sildenafil improves cardiac func... Visualizza
2294 Musolino C. Curcumin Ameliorates the In Vitr... Visualizza
2295 Musolino MV. Sildenafil improves cardiac func... Visualizza
2296 Musolino V. Impaired glucose and lipid metab... Visualizza
2297 Musolino V. Early up-regulation of hepatic m... Visualizza
2298 Musolino V. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2299 Musolino V. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2300 Musumeci O. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
2301 Muttenthaler M. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
4350 Mutti A. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
2302 Nacci C. POTENTIAL MECHANISMS LINKING DEF... Visualizza
2303 Nacci C. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
4351 Nacci C. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
2304 Nagahara N. 3-Mercaptopyruvate relaxes aorta... Visualizza
2305 Nannelli G. The Impact Of ALDH-2 Activity On... Visualizza
2306 Nannini M. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
2307 Napoli B. The protective effect of naringe... Visualizza
2308 Napoli C. SELECTION AND CHARACTERIZATION O... Visualizza
4352 Napoli C. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
2309 Napoli E. Phytochemical Profile and Photot... Visualizza
2310 Napoli, E. Changes of small bowel inhibitor... Visualizza
2311 Nappi P. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
2312 Nappo A. Reporting of adverse drug reacti... Visualizza
2313 Nassini R. The antimigraine butterbur ingre... Visualizza
2314 Nassini RN. Aromatase inhibitor-evoked pain ... Visualizza
4353 Natale G. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
2315 Navarra M. Growth inhibition, cell-cycle ar... Visualizza
2316 Navarra M. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
4354 Navarra M. Potential of a flavonoid-rich ex... Visualizza
2317 Navarra P. Interactions between antiretrovi... Visualizza
2318 Naviglio S. Pharmacoepigenomic markers invol... Visualizza
2319 Nencioni L. Antiviral and antioxidant activi... Visualizza
2320 Nesci V. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
2321 Nesci V. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
4355 Neubert A. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
2322 Nguyen TP. Cross-Disease Analysis of Alzhei... Visualizza
2323 Niada S. Bisphosphonates modulate bone bi... Visualizza
2856 Niada S. ASC-DERIVED CONDITIONED MEDIUM (... Visualizza
2324 Nicchia GP. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
4356 Niccolai A. Nutraceutical properties of Arth... Visualizza
4357 Nicolella G. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
2325 Nicoletti F. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2326 Nicoletti M. Antiviral and antioxidant activi... Visualizza
2327 Nicolotti O. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
2328 Nicolotti O. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
2329 Nicotri S. Failures to further developing o... Visualizza
2330 Nieri P. Role of miR-34a as biomarker and... Visualizza
2331 Nieri P. Potential relationship between t... Visualizza
2332 Nieri P. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
2333 Niero F. MARKAR survey: influence of dire... Visualizza
2334 Nigro D. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
2335 Nigro D. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
2336 Nigro D. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
4358 Nigro D. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
2337 Nigro EA. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
2338 Nisticò R. ACID-SENSING ION CHANNEL 1A IS R... Visualizza
2339 Nisticò R. Involvement of bradykinin B2 rec... Visualizza
2340 Nistico R. Involvement of the Prokineticin ... Visualizza
4359 Nitrato A. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2341 Nitrato izzo A. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
2342 Nitrato izzo A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
2343 Nizzari M. PRION PROTEIN SIGNALLING CONTROL... Visualizza
2344 Nobili S. SELECTION AND CHARACTERIZATION O... Visualizza
2345 Nobili S. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
2346 Nobili S. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
2347 Nobili S. Next generation sequencing for i... Visualizza
4360 Nobili S. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
4361 Nobili S. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
2348 Nocentini G. Prevention of diabetes in NOD mi... Visualizza
4362 Nofer JR. Sphingosine 1-Phosphate And Athe... Visualizza
2349 Norata D. Fatty acid synthesis is crucial ... Visualizza
2350 Norata D. Apolipoprotein E modulates adapt... Visualizza
2351 Norata GD. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
4363 Norata GD. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
2352 Notarbartolo M. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
2353 Nucera NS. Sildenafil improves cardiac func... Visualizza
2354 Nucera S. Early up-regulation of hepatic m... Visualizza
2355 Nucera S. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2356 Nucifora D. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
2357 Nunnari P. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
2358 Nunnari P. The importance of Integrated Car... Visualizza
4364 Nunnari P. Insulin analogue glargine 300 U/... Visualizza
2359 Nunnari PN. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2360 Nunziata A. IMPORTANCE OF ADHERENCE TO TREAT... Visualizza
2361 Nunziata A. Pathological gambling new therap... Visualizza
2363 O'Donnell V. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
2364 O'donnell V. Generation of 12- hydroxyeicosat... Visualizza
2362 Occhiuto F. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
2365 Oguz SH. Vitamin D replacement in pre-men... Visualizza
2366 Oliva F. Recombinant LCAT rescues defecti... Visualizza
2367 Olivero G. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2368 Olivero G. Functional interaction between n... Visualizza
2369 Olivero G. Prophylactic versus Therapeutic ... Visualizza
2370 Olivero G. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
2371 Ombrato R. In vitro and in vivo antibacteri... Visualizza
2372 Onder G. NSAIDs utilization in a large co... Visualizza
4365 Onder G. Real-world evidence on the risk ... Visualizza
2373 Onofri F. Altered Mechanisms Underlying th... Visualizza
2374 Onore ME. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
2375 Oppedisano F. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2376 Oppedisano F. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2377 Oppedisano F. Early up-regulation of hepatic m... Visualizza
2378 Oppedisano OF. Sildenafil improves cardiac func... Visualizza
2379 Opri S. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4366 Opri S. WEB-BASED REPORTING OF ADVERSE D... Visualizza
4367 Orabona C. REINSTALLING IMMUNE REGULATORY T... Visualizza
4368 Orabona C. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
4369 Origa R. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
2380 Orlandi P. Melanocortin receptor-4 as a nov... Visualizza
2381 Orlandi P. Metronomic vinorelbine is active... Visualizza
2382 Orlandi P. Colon cancer therapy beyond tumo... Visualizza
2383 Orlando G. Effects of Growth Hormone-Releas... Visualizza
2384 Orlando G. Peripheral RVD-hemopressin(_) ad... Visualizza
2385 Orlando G. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
4370 Orlando G. Emotional Disorders Induced by H... Visualizza
2386 Orlando P. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2387 Orso G. The protective effect of naringe... Visualizza
2388 Orso G. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2389 Orso G. Enteric glia is involved in colo... Visualizza
2390 Orso G. Involvement of catechol-O-methyl... Visualizza
2391 Orso, G. Antibiotic-induced dysbiosis aff... Visualizza
2392 Orso, G. Changes of small bowel inhibitor... Visualizza
2393 Ossato A. Acute behavioral and molecular e... Visualizza
2394 Ossoli A. Recombinant LCAT rescues defecti... Visualizza
2395 Ostacolo C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2396 Oteri A. Trends in Spontaneous Adverse Dr... Visualizza
2397 Ottani A. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
2398 Ottani A. Melanocortin receptor-4 as a nov... Visualizza
4371 Ottani A. MECHANISM OF HYDROGEN SULFIDE AG... Visualizza
4372 Ottani A. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
2399 P V. Healthcare resources use in pati... Visualizza
2400 P V. Burden of comorbidities in HCV p... Visualizza
2403 Paccagnella N. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
2404 Pace S. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
2405 Pacini A. Into the unexplored pathophysiol... Visualizza
2406 Pacor S. TARGETING THE CANCER RESISTOME T... Visualizza
2407 Padolecchia C. Functional interaction between n... Visualizza
4373 Padovani L. METAPLASTIC TREATMENTS WITH KETA... Visualizza
4374 Padula R. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
2408 Pagano E. A COMPARISON BETWEEN A CANNABIS ... Visualizza
2409 Pagano E. TRPM8 and experimental colorecta... Visualizza
2410 Pagano E. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
4375 Pagliarini M. WEB-BASED REPORTING OF ADVERSE D... Visualizza
4376 Pagnotta E. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
2411 Paladin D. MOLECULAR MONITORING OF CHRONIC ... Visualizza
2412 Paladin D. CLINICAL VALIDATION OF THE REALQ... Visualizza
2413 Paladin D. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
2414 Paladin D. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
2415 Paladini MS. Multiple sclerosis and depressio... Visualizza
2416 Palazzo E. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
4377 Pallavicini A. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
2417 Palleria C. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
2418 Palleria C. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
2419 Palleria C. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
2420 Palleria C. TREND OF ADVERSE DRUG REACTION R... Visualizza
2421 Palleria C. MONITORING SAFETY AND USE OF OLD... Visualizza
2422 Pallio G. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
2423 Pallio G. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
2424 Pallio G. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
2425 Pallio G. Activation of the EPOR-b common ... Visualizza
2426 Pallio G. Cadmium and its role in brain dy... Visualizza
2427 Pallio G. Survivin and NAIP in Human Benig... Visualizza
4378 Pallio G. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4379 Pallio G. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4380 Pallio G. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
2428 Pallotta L. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
4381 Pallotta M. REINSTALLING IMMUNE REGULATORY T... Visualizza
4382 Pallotta M. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
4383 Pallotta MT. The proteasome inhibitor bortezo... Visualizza
2429 Pallottini V. CHANGES IN THE ENDOCANNABINOID S... Visualizza
2430 Palma E. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2431 Palma E. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2432 Palma lopez LP. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
2433 Palma PE. Sildenafil improves cardiac func... Visualizza
2434 Palmeri A. cGMP MODULATES LONG-TERM POTENTI... Visualizza
4384 Palmisano M. N/OFQ and CRF systems dysregulat... Visualizza
2435 Palumbo G. The ABCB1 pharmacogenetics of R-... Visualizza
4385 Panagia P. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
2436 Pandolfi A. CM554, A NEW POTENT AND SELECTIV... Visualizza
2437 Pani A. The importance of Integrated Car... Visualizza
2438 Pani A. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
4386 Pani A. Insulin analogue glargine 300 U/... Visualizza
2439 Pani AP. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2440 Pannini S. Evaluation of salivary catalase ... Visualizza
2441 Pannunzio A. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
2442 Pannuti A. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
2443 Pantaleo MA. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
2444 Panuccio G. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4387 Panuccio G. Meninges are a reservoir for new... Visualizza
2445 Panza E. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
2446 Panza E. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
2447 Panza E. Modulation of the inflammatory r... Visualizza
4388 Panza EP. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
2448 Paolini M. Effects of electronic cigarette ... Visualizza
2449 Paolini M. Development of microparticles fo... Visualizza
2450 Paolini M. The chemopreventive effects of i... Visualizza
2452 Paolone G. Sestrin 3 as a regulator of pro-... Visualizza
2453 Paone S. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2454 Papaleo F. CANNABINOID INVOLVMENT IN THE DE... Visualizza
2455 Papaleo F. Effect of amphetamine on choroid... Visualizza
2456 Papaleo F. Involvement of catechol-O-methyl... Visualizza
3527 Papaleo F. A precision medicine genetic mar... Visualizza
4389 Papaleo F. Dopamine D3 receptors control dy... Visualizza
4390 Papaleo F. A precision medicine genetic mar... Visualizza
2457 Papapetropoulos A. 3-Mercaptopyruvate relaxes aorta... Visualizza
2458 Papp M. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
2459 Pardini C. Melanocortin receptor-4 as a nov... Visualizza
2460 Pardu A. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
4391 Pardu A. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2461 Parente L. Effects of Prisma® Skin dermal ... Visualizza
2462 Parente L. Hypoxia regulates ANXA1 expressi... Visualizza
4392 Parente L. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
2463 Parenti A. Tryptophan 2,3-dioxygenase inhib... Visualizza
4393 Parenti C. Chronic treatment with fluoxetin... Visualizza
2464 Parisi OA. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2465 Parisi OA. A COMPARISON BETWEEN A CANNABIS ... Visualizza
2466 Parisi OA. TRPM8 and experimental colorecta... Visualizza
4394 Parisotto M. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
2467 Parolaro D. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
2468 Parolaro D. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
2469 Parravicini C. Inhibition of SIRT1 Deacetylase ... Visualizza
1198 parrella E. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2470 Parrilli M. FREQUENCY AND CHARACTERISTICS OF... Visualizza
2471 Parrilli M. INTENSIVE MONITORING PROGRAM OF ... Visualizza
2472 Parrilli M. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
2473 Pascale A. MODULATION OF OXIDATIVE AND INFL... Visualizza
2474 Pascale A. Small molecules to treat diabeti... Visualizza
2475 Pasqualetti F. Melanocortin receptor-4 as a nov... Visualizza
2476 Pasqualini L. Anti-angiogenic effect of therap... Visualizza
2477 Pasquini S. A2B adenosine receptors stimulat... Visualizza
2478 Pasquini S. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
2479 Pasquini S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
2480 Passalacqua M. VULNERABILITY TO SEIZURES AND AS... Visualizza
2481 Passalacqua M. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
4395 Passalacqua M. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
3478 Passani M. Histaminergic neurons partake in... Visualizza
2482 Passani MB. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2483 Passani MB. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
2484 Passerini N. Development of microparticles fo... Visualizza
2485 Pastorello M. Real world data about biosimilar... Visualizza
2486 Pastorello M. EVALUATION OF HEALTH DIRECT COST... Visualizza
2487 Pastoris O. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
2488 Paterniti I. Multiple mechanisms of dimethyl ... Visualizza
2489 Paterniti I. Dimethyl fumarate attenuates neu... Visualizza
2490 Paterniti I. Absence of TLR4 reduces neuroinf... Visualizza
4396 Paterniti I. INHIBITION OF MAMMALIAN TARGET O... Visualizza
2491 Patrignani P. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
2492 Patrignani P. Conditioned medium of human peri... Visualizza
2493 Patrignani P. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
2494 Patrignani P. Targeting platelet purinergic si... Visualizza
2495 Patrignani P. Generation of 12- hydroxyeicosat... Visualizza
2496 Patrignani P. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
2497 Patrignani P. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3477 Patrignani P. Acetylsalicylic acid and cancer:... Visualizza
4397 Patrignani P. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4398 Patrignani P. MICRORNA-574-5P MODULATES MICROS... Visualizza
4399 Patrignani P. Platelet-derived microparticles ... Visualizza
4400 Patrono C. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2498 Pattarozzi A. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
2499 Pattarozzi A. Subcutaneous slow-release metfor... Visualizza
2500 Pavanello S. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
2501 Pavia M. MONITORING SAFETY AND USE OF OLD... Visualizza
4401 Pazzagli M. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
2402 Pòalazzo E. Palmitoylethanolamide Reduces Ne... Visualizza
2502 Pea F. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
4402 Peana AT. Real-time monitoring of MPTP-ind... Visualizza
4403 Peana AT. Real-time detection of ethanol i... Visualizza
2503 Pecoraro M. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
2504 Pedata F. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
2505 Pedata F. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
2506 Pedata F. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
4404 Pedata F. Molecular basis of adenosine A3 ... Visualizza
2507 Peeters G. On the possible relationship bet... Visualizza
2508 Pelaia G. Therapeutic benefits of methylxa... Visualizza
2509 Pelin M. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
2510 Pelin M. CHARACTERIZATION OF THE MECHANIS... Visualizza
2511 Pelin M. Surfaced-enhanced Raman spectros... Visualizza
2512 Pellegatta F. Apolipoprotein E modulates adapt... Visualizza
2513 Pellegrini C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
2514 Pellegrini C. Bifidobacterium Longum and Lacto... Visualizza
2515 Pellegrini C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
2516 Pellegrini C. Enteric glia is involved in colo... Visualizza
4405 Pellegrini C. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
2517 Pellegrini-gampietro DE. Central effects induced by syste... Visualizza
4406 Pellegrini-giampietro DE. METAPLASTIC TREATMENTS WITH KETA... Visualizza
2518 Penco I. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
2519 Penna F. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
2520 Pepe G. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
2521 Pepe G. STUDY OF MICROGLIA PROLIFERATION... Visualizza
4407 Perego C. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
4408 Pericolini E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2522 Perluigi M. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
2523 Perone M. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
2524 Perrella M. Characterization of adipokines s... Visualizza
2525 Perretti M. MODULATION OF DIABETIC RETINOPAT... Visualizza
2526 Perri M. Myotrophin and miR-375 as pharma... Visualizza
2527 Perri MR. Therapeutic benefits of methylxa... Visualizza
4409 Perrone F. The high price of anticancer dru... Visualizza
2528 Perrone G. SELECTION AND CHARACTERIZATION O... Visualizza
4410 Perrone G. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
2529 Perucca E. OVERTREATMENT IN PHARMACORESISTA... Visualizza
2530 Pescara T. Prevention of diabetes in NOD mi... Visualizza
2531 Pesce M. Rifaximin induces a PXR-mediated... Visualizza
2532 Pesce M. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
2533 Pesce V. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
2534 Petragnani N. Targeting platelet purinergic si... Visualizza
2535 Petragnani N. Conditioned medium of human peri... Visualizza
2536 Petrella A. Hypoxia regulates ANXA1 expressi... Visualizza
2537 Petrella A. Effects of Prisma® Skin dermal ... Visualizza
4411 Petrella A. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
2538 Petrella C. Involvement of bradykinin B2 rec... Visualizza
2539 Petrella M. PPAR gamma Activation reduces al... Visualizza
2540 Petretto E. Sestrin 3 as a regulator of pro-... Visualizza
2541 Petrillo MG. Prevention of diabetes in NOD mi... Visualizza
4412 Petrillo MG. A NOVEL INTERACTION BETWEEN GLUC... Visualizza
2542 Petrini M. The ABCB1 pharmacogenetics of R-... Visualizza
2543 Petrocchi passeri P. Involvement of bradykinin B2 rec... Visualizza
2544 Petrocelli A. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
2545 Petrolini VM. Gamma-hydroxybutyrate intoxicati... Visualizza
2546 Petrolini VM. Analytically confirmed post-inje... Visualizza
4413 Petrucci G. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2547 Petti LP. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
2548 Pezzolla F. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
2549 Piano I. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
2550 Piano I. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
4414 Piano I. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
4415 Piazza C. Retinal bioavailability of curcu... Visualizza
2551 Piazza S. Cutaneous hypoxia: effect of oxy... Visualizza
4416 Piazza S. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
4417 Piazza S. Thistles from Sardinia: evaluati... Visualizza
4418 Picariello L. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
2552 Piccinin S. Involvement of bradykinin B2 rec... Visualizza
2553 Piccirillo S. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
4419 Piccirillo S. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
2554 Piccolo M. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
2555 Piegari E. Ranolazine attenuates adverse my... Visualizza
2556 Piegari E. Effects of lung resident mesench... Visualizza
4420 Piegari E. Cardio-renal positive effects of... Visualizza
2557 Piemontese DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
2558 Pierfranco spano PS. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2559 Pierno S. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
2560 Pierno S. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
2561 Pierno S. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
2562 Pierno S. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
2563 Pieroni S. A CLINICIAN NETWORK FOR SHARING ... Visualizza
4421 Pieroni S. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
1543 pignataro G. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2564 Pignatello R. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2565 Pignatiello S. TRPM8 and experimental colorecta... Visualizza
2566 Pingeon M. Health status and concomitant pr... Visualizza
3435 Pingeon M. A novel methodology for the dosa... Visualizza
2567 Pini A. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
4422 Pini A. Megalin and Sodium-Hydrogen Exch... Visualizza
2568 Pino A. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
2569 Pino A. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
4423 Pino A. Meninges are a reservoir for new... Visualizza
2570 Pino MS. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
28 pinto A. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2571 Pinto A. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
2572 Pinto A. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
2573 Pinto A. Intestine as a Source of Inflamm... Visualizza
2574 Pinto A. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3436 Pinto A. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
4424 Pinto A. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
4425 Pinto AP. Human Peripheral blood mononucle... Visualizza
2575 Pinzani P. SELECTION AND CHARACTERIZATION O... Visualizza
4426 Pinzani P. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
2576 Piontini AP. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
2577 Piragine E. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
4427 Piragine E. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
4428 Piragine E. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
4429 Piragine E. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
4430 Piras F. A precision medicine genetic mar... Visualizza
4431 Pirillo A. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
2578 Piro B. TREND OF ADVERSE DRUG REACTION R... Visualizza
2579 Piro R. MONITORING SAFETY AND USE OF OLD... Visualizza
2580 Pirolo R. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
2581 Pirolo R. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
2582 Pirozzi C. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
2583 Pirozzi C. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
4432 Pirozzi C. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2584 Pirro M. Aryl hydrocarbon receptor: a nov... Visualizza
2585 Pirro MP. CpG type-A induction of an early... Visualizza
2586 Pisanu C. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
2587 Pisanu C. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
2588 Piscitelli A. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
2589 Piscitelli F. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
2590 Piscitelli F. Hedonic eating in Prader-Willi s... Visualizza
2591 Piscitelli F. A COMPARISON BETWEEN A CANNABIS ... Visualizza
2592 Piscitelli F. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2593 Piscopo C. RIMONABANT KILLS COLON CANCER ST... Visualizza
2594 Pistelli L. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
4433 Pistis M. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2595 Pittalà V. Small molecules to treat diabeti... Visualizza
2596 Pittaluga A. Prophylactic versus Therapeutic ... Visualizza
2597 Pittaluga A. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2598 Pittaluga A. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
2599 Pittaluga A. Functional interaction between n... Visualizza
3580 Pittaluga A. Environmental enrichment modulat... Visualizza
4434 Piva A. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
4435 Piva A. METAPLASTIC TREATMENTS WITH KETA... Visualizza
4436 Pizzamiglio L. ATM INHIBITION AS INNOVATIVE STR... Visualizza
2026 pizzi M. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
3494 Pizzi M. Epigenetic regulation of apoptos... Visualizza
2600 Pizzimenti V. Access to the market of medicine... Visualizza
2601 Pizzino CG. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
2602 Pizzino G. MODELING ROS1 TRANSLOCATION IN L... Visualizza
2603 Pizzino G. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
2604 Pizzino G. Activation of the EPOR-b common ... Visualizza
2605 Pizzino G. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
2606 Pizzino G. Survivin and NAIP in Human Benig... Visualizza
2607 Pizzino G. Cadmium and its role in brain dy... Visualizza
4437 Pizzino G. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
4438 Pizzino G. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4439 Pizzino G. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
2608 Pizzoferrato M. Interactions between antiretrovi... Visualizza
2609 Platania C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2610 Platania CB. Structure based approach for sea... Visualizza
2611 Platania CB. Role of TGF-_1 in age-related ma... Visualizza
2612 Platania CB. Effects of Taurine in dry eye mo... Visualizza
2613 Platania CB. Small molecules to treat diabeti... Visualizza
2614 Platania CB. Role of P2X7 receptor in early d... Visualizza
4440 Platania CB. Retinal bioavailability of curcu... Visualizza
2615 Poeta L. The loss of Aristaless related h... Visualizza
2616 Polesel J. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
2617 Polesel J. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
2618 Polidori C. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
2619 Polini B. Potential relationship between t... Visualizza
2620 Polini B. Role of miR-34a as biomarker and... Visualizza
2621 Pollastro F. The antimigraine butterbur ingre... Visualizza
2622 Pollina addario SW. Intravitreal anti-VEGF injection... Visualizza
2623 Poluzzi E. MYOPERICARDITIS AND VACCINES: GA... Visualizza
2624 Poluzzi E. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
2625 Poluzzi E. Occurrence of Liver Injury with ... Visualizza
2626 Poluzzi E. Renal impairment in very low bir... Visualizza
4441 Poluzzi E. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
4442 Poluzzi E. Interactions between vaccines ag... Visualizza
2627 Poma P. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
2628 Pompili B. Development of hyaluronan/mannit... Visualizza
2629 Pons N. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
2630 Ponzoni L. PROSOCIAL AND ANXIOLYTIC EFFECT ... Visualizza
2631 Popoli M. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
2632 Popoli M. Environmental Chronic Stress Ind... Visualizza
2633 Popoli M. Altered Mechanisms Underlying th... Visualizza
3547 Popoli M. Maladaptive plasticity induced b... Visualizza
3565 Popoli P. Innovation in orphan drugs: the ... Visualizza
2634 Popolo A. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
2635 Porciatti V. Autoregulation of retinal gangli... Visualizza
4443 Porreca E. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
3276 porrini V. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2636 Porro B. Fluoroscopy-associated oxidative... Visualizza
4444 Porro B. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2637 Possenti R. Involvement of bradykinin B2 rec... Visualizza
4445 Potì F. Sphingosine 1-Phosphate And Athe... Visualizza
2638 Potenza MA. CM554, A NEW POTENT AND SELECTIV... Visualizza
2639 Potenza MA. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
2640 Potenza MA. POTENTIAL MECHANISMS LINKING DEF... Visualizza
4446 Potenza MA. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
2641 Potenzieri AP. Understanding the pathogenesis o... Visualizza
2642 Pozzessere D. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
4447 Pozzi D. Role of the inflammation in the ... Visualizza
2643 Pozzi M. On the possible relationship bet... Visualizza
2644 Pozzo L. Evaluation of protective effect ... Visualizza
2645 Pratesi A. SELECTION AND CHARACTERIZATION O... Visualizza
2646 Prato M. Cutaneous hypoxia: effect of oxy... Visualizza
2647 Prato M. CHARACTERIZATION OF THE MECHANIS... Visualizza
2648 Prickaerts J. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
2649 Prini P. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
3523 Prini P. Role of the endocannabinoid syst... Visualizza
2650 Proli E. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
2651 Proto MC. RIMONABANT KILLS COLON CANCER ST... Visualizza
2652 Provensi G. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
2653 Provensi G. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2654 Provensi G. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
2655 Provenzano F. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
2656 Provenzano F. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
2657 Pruccoli L. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
2658 Pruneri G. Inhibition of SIRT1 Deacetylase ... Visualizza
2659 Puccetti P. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
4448 Puccetti P. REINSTALLING IMMUNE REGULATORY T... Visualizza
4449 Puccetti P. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
4450 Puccetti P. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
4451 Puccetti P. IDO1 activity in selected immune... Visualizza
2660 Puccetti PP. CpG type-A induction of an early... Visualizza
4452 Pugi A. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
2661 Puglia C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
3626 Pugliese A. M. Adenosine A2B receptors and sphi... Visualizza
2662 Pugliese AM. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
4453 Pugliese AM. Molecular basis of adenosine A3 ... Visualizza
2663 Pugliese G. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
4454 Puliafito A. INTUSSUSCEPTION RATES BEFORE AND... Visualizza
2664 Puligheddu M. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
2665 Puliti A. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
4455 Punreddy R. The high price of anticancer dru... Visualizza
4456 Purvis GS. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
4457 Putti MC. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
2666 Puzo MR. Intravitreal anti-VEGF injection... Visualizza
2667 Puzzo D. cGMP MODULATES LONG-TERM POTENTI... Visualizza
2668 Puzzolo D. Cadmium and its role in brain dy... Visualizza
2669 Puzzolo D. Survivin and NAIP in Human Benig... Visualizza
2670 Quaglia F. Development of hyaluronan/mannit... Visualizza
3618 Quaini F. Cardiotoxicity by Tyrosine Kinas... Visualizza
2671 Quaroni A. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
4458 Quartuccio L. Immunogenetics of prostate cance... Visualizza
2672 Quattrone D. NABILONE AND THC/CBD FOR THE TRE... Visualizza
2673 Querio G. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
2674 Quintieri L. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
4459 R. Iori Brassicaceae as source of H2S-re... Visualizza
2675 Racagni G. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
2676 Racagni G. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
2677 Racagni G. Acute behavioral and molecular e... Visualizza
2678 Racchi M. MODULATION OF OXIDATIVE AND INFL... Visualizza
2679 Radice S. MARKAR survey: influence of dire... Visualizza
2680 Radice S. On the possible relationship bet... Visualizza
4460 Radice S. Interactions between vaccines ag... Visualizza
2681 Rafaniello C. ESTIMATING INCIDENCE RATES OF AD... Visualizza
2682 Rafaniello C. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
3512 Rafaniello C. The Future of Pharmacovigilance:... Visualizza
4461 Rafaniello C. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
4462 Rafaniello C. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
4463 Rafaniello C. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
2683 Raffaeli W. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
2684 Ragazzi E. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
2685 Ragazzi E. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2686 Ragusa S. Evaluation of protective effect ... Visualizza
2687 Raimondi L. Angiotensin-II activates p-38 an... Visualizza
2688 Raimondi L. Central effects induced by syste... Visualizza
2689 Raimondi L. Enhancement of cardiac different... Visualizza
2690 Raiteri L. RELEASE OF [3H]GABA EVOKED BY HI... Visualizza
2691 Ramesh P. RIMONABANT KILLS COLON CANCER ST... Visualizza
2692 Rana F. Gender-dependent involvement of ... Visualizza
2693 Rana F. A LONG TERM TREATMENT WITH TAURI... Visualizza
2694 Rana F. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
4464 Ranalli P. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
4465 Randazzo M. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
2695 Rani B. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2696 Rantsiou K. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
4466 Ranzato E. ASTROCYTES AND ADULT NEURAL PROG... Visualizza
2697 Raouf J. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
2698 Raschi E. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
2699 Raschi E. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
2700 Raschi E. Renal impairment in very low bir... Visualizza
2701 Raschi E. Occurrence of Liver Injury with ... Visualizza
2702 Raschi E. MYOPERICARDITIS AND VACCINES: GA... Visualizza
4467 Raschi E. MAPPING THE GLOBAL SAFETY PROFIL... Visualizza
4468 Raschi E. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
4469 Raschi E. Interactions between vaccines ag... Visualizza
2703 Rascle A. The chemopreventive effects of i... Visualizza
2704 Rasola A. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2705 Rastelli ML. Chronic Oleoylethanolamide Treat... Visualizza
2706 Ratano P. Involvement of the Prokineticin ... Visualizza
2707 Ravani A. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
2708 Ravani A. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
2709 Ravani A. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
2710 Ravani A. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
2711 Ravani A. A2B adenosine receptors stimulat... Visualizza
2712 Ravegnini G. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
2713 Ravegnini G. DNA METHYLATION: GENE PROFILING ... Visualizza
2714 Ray S. IN VITRO AND IN VIVO MODELING OF... Visualizza
2715 Re N. CM554, A NEW POTENT AND SELECTIV... Visualizza
1245 rea F. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
2716 Rea F. NSAIDs utilization in a large co... Visualizza
2717 Rebosio C. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
2718 Rebosio C. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
2719 Rebosio C. cGMP MODULATES LONG-TERM POTENTI... Visualizza
2720 Recinella L. Effects of Growth Hormone-Releas... Visualizza
2721 Recinella L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
2722 Recinella L. Peripheral RVD-hemopressin(_) ad... Visualizza
4470 Recinella L. Emotional Disorders Induced by H... Visualizza
2723 Renata esposito RE. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
2724 Renesto A. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
2725 Resta F. Central effects induced by syste... Visualizza
3459 Resta F. Isoform-selective blockade of HC... Visualizza
3658 Restani P. Adverse reactions to botanicals ... Visualizza
2726 Restante G. Monitoring of Epidermal Growth F... Visualizza
2727 Ribatti V. Fluoroscopy-associated oxidative... Visualizza
2728 Riccardi C. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
2729 Riccardi C. Prevention of diabetes in NOD mi... Visualizza
2730 Riccardi C. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2731 Riccardi C. Structure based approach for sea... Visualizza
2732 Riccardi C. Stimulation of CB2 receptor affe... Visualizza
3509 Riccardi C. Glucocorticoid-Induced Leucine Z... Visualizza
4471 Riccardi C. Artocarpus tonkinensis, a Vietna... Visualizza
4472 Riccardi C. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4473 Riccardi C. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2733 Ricci E. Prevention of diabetes in NOD mi... Visualizza
2734 Ricci E. Stimulation of CB2 receptor affe... Visualizza
4474 Ricci E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2735 Ricci G. Gamma-hydroxybutyrate intoxicati... Visualizza
2736 Ricciarelli R. cGMP MODULATES LONG-TERM POTENTI... Visualizza
2737 Ricciarelli R. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
2738 Ricciarelli R. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
4475 Ridolfi L. Nutraceutical properties of Arth... Visualizza
2739 Riemma MA. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
2740 Rigamonti AE. Hedonic eating in Prader-Willi s... Visualizza
2741 Rigamonti AE. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
2742 Riganti C. Effects of NO and H2S releasing ... Visualizza
2743 Riganti C. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
4476 Riganti L. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
692 rigobello C. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
2744 Rimondini R. Cross-Disease Analysis of Alzhei... Visualizza
2745 Rinaldi M. Cadmium and its role in brain dy... Visualizza
2746 Rinaldi M. Survivin and NAIP in Human Benig... Visualizza
2747 Rinaldi M. SALMETEROL, A SELECTIVE AND LONG... Visualizza
2748 Rinaldi MG. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
2749 Riozzi B. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4477 Riparini G. THE SILENT INFORMATION REGULATOR... Visualizza
2750 Riva BR. Understanding the pathogenesis o... Visualizza
3496 Riva M. Stress, Epigenetic Changes and V... Visualizza
2751 Riva MA. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
2752 Riva MA. LONG-LASTING EFFECTS OF STRESS I... Visualizza
2753 Rizza R. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
2754 Rizzardini G. MARKAR survey: influence of dire... Visualizza
2755 Rizzi A. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4478 Rizzi A. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
2756 Rizzi L. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
2757 Rizzi L. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
2758 Rizzi L. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
2759 Rizzi N. Inhibition of SIRT1 Deacetylase ... Visualizza
2760 Roberto fattorusso RF. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2761 Roberto G. NSAIDs utilization in a large co... Visualizza
2762 Roberto G. Utilization of biological drugs ... Visualizza
4479 Roberto G. Real-world evidence on the risk ... Visualizza
4480 Roberto G. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
3474 Rocca B. Pharmacokinetic/Pharmacodynamic ... Visualizza
4481 Rocca B. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
4482 Rocchitta G. Real-time detection of ethanol i... Visualizza
4483 Rocchitta G. Real-time monitoring of MPTP-ind... Visualizza
2763 Rodinò S. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
2764 Rodrigues M. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
2765 Rodriguez FJ. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
2766 Rodriguez PC. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
2767 Rodriguez-estrada MT. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
2768 Rofi E. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
2769 Rofi E. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
2770 Rofi E. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
2771 Rofi E. Monitoring of Epidermal Growth F... Visualizza
2772 Rolando B. UNRAVELING THE MECHANISM OF ACTI... Visualizza
2773 Rolli FR. REtrospective study on ItaliaN A... Visualizza
4484 Romagnoli A. INHIBITION OF SPONTANEOUS COLON ... Visualizza
4485 Romagnoli A. Potential of a flavonoid-rich ex... Visualizza
2774 Romain DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
4486 Romanato L. Immunogenetics of prostate cance... Visualizza
3437 Romanelli. MN. Isoform-selective blockade of HC... Visualizza
2775 Romani RR. CpG type-A induction of an early... Visualizza
2776 Romanini A. Role of miR-34a as biomarker and... Visualizza
2777 Romano A. Chronic Oleoylethanolamide Treat... Visualizza
2778 Romano A. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
2779 Romano A. ROLE OF THE AREA POSTREMA IN THE... Visualizza
2780 Romano A. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
2781 Romano AR. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2782 Romano B. A COMPARISON BETWEEN A CANNABIS ... Visualizza
2783 Romano BR. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
2784 Romano E. Hypoxia regulates ANXA1 expressi... Visualizza
2785 Romano G. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2786 Romano GL. Autoregulation of retinal gangli... Visualizza
3438 Romano M. A novel methodology for the dosa... Visualizza
2787 Romano R. Palmitoylethanolamide Reduces Ne... Visualizza
2788 Romano R. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
2789 Romei C. RELEASE OF [3H]GABA EVOKED BY HI... Visualizza
4487 Romoli B. Rat Nicotine Sensitization Modul... Visualizza
4488 Romualdi C. Immunogenetics of prostate cance... Visualizza
2790 Romualdi P. Selective dynorphin and nocicept... Visualizza
3559 Romualdi P. Molecular mechanisms and rationa... Visualizza
4489 Romualdi P. Rat Nicotine Sensitization Modul... Visualizza
4490 Romuladi P. N/OFQ and CRF systems dysregulat... Visualizza
2791 Roncada P. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
2792 Roncato R. Next generation sequencing for i... Visualizza
2793 Roncato R. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
4491 Roncato R. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
2794 Ronchetti S. Stimulation of CB2 receptor affe... Visualizza
4492 Ronchetti S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2795 Roncon P. Sestrin 3 as a regulator of pro-... Visualizza
2796 Ronda N. Vitamin D replacement in pre-men... Visualizza
4493 Rosa AC. Megalin and Sodium-Hydrogen Exch... Visualizza
2797 Rosalinda sorrentino RS. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
4494 Rosano G. Effect of Chronic Kidney Disease... Visualizza
4495 Rosano G. Un-Suggested Prescriptions of No... Visualizza
2798 Rosaria R. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
4496 Rosati A. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
2799 Rosati E. OVERTREATMENT IN PHARMACORESISTA... Visualizza
4497 Roselletti E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2800 Rosini M. MODULATION OF OXIDATIVE AND INFL... Visualizza
2801 Rossetti AC. Multiple sclerosis and depressio... Visualizza
4498 Rossetti L. Shedding light on PCSK9 function... Visualizza
4499 Rossetti L. Vitamin D levels and Tissue Fact... Visualizza
2802 Rossetti T. Sestrin 3 as a regulator of pro-... Visualizza
2803 Rossi A. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
2804 Rossi A. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2805 Rossi A. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
4500 Rossi A. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
3577 Rossi D. Astrocytes as cell targets for t... Visualizza
2806 Rossi F. Stimulation of CB2 receptor affe... Visualizza
2807 Rossi F. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
2808 Rossi F. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
2809 Rossi F. Ranolazine attenuates adverse my... Visualizza
2810 Rossi F. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
2811 Rossi F. ESTIMATING INCIDENCE RATES OF AD... Visualizza
2812 Rossi F. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
2813 Rossi F. Palmitoylethanolamide Reduces Ne... Visualizza
4501 Rossi F. Un-Suggested Prescriptions of No... Visualizza
4502 Rossi F. Cardio-renal positive effects of... Visualizza
4503 Rossi F. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
4504 Rossi F. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
4505 Rossi F. Effect of Chronic Kidney Disease... Visualizza
2814 Rossi L. DRUGS - INDUCED DISSEMINATED INT... Visualizza
2815 Rossi S. MODULATION OF DIABETIC RETINOPAT... Visualizza
2816 Rossini E. In vitro identification of molec... Visualizza
2817 Rossini E. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
3672 Rossini M. Denosumab: not only postmenopaus... Visualizza
2818 Rostami AR. CpG type-A induction of an early... Visualizza
2819 Rota F. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
2820 Rouanet DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
2821 Roussel G. Hypothalamic Circuit Mediates Th... Visualizza
2822 Rovati GE. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
2823 Rovati LC. Characterization of adipokines s... Visualizza
1299 roviezzo F. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2824 Roviezzo F. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
4506 Roviezzo F. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
2825 Rozza FR. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
2826 Ruberto G. Phytochemical Profile and Photot... Visualizza
2827 Rubino T. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
2828 Rubino T. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
4507 Rubiolo P. Thistles from Sardinia: evaluati... Visualizza
2829 Rucci F. The importance of Integrated Car... Visualizza
4508 Rucci F. Insulin analogue glargine 300 U/... Visualizza
2830 Rucci FR. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2831 Rugge M. Involvement of catechol-O-methyl... Visualizza
2832 Ruggeri M. REtrospective study on ItaliaN A... Visualizza
4509 Ruggiero R. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
2833 Rullo L. Selective dynorphin and nocicept... Visualizza
4510 Rullo L. N/OFQ and CRF systems dysregulat... Visualizza
4511 Ruscica M. High density lipoproteins inhibi... Visualizza
4512 Ruscica M. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
2834 Rusconi S. Pharmacokinetics of darunavir/co... Visualizza
4513 Rusnati M. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
2835 Russo A. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
2836 Russo D. Anti-proliferative effects of Cy... Visualizza
2837 Russo D. Evaluation of protective effect ... Visualizza
2838 Russo E. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
2839 Russo E. MONITORING SAFETY AND USE OF OLD... Visualizza
2840 Russo E. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
2841 Russo E. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
2842 Russo E. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
2843 Russo E. Fluoroscopy-associated oxidative... Visualizza
2844 Russo E. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
2845 Russo E. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
2846 Russo E. TREND OF ADVERSE DRUG REACTION R... Visualizza
2847 Russo GI. Survivin and NAIP in Human Benig... Visualizza
2848 Russo M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2849 Russo R. Behavioral and Metabolic Charact... Visualizza
2850 Russo R. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
2851 Russo R. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
3479 Russo R. High palatable food exposure and... Visualizza
4514 Russo R. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2852 Russo S. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3129 russo T. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
3130 russo T. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2853 Ruzza C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4515 Ruzza C. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
2854 S D. Healthcare resources use in pati... Visualizza
2855 S D. Burden of comorbidities in HCV p... Visualizza
2858 Sacco A. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
2859 Sacco A. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
2860 Sacco A. Generation of 12- hydroxyeicosat... Visualizza
2861 Sacerdote P. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
2862 Sacerdote P. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
2863 Sadofsky LS. Aromatase inhibitor-evoked pain ... Visualizza
2027 saetta M. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
4516 Sagheddu C. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2864 Sahbani D. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
2865 Saija A. In Vitro Protective Effects of C... Visualizza
2866 Saija A. Phytochemical Profile and Photot... Visualizza
2867 Saija A. Curcumin Ameliorates the In Vitr... Visualizza
4517 Saija A. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
2868 Sala M. PROSOCIAL AND ANXIOLYTIC EFFECT ... Visualizza
2869 Sala ME. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
2870 Sala N. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
2871 Saletti C. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
2872 Salomone S. Structure based approach for sea... Visualizza
2873 Salomone S. Sulodexide prevents high glucose... Visualizza
2874 Salomone S. Role of P2X7 receptor in early d... Visualizza
4518 Salomone S. Buspirone rescues MK-801-induced... Visualizza
4519 Salomone S. Dopamine D3 receptor-dependent c... Visualizza
4520 Salomone S. Retinal bioavailability of curcu... Visualizza
4521 Salomone S. Dopamine D3 receptors control dy... Visualizza
4522 Salomone S. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
4523 Salvadori S. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
2875 Salvalai ME. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
2876 Salvatore T. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3615 Salvatorelli E. Anthracyclines and the problem o... Visualizza
2877 Salvatori R. Effects of Growth Hormone-Releas... Visualizza
2878 Salvemini D. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2879 Salvia C.G. Metronomic vinorelbine is active... Visualizza
4524 Salvianti F. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
2880 Salvitti T. RISK OF MORTALITY BETWEEN BIOSIM... Visualizza
4525 Salvo F. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
2881 Sammarini G. DNA METHYLATION: GENE PROFILING ... Visualizza
2882 Sammarini G. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
2883 Samuelli G. Characterization of adipokines s... Visualizza
2884 Sanarica F. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
2885 Sanarica F. EFFECT OF A LONG TERM TREATMENT ... Visualizza
2886 Sanarica F. A LONG TERM TREATMENT WITH TAURI... Visualizza
2887 Sances G. The pharmacogenetics of the resp... Visualizza
4526 Sanchez-Vicente L. _-Caryophyllene oxide as a new c... Visualizza
2888 Sanderson J. IN VITRO AND IN VIVO MODELING OF... Visualizza
4527 Sandri P. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
2890 Sandrini L. Carbaprostacyclin prevents venou... Visualizza
2891 Sandrini L. Environmental Chronic Stress Ind... Visualizza
2892 Sangiovanni E. Cutaneous hypoxia: effect of oxy... Visualizza
4528 Sangiovanni E. Thistles from Sardinia: evaluati... Visualizza
4529 Sangiovanni E. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
2893 Saniere L. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
4530 Sanna C. Thistles from Sardinia: evaluati... Visualizza
4531 Sannino S. A precision medicine genetic mar... Visualizza
2894 Sansaro D. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
2895 Sansaro D. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
4532 Sansone A. Results from an e-learning cours... Visualizza
2896 Santamaria A. PHYTO.VIG.GEST: VIGILANCE ON USE... Visualizza
2897 Santanaria R. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
2898 Santangelo A. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
2899 Santangelo E. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
4533 Santarpia M. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
4534 Santilli F. Shedding light on PCSK9 function... Visualizza
2900 Santini F. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
2901 Santori A. AMPHETAMINE AND THE 3,4-METHYLE... Visualizza
2902 Santoro A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
2903 Santoro V. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
2904 Sanvito F. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
2905 Saponara S. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
2906 Saponara S. Effects of NO and H2S releasing ... Visualizza
4535 Saracchini S. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
2907 Sarnelli G. Rifaximin induces a PXR-mediated... Visualizza
2908 Sarnelli G. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
4536 Sarnelli G. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
2909 Sartiani L. Angiotensin-II activates p-38 an... Visualizza
2910 Sartiani L. Enhancement of cardiac different... Visualizza
3460 Sartiani L. Isoform-selective blockade of HC... Visualizza
4537 Sartiani L. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
4538 Sartiani L. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
4539 Sartor F. Immunogenetics of prostate cance... Visualizza
2911 Sartorio A. Hedonic eating in Prader-Willi s... Visualizza
2912 Sartorio A. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
2913 Saul MJ. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4540 Saul MJ. MICRORNA-574-5P MODULATES MICROS... Visualizza
2914 Sautebin L. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
4541 Sautebin L. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
2915 Sava G. TARGETING THE CANCER RESISTOME T... Visualizza
4542 Sava G. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
2916 Savai R. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
2917 Saverio N. Impaired glucose and lipid metab... Visualizza
2918 Scafuro MA. Palmitoylethanolamide Reduces Ne... Visualizza
2919 Scaglione F. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
2920 Scaglione F. The importance of Integrated Car... Visualizza
4543 Scaglione F. Insulin analogue glargine 300 U/... Visualizza
2921 Scaglione FS. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2922 Scala R. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
2923 Scalisi G. Aryl hydrocarbon receptor: a nov... Visualizza
2924 Scalisi G. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
4544 Scalisi G. IDO1 activity in selected immune... Visualizza
4545 Scalisi G. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
2925 Scalisi GS. CpG type-A induction of an early... Visualizza
2926 Scalorbi S. Reporting of adverse drug reacti... Visualizza
2927 Scarano F. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2928 Scarano F. Impaired glucose and lipid metab... Visualizza
2929 Scarano F. Early up-regulation of hepatic m... Visualizza
3441 Scarano F. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2930 Scarano SF. Sildenafil improves cardiac func... Visualizza
2931 Scaravaggi G. Antidote treatment in Viper enve... Visualizza
2932 Scaravaggi G. Analytically confirmed post-inje... Visualizza
2933 Scaravaggi G. Gamma-hydroxybutyrate intoxicati... Visualizza
2934 Scaravaggi G. Methotrexate therapeutic error i... Visualizza
4546 Scarpelli P. The bile acid receptor GPBAR1 re... Visualizza
2935 Scarpignato C. Enteric glia is involved in colo... Visualizza
4547 Scarselli M. Clozapine as the most efficaciou... Visualizza
2936 Scatigna M. The importance of Integrated Car... Visualizza
3566 Scatigna M. Clinical Research of drugs for r... Visualizza
2937 Scavone C. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
4548 Scavone C. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
4549 Scavone C. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
4550 Scavone C. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
2938 Scheggi S. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
4551 Scheggia D. A precision medicine genetic mar... Visualizza
2939 Scherz MW. A PRECLINICAL SET UP OF A RAT MO... Visualizza
2940 Schiavi S. AUTISTIC-LIKE BEHAVIORAL ABNORMA... Visualizza
2941 Schiavi S. CHANGES IN THE ENDOCANNABINOID S... Visualizza
2942 Schiavini M. MARKAR survey: influence of dire... Visualizza
2943 Schiavon A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
2944 Schiavone S. Generation of 12- hydroxyeicosat... Visualizza
2945 Schiavone S. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
3546 Schiavone S. Early blood brain barrier dysfun... Visualizza
4552 Schiavone S. Platelet-derived microparticles ... Visualizza
2946 Schicchi A. Antidote treatment in Viper enve... Visualizza
2947 Schicchi A. Methotrexate therapeutic error i... Visualizza
2948 Schiffer D. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
2949 Schmidt SD. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2950 Schon M. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
2951 Schulze TG. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
4553 Schwarcz R. Gestational cannabinoid exposure... Visualizza
2952 Scicchitano M. Impaired glucose and lipid metab... Visualizza
2953 Scicchitano M. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2954 Scicchitano M. Early up-regulation of hepatic m... Visualizza
2955 Scicchitano SM. Sildenafil improves cardiac func... Visualizza
2956 Scilimati A. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
2957 Scilimati A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
4554 Scionti F. Identification and validation of... Visualizza
2958 Scirocco A. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
2959 Sciuccati E. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
2960 Scognamiglio G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
2961 Scolari F. REtrospective study on ItaliaN A... Visualizza
2962 Scondotto G. Intravitreal anti-VEGF injection... Visualizza
2963 Scondotto S. Intravitreal anti-VEGF injection... Visualizza
2964 Scondotto S. Real world data about biosimilar... Visualizza
2965 Scondotto S. EVALUATION OF HEALTH DIRECT COST... Visualizza
2966 Scotti L. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
2967 Scotti L. USE OF PROTON PUMP INHIBITORS AN... Visualizza
4555 Scotti L. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
2968 Scuderi C. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
2969 Scuderi C. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
2970 Scuderi C. Involvement of the Prokineticin ... Visualizza
2971 Segnani C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
2972 Segnani C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
2973 Segnani C. Enteric glia is involved in colo... Visualizza
2974 Seguella L. Rifaximin induces a PXR-mediated... Visualizza
2975 Seguella L. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
4556 Seguella L. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
2976 Seguini M. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
2977 Seguini M. Altered Mechanisms Underlying th... Visualizza
4557 Sellitto C. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
2978 Serafini MM. MODULATION OF OXIDATIVE AND INFL... Visualizza
2979 Serani A. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
2980 Serra N. Palmitoylethanolamide Reduces Ne... Visualizza
4558 Serra PA. Real-time detection of ethanol i... Visualizza
3610 Serretti A. Clinical applications of pharmac... Visualizza
2981 Servadio M. AUTISTIC-LIKE BEHAVIORAL ABNORMA... Visualizza
2982 Servadio M. CHANGES IN THE ENDOCANNABINOID S... Visualizza
4559 Sessa M. Un-Suggested Prescriptions of No... Visualizza
4560 Sessa M. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
4561 Sessa M. Effect of Chronic Kidney Disease... Visualizza
4562 Sessa M. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
2983 Sestili P. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
2984 Setti S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
2985 Severi C. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
2986 Severini C. Involvement of bradykinin B2 rec... Visualizza
2987 Severino G. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
2988 Severino L. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
1979 sgambato M. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
1980 sgambato M. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
1981 sgambato M. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2989 Sgambato M. Effects of lung resident mesench... Visualizza
2990 Sgambellone S. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
2991 Sgarra L. POTENTIAL MECHANISMS LINKING DEF... Visualizza
2992 Sgarra L. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
4563 Sgarra L. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
4564 Sgroi C. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
2993 Shaham Y. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
4565 Shen QW. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
2994 Shimizu J. Prevention of diabetes in NOD mi... Visualizza
2995 Shohreh R. Effects of Growth Hormone-Releas... Visualizza
2996 Siccardi A. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
2997 Sigala S. In vitro identification of molec... Visualizza
2998 Sigala S. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
2999 Simeone R. Measurement of deferasirox plasm... Visualizza
4566 Simi L. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
3000 Simiele M. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3001 Simonato M. Sestrin 3 as a regulator of pro-... Visualizza
4567 Simoncelli E. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
3002 Simonelli F. MODULATION OF DIABETIC RETINOPAT... Visualizza
3003 Simonelli S. Recombinant LCAT rescues defecti... Visualizza
3004 Simonetta baraldo SB. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3005 Simoni E. MODULATION OF OXIDATIVE AND INFL... Visualizza
4568 Simoni M. Sphingosine 1-Phosphate And Athe... Visualizza
3614 Siniscalco D. Endocannabinoid system dysregula... Visualizza
3006 Siracusa L. Phytochemical Profile and Photot... Visualizza
4569 Siracusa R. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
4570 Siracusano A. Cardio-renal positive effects of... Visualizza
3007 Sirago G. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
3008 Sirignano M. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3009 Sita G. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
3010 Sita G. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
3011 Sita G. Cross-Disease Analysis of Alzhei... Visualizza
4571 Sita G. NEUROPROTECTIVE EFFECT OF CAFFEI... Visualizza
3012 Smedile T. Tryptophan 2,3-dioxygenase inhib... Visualizza
3013 Smeriglio A. IN VITRO AND IN VIVO MODELING OF... Visualizza
3014 Smeriglio A. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
3015 Smeriglio A. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
4572 Smeriglio A. Aldose Reductase Inhibitors from... Visualizza
3016 Soggiu A. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3017 Solari A. Subcutaneous slow-release metfor... Visualizza
3018 Soldovieri MV. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
3019 Soldovieri MV. Compound heterozygosis in the kc... Visualizza
4573 Solito E. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3020 Sommella E. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
3021 Sonzogni A. Measurement of deferasirox plasm... Visualizza
4574 Sorcini D. The bile acid receptor GPBAR1 re... Visualizza
4575 Sorcini D. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3022 Sorrentino A. TREND OF ADVERSE DRUG REACTION R... Visualizza
3023 Sorrentino C. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
3461 Sorrentino C. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
3024 Sorrentino R. 3-Mercaptopyruvate relaxes aorta... Visualizza
3025 Sorrentino R. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3026 Sorrentino R. Development of hyaluronan/mannit... Visualizza
3027 Sorrentino R. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
4576 Sorrentino R. Hydrogen sulfide pathway as a ne... Visualizza
4577 Sorrentino R. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
4578 Sorrentino RS. Human Peripheral blood mononucle... Visualizza
3028 Sortino MA. THE CONTRIBUTION OF MICROGLIA TO... Visualizza
4579 Sortino MA. MODULATION OF ASTROCYTE PROCESSE... Visualizza
4580 Sortino MA. Chronic treatment with fluoxetin... Visualizza
3029 Sosa S. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
3030 Sosa S. CHARACTERIZATION OF THE MECHANIS... Visualizza
3031 Sottosanti L. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
3510 Sottosanti L. Current roles of patients in Pha... Visualizza
4581 Sottosanti L. WEB-BASED REPORTING OF ADVERSE D... Visualizza
3032 Soukupova M. Sestrin 3 as a regulator of pro-... Visualizza
3033 Spagnuolo R. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
4582 Spalletta G. A precision medicine genetic mar... Visualizza
3034 Spampinato S. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
3035 Spampinato S. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
3036 Spampinato S. Identification of a novel, funct... Visualizza
3037 Spampinato S. Morphine differently influences ... Visualizza
3038 Spampinato S. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
3039 Spampinato SF. THE CONTRIBUTION OF MICROGLIA TO... Visualizza
4583 Spano PF. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
1544 spaziano G. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
1545 spaziano G. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
1546 spaziano G. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3040 Spaziano G. Effects of lung resident mesench... Visualizza
3041 Spaziano G. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
3413 Spaziano G. NOCICEPTIN/ORPHANINFQ (N/OFQ) CO... Visualizza
3042 Specchio LM. OVERTREATMENT IN PHARMACORESISTA... Visualizza
3043 Speciale A. In Vitro Protective Effects of C... Visualizza
3044 Speciale A. Phytochemical Profile and Photot... Visualizza
3045 Speciale A. Curcumin Ameliorates the In Vitr... Visualizza
4584 Speciale A. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
1194 Spina E. Safety profile of antipsychotic ... Visualizza
3046 Spina E. Trends in Spontaneous Adverse Dr... Visualizza
3047 Spina E. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
3048 Spina E. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
3049 Spina E. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
3050 Spina E. Access to the market of medicine... Visualizza
4585 Spina E. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
4586 Spina E. Facilitation Of Reporting in hos... Visualizza
3625 Spinaci A. Nucleotide derivatives as new li... Visualizza
3051 Spinelli V. Enhancement of cardiac different... Visualizza
3462 Spinelli V. Isoform-selective blockade of HC... Visualizza
3052 Spinetti G. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
4587 Spini A. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
3053 Sportiello L. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
4588 Sportiello L. SAFETY PROFILE OF BIOLOGIC DRUGS... Visualizza
4589 Sportiello L. PREVENTABILITY OF NON-STEROIDAL ... Visualizza
3054 Spyrakis F. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
3055 Squadrito F. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
3056 Squadrito F. Cadmium and its role in brain dy... Visualizza
3057 Squadrito F. Survivin and NAIP in Human Benig... Visualizza
3058 Squadrito F. MODELING ROS1 TRANSLOCATION IN L... Visualizza
3059 Squadrito F. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
3060 Squadrito F. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
3061 Squadrito F. Activation of the EPOR-b common ... Visualizza
3062 Squadrito F. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
4590 Squadrito F. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4591 Squadrito F. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4592 Squadrito F. TACKLE ATHEROSCLEROSIS VIA GENOM... Visualizza
4593 Squadrito F. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
3063 Squassina A. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
3497 Squassina A. Do mood stabilizers interfere wi... Visualizza
3064 Squillace N. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
4594 Stancampiano A. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
3065 Stark H. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
3529 Stark T. Early modulation of the endocann... Visualizza
4595 Staropoli N. Identification and validation of... Visualizza
3066 Steardo L. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
3067 Steardo L. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
3068 Steardo L. Rifaximin induces a PXR-mediated... Visualizza
3069 Steardo L. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
4596 Steardo L. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
3070 Stefanucci A. Peripheral RVD-hemopressin(_) ad... Visualizza
3071 Stein S. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3072 Steinhilber D. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4597 Steinhilber D. MICRORNA-574-5P MODULATES MICROS... Visualizza
3073 Stella F. On the possible relationship bet... Visualizza
3074 Stocco G. Surfaced-enhanced Raman spectros... Visualizza
3075 Stocco G. THE ROLE OF THE mRNA BINDING PRO... Visualizza
3076 Stocco G. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
3077 Stocco G. Pharmacoepigenomic markers invol... Visualizza
3473 Stocco G. Therapeutic drug monitoring in p... Visualizza
3078 Stochino ME. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
3079 Stoev S. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
3080 Stoppa G. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4598 Stoppa G. WEB-BASED REPORTING OF ADVERSE D... Visualizza
4599 Stopponi S. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
4600 Straub RE. A precision medicine genetic mar... Visualizza
3081 Striano S. OVERTREATMENT IN PHARMACORESISTA... Visualizza
4601 Strongoli MC. Identification and validation of... Visualizza
3082 Stucchi M. Recombinant LCAT rescues defecti... Visualizza
3083 Stucchi S. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
3084 Sturkenboom M. WHAT IS THE EFFECT OF RISK MINIM... Visualizza
3085 Sturlese M. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
3086 Suess B. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4602 Suess B. MICRORNA-574-5P MODULATES MICROS... Visualizza
3087 Sultana J. In search of biological substant... Visualizza
3088 Sultana J. WHAT IS THE EFFECT OF RISK MINIM... Visualizza
4603 Sung TV. Artocarpus tonkinensis, a Vietna... Visualizza
3089 Supuran CT. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
3090 Susini TS. Aromatase inhibitor-evoked pain ... Visualizza
3091 Sut S. HPLC-MS Analysis of Glucosinolat... Visualizza
4604 Tacchetti C. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
3092 Tacconelli S. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
3093 Tacconelli S. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
3094 Tacconelli S. Generation of 12- hydroxyeicosat... Visualizza
3095 Tacconelli S. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
3096 Tacconelli S. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4605 Tacconelli S. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4606 Tacconelli S. MICRORNA-574-5P MODULATES MICROS... Visualizza
4607 Tacconelli S. Platelet-derived microparticles ... Visualizza
3097 Tafani M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
4608 Tagliaferri P. Identification and validation of... Visualizza
3098 Taglialatela M. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
3099 Taglialatela M. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
3100 Taglialatela M. Compound heterozygosis in the kc... Visualizza
3631 Taglialatela M. Novel molecular targets for pers... Visualizza
3101 Taglialatela-scafati O. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
3102 Tamma M. Kv7 channels are involved in hum... Visualizza
4609 Tarallo S. CLOPIDOGREL PHARMACOGENETICS: A ... Visualizza
3103 Tarantino E. Carbaprostacyclin prevents venou... Visualizza
3104 Tari D. EVALUATION OF HEALTH DIRECT COST... Visualizza
3105 Tari DU. Real world data about biosimilar... Visualizza
3106 Tari M. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3107 Tarozzi A. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
3108 Tarozzi A. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
3593 Tarozzi A. Trascriptome Meta Analysis to Id... Visualizza
4610 Tarozzi A. NEUROPROTECTIVE EFFECT OF CAFFEI... Visualizza
3109 Tartaglione G. Effects of lung resident mesench... Visualizza
3110 Tascedda F. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
3111 Tascedda F. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
3112 Tassi R. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
4611 Tassi R. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
4612 Tassi R. COMPARISON OF FOUR DIFFERENT ASS... Visualizza
4613 Tassone P. Identification and validation of... Visualizza
3113 Tassorelli C. The pharmacogenetics of the resp... Visualizza
3114 Tavano D. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
3115 Tavano TD. Sildenafil improves cardiac func... Visualizza
3116 Tavernese A. Early up-regulation of hepatic m... Visualizza
3117 Taviano MF. Evaluation of protective effect ... Visualizza
3118 Tedesco CC. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3119 Tedesco CC. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
3120 Tedesco S. G-protein coupled estrogen recep... Visualizza
3121 Tedesco S. Effects of digitoxin on cell mig... Visualizza
3122 Tenci B. Studying the mechanism of rat ad... Visualizza
3123 Tenci B. Alteration of visceral sensitivi... Visualizza
3124 Tenci B. A PRECLINICAL SET UP OF A RAT MO... Visualizza
3125 Tenci B. Into the unexplored pathophysiol... Visualizza
3126 Tenci B. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
3127 Tenci B. Development of an in vitro model... Visualizza
3128 Tenci B. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
4614 Tenci B. Brassicaceae as source of H2S-re... Visualizza
3131 Terlizzi M. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3132 Terlizzi M. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
4615 Terlizzi MT. Human Peripheral blood mononucle... Visualizza
3133 Termini R. Pharmacokinetics of darunavir/co... Visualizza
3134 Terrazzino S. The pharmacogenetics of the resp... Visualizza
3135 Terreni AT. Aromatase inhibitor-evoked pain ... Visualizza
3136 Terzuoli E. TARGETING THE CANCER RESISTOME T... Visualizza
3137 Terzuoli E. Tumor stemness and cancer drug-r... Visualizza
3138 Terzuoli E. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4616 Terzuoli E. Interaction between mPGES-1 and ... Visualizza
4617 Terzuoli E. Hydroxytyrosol inhibits EGFR sig... Visualizza
3139 Terzuoli ET. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
3140 Testai L. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
3141 Testai L. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
4618 Testai L. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
4619 Testai L. Brassicaceae as source of H2S-re... Visualizza
4620 Testai L. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
4621 Testai L. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
3142 Theisen DJ. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3143 Thellung S. PRION PROTEIN SIGNALLING CONTROL... Visualizza
4622 Thiemermann C. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
4623 Thurmond R. Megalin and Sodium-Hydrogen Exch... Visualizza
4624 Thuy TT. Artocarpus tonkinensis, a Vietna... Visualizza
3144 Tiberio GA. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
3145 Tillati S. WHAT IS THE EFFECT OF RISK MINIM... Visualizza
2021 tinè M. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3146 Tinuper P. OVERTREATMENT IN PHARMACORESISTA... Visualizza
3147 Tiozzo S. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
3148 Tiozzo S. CLINICAL VALIDATION OF THE REALQ... Visualizza
3149 Tirotta E. Bifidobacterium Longum and Lacto... Visualizza
3150 Tirotta E. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3151 Tirotta E. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3152 Tirotta E. Enteric glia is involved in colo... Visualizza
4625 Tirotta E. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
3153 Tiseo M. Monitoring of Epidermal Growth F... Visualizza
3620 Tocchetti C. G. Cardio-Oncology in the real life... Visualizza
3154 Toffoli G. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3155 Toffoli G. Next generation sequencing for i... Visualizza
3156 Toffoli G. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
4626 Toffoli G. Immunogenetics of prostate cance... Visualizza
4627 Toffoli G. PREPARE (PRE-EMPTIVE PHARMACOGEN... Visualizza
3157 Tognolini M. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3158 Tognolini M. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
3159 Tognolini M. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
4628 Tognolini M. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
3160 Tokgözoglu L. Vitamin D replacement in pre-men... Visualizza
3161 Tolomelli A. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
3162 Tolomeo A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
4629 Tonelli F. A TRANSCRIPTOMIC PROFILE PREDICT... Visualizza
3163 Tonello RT. Aromatase inhibitor-evoked pain ... Visualizza
3164 Tongiani S. In vitro and in vivo antibacteri... Visualizza
2451 tonin P. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
3165 Toniolo C. Antiviral and antioxidant activi... Visualizza
3166 Topai A. Interactions between antiretrovi... Visualizza
3500 Torella D. Endogenous cardiac regeneration:... Visualizza
3167 Tornaboni G. Evaluation of salivary catalase ... Visualizza
3168 Tornese P. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
4630 Torp-pedersen C. Effect of Chronic Kidney Disease... Visualizza
4631 Torp-pedersen C. Un-Suggested Prescriptions of No... Visualizza
4632 Torregrossa R. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3169 Torrent-farnell J. Failures to further developing o... Visualizza
3170 Torretta S. INVESTIGATION OF A PUTATIVE NICO... Visualizza
4633 Torrini M. Incidence of ticagrelor-related ... Visualizza
4634 Torrisi SA. Buspirone rescues MK-801-induced... Visualizza
4635 Torrisi SA. Dopamine D3 receptors control dy... Visualizza
4636 Torrisi SA. Dopamine D3 receptor-dependent c... Visualizza
3171 Torsello A. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
3172 Torsello A. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
3173 Torsello A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
4637 Tortora K. INHIBITION OF SPONTANEOUS COLON ... Visualizza
4638 Tortora K. Potential of a flavonoid-rich ex... Visualizza
3174 Tortorella P. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
3175 Toscano A. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
3176 Toscano A. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
3177 Trabace L. STUDYING SOCIAL WITHDRAWAL IN A ... Visualizza
3178 Trabace L. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
3179 Trabace L. A LONG TERM TREATMENT WITH TAURI... Visualizza
4639 Trabattoni D. Shedding light on PCSK9 function... Visualizza
3180 Traccis F. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3181 Tragni E. USE OF PROTON PUMP INHIBITORS AN... Visualizza
4640 Tragni E. ADHERENCE TO THERAPY WITH DIFFER... Visualizza
3182 Trallori E. Development of an in vitro model... Visualizza
3183 Trallori E. Into the unexplored pathophysiol... Visualizza
3184 Trallori E. Studying the mechanism of rat ad... Visualizza
3185 Trallori E. Alteration of visceral sensitivi... Visualizza
3186 Trallori E. A PRECLINICAL SET UP OF A RAT MO... Visualizza
4641 Trallori E. Brassicaceae as source of H2S-re... Visualizza
3187 Tramontano T. Development of hyaluronan/mannit... Visualizza
3188 Tramontano T. 3-Mercaptopyruvate relaxes aorta... Visualizza
4642 Tramontano T. Hydrogen sulfide pathway as a ne... Visualizza
3189 Travelli C. INVESTIGATION OF A PUTATIVE NICO... Visualizza
3190 Traversa G. EVALUATION OF HEALTH DIRECT COST... Visualizza
3191 Traversa G. Real world data about biosimilar... Visualizza
4643 Traversa G. The high price of anticancer dru... Visualizza
4644 Tredici M. Nutraceutical properties of Arth... Visualizza
3192 Tremoli E. Fluoroscopy-associated oxidative... Visualizza
3193 Tremoli E. Environmental Chronic Stress Ind... Visualizza
3194 Tremoli E. Carbaprostacyclin prevents venou... Visualizza
3195 Tremoli E. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3196 Tremoli E. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
4645 Tremoli E. Shedding light on PCSK9 function... Visualizza
4646 Tremoli E. Vitamin D levels and Tissue Fact... Visualizza
4647 Tremoli E. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
3197 Trenti A. Anti-angiogenic effect of therap... Visualizza
3198 Trenti A. Effects of digitoxin on cell mig... Visualizza
3199 Trenti A. G-protein coupled estrogen recep... Visualizza
3200 Trevisi L. Anti-angiogenic effect of therap... Visualizza
3201 Trevisi L. G-protein coupled estrogen recep... Visualizza
3202 Trevisi L. Effects of digitoxin on cell mig... Visualizza
3203 Trezza V. AUTISTIC-LIKE BEHAVIORAL ABNORMA... Visualizza
3204 Trezza V. CHANGES IN THE ENDOCANNABINOID S... Visualizza
3611 Trezza V. Targeting anandamide metabolism ... Visualizza
3205 Tricarico D. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
3206 Tricarico D. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
3207 Tricarico D. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
3208 Tricarico D. Gender-dependent involvement of ... Visualizza
3209 Tricarico D. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
3210 Tricarico D. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
3211 Tricarico D. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
3568 Tricarico D. Ethics Committees and orphan dru... Visualizza
3212 Trifirò G. WHAT IS THE EFFECT OF RISK MINIM... Visualizza
3213 Trifirò G. Intravitreal anti-VEGF injection... Visualizza
3214 Trifirò G. Access to the market of medicine... Visualizza
3215 Trifirò G. EVALUATION OF HEALTH DIRECT COST... Visualizza
3216 Trifirò G. Real world data about biosimilar... Visualizza
3217 Trifirò G. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
3218 Trifirò G. NSAIDs utilization in a large co... Visualizza
4648 Trifirò G. REAL WORLD DATA ON BIOLOGICAL DR... Visualizza
4649 Trifirò G. Real-world evidence on the risk ... Visualizza
3219 Trifiro' G. In search of biological substant... Visualizza
3220 Trifiro' G. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3221 Trifiro' G. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
3222 Trincas P. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
4650 Trinchese G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
3223 Troia A. Cutaneous hypoxia: effect of oxy... Visualizza
3224 Troisi F. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
3225 Trombetta D. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
3226 Trombetta D. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
3227 Trombetta D. IN VITRO AND IN VIVO MODELING OF... Visualizza
1904 Trombini M. Safety profile of antipsychotic ... Visualizza
3228 Troncoso N. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
3229 Trotta F. RISK OF MORTALITY BETWEEN BIOSIM... Visualizza
3230 Trotta F. Real world data about biosimilar... Visualizza
4651 Trotta F. The high price of anticancer dru... Visualizza
3231 Trotta MC. PHARMACOLOGICAL MODULATION OF CA... Visualizza
3232 Trotta MC. MODULATION OF DIABETIC RETINOPAT... Visualizza
3233 Trubiani O. Conditioned medium of human peri... Visualizza
3234 Tubaro A. CHARACTERIZATION OF THE MECHANIS... Visualizza
3235 Tubaro A. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
3236 Tubon I. Effects of ethanolic extracts of... Visualizza
3237 Tuccori M. A CLINICIAN NETWORK FOR SHARING ... Visualizza
3238 Tuccori M. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
3239 Tuccori M. INTENSIVE MONITORING PROGRAM OF ... Visualizza
3514 Tuccori M. Introduction on Risk Communicati... Visualizza
4652 Tuccori M. MUSCULAR ADVERSE DRUG REACTIONS ... Visualizza
3240 Tulissi P. Tacrolimus Therapeutic Drug Moni... Visualizza
3241 Turano F. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
3242 Turco A. Aryl hydrocarbon receptor: a nov... Visualizza
3243 Turco A. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
4653 Turco A. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
4654 Turco A. IDO1 activity in selected immune... Visualizza
3244 Turco AT. CpG type-A induction of an early... Visualizza
3245 Turnu L. Fluoroscopy-associated oxidative... Visualizza
3246 Turrini E. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
4655 Turrini E. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
3247 Turriziani A. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
3248 Ubaldi M. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
4656 Ubaldi M. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
4657 Ubaldi M. N/OFQ and CRF systems dysregulat... Visualizza
3249 Ubaldina U. Targeting nicotinamide phosphory... Visualizza
3250 Uboldi P. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
3251 Uglietti A. Pharmacokinetics of darunavir/co... Visualizza
3252 Ugolini F. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
3253 Ugolini F. The antimigraine butterbur ingre... Visualizza
4658 Ugolini L. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
3254 Ungaro F. Development of hyaluronan/mannit... Visualizza
3255 Urbanek K. Ranolazine attenuates adverse my... Visualizza
3256 Urbanek K. Effects of lung resident mesench... Visualizza
3503 Urbanek K. Treatment of heart failure with ... Visualizza
4659 Urbanek K. Cardio-renal positive effects of... Visualizza
3257 Usai C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3258 Usai C. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
3259 Usai C. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
3261 Vaca G. Identification of a novel, funct... Visualizza
3262 Vacca CV. CpG type-A induction of an early... Visualizza
3263 Vacca M. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3264 Vacca M. Peripheral RVD-hemopressin(_) ad... Visualizza
3265 Vacca M. Effects of Growth Hormone-Releas... Visualizza
4660 Vacca M. Emotional Disorders Induced by H... Visualizza
3266 Vaccheri A. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
3267 Vaccheri A. Reporting of adverse drug reacti... Visualizza
3268 Vaccheri A. DRUGS - INDUCED DISSEMINATED INT... Visualizza
4661 Vacondio F. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
3269 Vaglini F. Melanocortin receptor-4 as a nov... Visualizza
3270 Valenti G. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
3445 Valentini G. A novel methodology for the dosa... Visualizza
3271 Valentino M. The loss of Aristaless related h... Visualizza
3272 Valenza M. EFFECTS OF A NOVEL SELECTIVE SHO... Visualizza
3273 Vallifuoco M. Kv7 channels are involved in hum... Visualizza
3274 Vallone C. Tacrolimus Therapeutic Drug Moni... Visualizza
3275 Vandini E. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
4662 Vandini E. MECHANISM OF HYDROGEN SULFIDE AG... Visualizza
4663 Vandini E. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
3277 Vanetti C. FATTY ACIDS RESTORE IN VITRO ANG... Visualizza
3278 Vanetti C. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
3279 Vanetti C. Hedonic eating in Prader-Willi s... Visualizza
3280 Vangelista L. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
3281 Vannacci A. Risk of bone fractures among use... Visualizza
3282 Vannacci A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
3283 Vannacci A. Drug-utilization of new oral ant... Visualizza
3284 Vannacci A. Pharmacoutilization of Antidiabe... Visualizza
3285 Vannacci A. Adverse drug reactions in paedia... Visualizza
3286 Vannacci A. INTENSIVE MONITORING PROGRAM OF ... Visualizza
3287 Vannacci A. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
4664 Vannacci A. Incidence of ticagrelor-related ... Visualizza
4665 Vannacci A. Real-world evidence on the risk ... Visualizza
3288 Vantaggiato C. Inhibition of SIRT1 Deacetylase ... Visualizza
3289 Varani K. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
3290 Varani K. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
3291 Varani K. A2B adenosine receptors stimulat... Visualizza
3663 Varani K. Pulsed electromagnetic field med... Visualizza
3292 Varano F. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
3293 Varrenti M. Recombinant LCAT rescues defecti... Visualizza
3294 Vasaturo M. A multiple approach allowed unve... Visualizza
3295 Vasile E. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
3260 Vázquez E. CHARACTERIZATION OF THE MECHANIS... Visualizza
4666 Vecchiarelli A. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3296 Vecchiato M. Effects of the metronomic treatm... Visualizza
4667 Vecchio I. Identification and validation of... Visualizza
3297 Vecchio S. Methotrexate therapeutic error i... Visualizza
3298 Vecchio S. Antidote treatment in Viper enve... Visualizza
3299 Vegeto E. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
3300 Vegeto E. STUDY OF MICROGLIA PROLIFERATION... Visualizza
3301 Veglia F. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
3302 Veglia F. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3303 Veglia F. Recombinant LCAT rescues defecti... Visualizza
3304 Vellecco V. Kv7 channels are involved in hum... Visualizza
4668 Vellecco V. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3305 Velo GP. A prospective observational stud... Visualizza
3306 Venniro M. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
4669 Venniro M. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
3307 Ventura A. MODELING ROS1 TRANSLOCATION IN L... Visualizza
3308 Ventura A. THE ROLE OF THE mRNA BINDING PRO... Visualizza
3309 Ventura A. Pharmacoepigenomic markers invol... Visualizza
3310 Venturini A. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
3311 Venturini A. VULNERABILITY TO SEIZURES AND AS... Visualizza
4670 Venturini A. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
3312 Verdecchia P. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
4672 Verderio C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
3313 Verdini V. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
3314 Vergani L. VULNERABILITY TO SEIZURES AND AS... Visualizza
3315 Vergassola M. Prophylactic versus Therapeutic ... Visualizza
3316 Vergassola M. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
3317 Vergassola M. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3318 Vergori A. Pharmacokinetics of darunavir/co... Visualizza
3319 Verlato G. A prospective observational stud... Visualizza
3320 Verpelli C. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3321 Vetrano SV. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
3322 Vezzoli S. In vitro identification of molec... Visualizza
3323 Viana M. The pharmacogenetics of the resp... Visualizza
3324 Vianello C. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
3325 Vicentini LM. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
3326 Vicentini LM. FATTY ACIDS RESTORE IN VITRO ANG... Visualizza
3327 Vicini R. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
3328 Viganò F. GPR17-expressing oligodendrocyte... Visualizza
3329 Villa A. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
3330 Villa A. STUDY OF MICROGLIA PROLIFERATION... Visualizza
3331 Villa RF. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
3332 Vincenzi F. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
3333 Vincenzi F. A2B adenosine receptors stimulat... Visualizza
3334 Vincenzi F. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
3621 Vincenzi F. Allosteric modulation of A1 aden... Visualizza
3335 Vinckier S. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
3336 Vinueza D. Effects of ethanolic extracts of... Visualizza
3337 Viola E. A prospective observational stud... Visualizza
3338 Viola E. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4673 Viola E. WEB-BASED REPORTING OF ADVERSE D... Visualizza
3339 Viotti A. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
3340 Virdis A. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
4674 Virgili F. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
4675 Virgili G. COMPARATIVE EFFICACY OF ANTIEPIL... Visualizza
3341 Visca P. Development of hyaluronan/mannit... Visualizza
3342 Viscardi P. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
4676 Viscomi C. Identification and validation of... Visualizza
4677 Vitale A. THE PREDICTIVE VALUE OF ABCB1, A... Visualizza
3343 Vitale C. NSAIDs utilization in a large co... Visualizza
4678 Vitale C. Real-world evidence on the risk ... Visualizza
3344 Vitale D. Trends in Spontaneous Adverse Dr... Visualizza
3447 Vitale D.C. Off-label drug use and safety of... Visualizza
3448 Vitale D.C. Off-label drug use at the Policl... Visualizza
3449 Vitale D.C. Ensure patients access to invest... Visualizza
3345 Vitale DC. Off-label drug use at the Univer... Visualizza
3346 Vitali F. Renal impairment in very low bir... Visualizza
3347 Vitalone A. Effects of the metronomic treatm... Visualizza
3553 Vitalone A. Botanicals and vigilance... Visualizza
4679 Vitalone A. Suspected adverse reactions to h... Visualizza
3348 Vitarelli G. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
3349 Vitiello A. Pharmacoutilization of Antidiabe... Visualizza
3350 Vitiello A. Adverse drug reactions in paedia... Visualizza
3351 Vitiello A. Drug-utilization of new oral ant... Visualizza
3352 Vivaldi C. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
3353 Vivarelli F. The chemopreventive effects of i... Visualizza
3354 Vivarelli F. Effects of electronic cigarette ... Visualizza
3355 Vivarelli F. Development of microparticles fo... Visualizza
3356 Vivarelli F. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
3357 Vivo V. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
3358 Vivo V. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
3359 Vizzarri F. Evaluation of protective effect ... Visualizza
3360 Voci A. VULNERABILITY TO SEIZURES AND AS... Visualizza
4680 Volpi C. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
4681 Volpi C. REINSTALLING IMMUNE REGULATORY T... Visualizza
3361 Volpi CV. CpG type-A induction of an early... Visualizza
3362 Vona A. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
3363 Vona A. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
3364 Vona A. Studying the mechanism of rat ad... Visualizza
4682 Vrhovsek U. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
3365 Waldron KW. IN VITRO AND IN VIVO MODELING OF... Visualizza
3366 Wang G. Apolipoprotein E modulates adapt... Visualizza
3367 Warren BL. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
4683 Waters A. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3368 Weckhuysen S. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
3369 Weigl J. The chemopreventive effects of i... Visualizza
4684 Weinberger DR. A precision medicine genetic mar... Visualizza
3370 Werz O. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
4685 Werz O. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
4686 Whiteman M. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
4687 Wong I. LONG-TERM SAFETY OF DEFERIPRONE ... Visualizza
4688 Wood ME. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
4689 Woods A.S. A2A-D2 HETERODIMERS ON STRIATAL ... Visualizza
3371 Wurth R. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
3372 Wyns S. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4690 Yaqoob MM. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
4691 Yew DT. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
3373 Ylösmäki E. Role of miR-34a as biomarker and... Visualizza
3374 Zaccaria GM. The ABCB1 pharmacogenetics of R-... Visualizza
3375 Zambelli V. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
3376 Zamberletti E. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
3612 Zamberletti E. The non-psychotropic plant canna... Visualizza
4692 Zammataro M. Chronic treatment with fluoxetin... Visualizza
4693 Zampella A. The bile acid receptor GPBAR1 re... Visualizza
4694 Zanda MT. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
3377 Zanelli T. Characterization of adipokines s... Visualizza
3378 Zannoni A. Effects of ethanolic extracts of... Visualizza
4695 Zannoni A. In vitro effects of mediators de... Visualizza
3379 Zanotti DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
3380 Zanotti I. Proatherosclerotic effect of tri... Visualizza
4696 Zanusso C. Immunogenetics of prostate cance... Visualizza
4697 Zaveri NT. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
3381 Zhang M. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
3382 Zhang Y. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
3383 Zhao S. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
4698 Zhao S. Meninges are a reservoir for new... Visualizza
2028 ziche M. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
3384 Ziche M. The Impact Of ALDH-2 Activity On... Visualizza
3385 Ziche M. Tumor stemness and cancer drug-r... Visualizza
4699 Ziche M. Hydroxytyrosol inhibits EGFR sig... Visualizza
4700 Ziche M. IMMUNE RELATED ADVERSE EVENTS AS... Visualizza
4701 Ziche M. Interaction between mPGES-1 and ... Visualizza
3386 Zimetti F. Vitamin D replacement in pre-men... Visualizza
4702 Zinellu M. Real-time detection of ethanol i... Visualizza
3387 Zini I. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
3388 Zini I. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
3389 Zoccali R. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
4703 Zoli M. Rat Nicotine Sensitization Modul... Visualizza
3390 Zorzin S. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
3391 Zorzin S. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
3392 Zuccari G. Subcutaneous slow-release metfor... Visualizza
3393 Zucchini S. Sestrin 3 as a regulator of pro-... Visualizza
3394 Zulato E. Anti-angiogenic effect of therap... Visualizza